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  1Articular cartilage
The human knee joint is a complex synovial joint, consisting of a joint capsule, 
which is stabilized by ligaments and muscles, and articular cartilage, which is a 
hyaline tissue covering the ends of the long bones [1-4]. Articular cartilage 
provides a low-friction and load-bearing surface for efficient and flexible motion 
of joints [2, 5, 6] with an average thickness of 2.4 mm in load bearing areas in 
adults [5, 7]. Cartilage consists of chondrocytes embedded in a complex 
extracellular matrix (ECM, Fig. 1) [8, 9]. The cells are dispersed in the ECM at a low 
cell density of only 1-5% of the total volume [5-7]. The matrix components are 
synthesized and secreted by the chondrocytes, which also regulate matrix 
metabolism [4, 8]. The ECM consists mainly of water (about 80%) and solid 
materials (about 20%), where the “solid materials” contain collagen (60%), 
proteoglycans (30%) and other (glyco)proteins (10%) [7]. Collagen fibers and 
proteoglycans have important functions in resisting shear stresses and shock 
absorption [8]. The proteoglycans consist of a core protein with negatively charged 
glycoaminoglycans (GAGs), such as chondroitin sulfate and keratan sulfate [2]. 
GAGs are highly negatively charged and thereby attract small cations and water. 
This results in high water content and load-dependent deformation of the tissue. 
The ECM also functions as an environment to transduce signals to cells, store 
growth factors and cytokines, protect chondrocytes from mechanical stress, and 
Figure 1  Cross-section of healthy articular cartilage and the underlying subchondral bone 
(Safranin-O staining). Cells (blue) are dispersed in an extracellular matrix, consisting of water, 
collagen, proteoglycans and glycosaminoglycans (red). The subchondral bone (green) is found 
below the cartilage layer.
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help cells to maintain their phenotype [8]. Although the tissue appears biologically 
simple due to its avascular, aneural, alymphatic nature, and low metabolic 
activity, articular cartilage has a complex ECM organization that is important for 
its biomechanical properties [4, 5, 10].
Treatment of cartilage defects and the clinical problem
Traumatic injuries and osteoarthritis can result in disruption or loss of structure and 
function of cartilage, and patients with such defects often suffer from progressive 
joint dysfunction and pain [2, 4]. These defects do not heal spontaneously due to 
the avascular nature of the tissue and it remains a challenge to restore articular 
cartilage. Knee arthroplasty is a surgical procedure that may be applied to replace 
the articular surface by a prosthesis. Limitations of this surgical treatment are 
the costs and invasiveness, and revisions may be needed in time. Treatments such 
as microfracture surgery [11], mosaicplasty [12] and autologous chondrocyte 
implantation [13] are applied to regenerate cartilage tissue. Microfracture surgery, 
also known as bone marrow stimulation, aims to induce a reparative response by 
damaging the subchondral bone plate below the cartilage lesion to initiate 
bleeding and releasing mesenchymal stem cells, which form neotissue [14]. This 
procedure may be advantageous over other regenerative approaches because 
patients can be treated with one-stage minimally invasive surgery and patients 
will therefore experience less pain, have a shorter recovery period and require 
shorter hospitalization time. Moreover, harvesting of autologous cells and tissues 
is not needed, which avoids problems like donor-site morbidity, cell culture costs, 
off-the-shelf availability, regulatory issues, and multiple-stage surgical procedures 
[15]. The clinical outcome mainly depends on patient age and defect size, and the 
treatment results in long-term pain relief and restored knee function in 75% of 
the patients with subchondral defects [4]. Despite therapy, the formed neotissue 
generally consists of fibrocartilage, which has inferior mechanical and biological 
properties compared to native cartilage [15]. The difficulty for the regeneration 
of hyaline cartilage by bone marrow stimulation may be explained by the lack 
of direct control of the chondrogenic process, and the need to regenerate more 
durable cartilage tissue persists. A template to guide and stimulate cartilage 
regeneration as addressed in this study be may the solution [16].
11
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  1Cartilage regeneration using regenerative medicine and tissue engineering
Regenerative medicine and tissue engineering may offer promising alternatives 
and/or additions to clinical strategies that aim to restore damaged cartilage tissue. 
Regenerative medicine strives to restore normal body functions by repairing or 
replacing tissues and organs, and it encompasses various disciplines such as drug 
delivery, nanotechnology, proteomics, genomics, biochemistry, chemical engineering 
and tissue engineering. The field of tissue engineering focuses on applying scaffolds, 
cells and biologics to create functional tissues with the goal to restore, maintain, 
or improve tissue and organ function (Fig. 2) [17].
 Regenerative medicine may offer a promising addition to bone marrow 
stimulation by the implantation of scaffolds. The general efficacy of implanting 
acellular scaffolds after applying bone marrow stimulation (microfracture and 
Figure 2  Regenerative medicine and tissue engineering aim to regenerate tissues and 
organs. Regenerative medicine strives to restore normal body functions by repairing or 
replacing tissues and organs. Tissue engineering approaches can be applied to achieve this 
goal, which generally encompasses the construction of scaffolds and the incorporation of 
cells and biologics to create functional tissues.
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subchondral drilling) was demonstrated in a systematic review of literature 
and meta-analysis [18]. Results indicated superior cartilage regeneration after 
implantation of acellular scaffolds, which further improved by incorporation of 
biologics, compared to bone marrow stimulation alone. Although these results 
indicated that bone marrow stimulation in combination with the implantation of 
scaffolds is a promising strategy to restore cartilage tissue, the quality of neotissue 
does not yet resemble the tissue quality of native cartilage. Also regenerated 
cartilage using commercial products such as TruFit™ Bone Graft Substitute [19], 
ChondroMimetic™ [19] and Fin-Ceremica’s osteochondral biomimetic scaffold 
[20, 21] lacks the tissue quality of native articular cartilage [18]. Therefore, the 
need to improve implants for cartilage regeneration remains.
Unidirectional collagen scaffolds
In this thesis, the development of unidirectional collagen scaffolds and modifications 
for improvements related to mechanical strength, instructive cues and bioactivity 
were investigated. Unidirectional scaffolds are favorable to reconstruct tissues 
displaying an anisotropic extracellular matrix (ECM) as they provide a template 
for aligned ECM deposition to structurally and mechanically integrate with 
surrounding tissue [22, 23]. The newly formed ECM is deposited according to the 
scaffold structure [23, 24], which mimics the orientation of unidirectional collagen 
fibrils and steers the arrangement of chondrocytes in vertical columns, while 
joint loading should ultimately remodel the tissue to resemble the complex 
organization of native cartilage [5, 6]. Type I collagen is the most abundant 
scaffolding material in the body, and can be used to construct biocompatible, 
biodegradable and bioactive collagen scaffolds by lyophilization [25]. However, 
the use of type II collagen seems a logical choice for scaffold construction since 
type II collagen is the structural component in cartilage used by nature. 
Comparing type I and type II collagen scaffolds indicated that type I collagen 
scaffolds are also suitable for cartilage regeneration since dedifferentiated 
chondrocytes are able to redifferentiate in PLGA-type I collagen hybrid meshes 
[26] and gene expressions for chondrocytes were similar when cultured in type I 
and type II collagen scaffolds [27]. Additionally, the use type I over type II collagen 
to construct collagen scaffolds may be favorable since less cell migration was 
found in type II collagen scaffolds in vivo because cells were directed into a 
chondrogenic phenotype upon arrival in the scaffolds, while type I collagen 
scaffolds facilitated the influx of progenitor cells from the subchondral bone 
towards the defect site and throughout the implanted scaffolds [28]. Type I 
unidirectional collagen scaffolds have been implanted in osteochondral defects 
13
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  1where they facilitated the migration of bone marrow-derived mesenchymal stem 
cells (MSCs) [29]. 
Improving unidirectional collagen scaffolds
Cartilage regeneration may be improved by applying unidirectional collagen 
scaffolds with improved bioactivity. Regeneration guided by the unidirectional 
scaffold as a template and activated by incorporated biological stimuli has not 
been investigated [29]. 
 MSCs sense the scaffold substrate upon arrival in the scaffold. Intrinsic 
structural properties of scaffolds have been shown to regulate cellular migration, 
attachment, viability and differentiation [30, 31]. For example, it has been shown 
that MSCs preferentially adhere to ridged surfaces [32] and that micro- and 
nanoscale features can enhance chondrogenesis [33-35]. Incorporation of 3D 
topographical features in unidirectional collagen scaffolds may enhance 
chondrogenesis of MSCs. 
 Bone and cartilage development is guided by various growth factors, of 
which the spatiotemporal presence of these biologicals guides osteochondral 
maturation [36]. Of these biologics, incorporation of stromal cell-derived factor-1 
to the scaffold may results in the attraction of MSCs from the bone marrow 
towards the implant [37]. Growth factors such as bone morphogenetic protein 
(BMP), transforming growth factor beta (TGF-β) and fibroblast growth factor (FGF) 
have been incorporated in scaffolds to stimulate cartilage regeneration [38]. 
Growth factors can be loaded to collagen scaffolds by their non-covalent 
interaction with glycosaminoglycans (GAGs) covalently immobilized to collagen 
scaffolds [39-45]. The non-covalent immobilization of growth factors to GAGs is 
important for growth factor signaling, controlling the dose and bioactivity, and to 
protect growth factors from degradation [46, 47]. Unidirectional collagen scaffolds 
with enhanced bioactivity may be prepared by loading of growth factors 
stimulating cartilage regeneration.
 Various strategies to improve unidirectional collagen scaffolds were developed, 
as described in this thesis, and were related to (Fig. 3):
(1)  incorporation of topographical features to steer chondrogenic differentiation 
of MSCs
(2)  enhancement of bioactivity to stimulate osteochondral regeneration
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Aim and outline of this thesis
Central concept and clinical considerations: development of clinically 
applicable instructive implants to regenerate cartilage
This research focuses on the construction and evaluation of instructive 
unidirectional collagen scaffolds. The vision of the research strategy encompasses 
the implementation of different components in scaffolds, which are considered 
important features for implants to regenerate articular cartilage. Overall, 
increased bioactivity in an unidirectional collagen scaffold, which facilitates 
infiltration of bone marrow-derived MSCs [29] and steers deposition of ECM 
Figure 3  Representation of the research strategy; development and in vitro evaluation of 
bioactive unidirectional collagen scaffolds, as potential implants to induce cartilage 
regeneration after bone marrow stimulation. The unidirectional architecture facilitates 
the influx of bone marrow-derived mesenchymal stem cells (MSCs) and provides a template 
to mimic collagen fibril orientation and columnar organization of chondrocytes. The 
following additions were addressed: 1) incorporated topographical features to steer 
chondrogenic differentiation of MSCs and 2) increased bioactivity by growth factor loading 
to stimulate cartilage regeneration.
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Figure 1. Cartilage regeneration by implantation of unidirectional collagen scaolds in 
osteochondral defects. The architecture of the scaold facilitates inux of bone marrow-derived 
mesechymal stem cells and provides instructions to mimic the native orientation of collagen
brils and columnar chondrocyte organization.
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  1according to the architecture of the template [23, 24], may result in a medical 
device inducing cartilage regeneration. 
 Unidirectional collagen scaffolds are acellular devices and can be prepared 
from medical-grade collagen in GMP facilities. As a new technology in clinical 
practice, the consideration between acellular and cell-laden scaffolds is important. 
By applying acellular scaffolds, the advantages of bone marrow stimulation are 
maintained, including off-the-shelf availability and the absence of cell culture 
costs [48, 49]. 
The overall goal of this study was to develop an off-the-shelve construct to be 
used in combination with bone marrow stimulation for the regeneration of 
articular cartilage.
In chapter 2, a systematic review and meta-analysis was performed to assess all 
current evidence for the efficacy of articular cartilage regeneration using acellular 
biomaterials implanted in the knee and ankle joint after bone marrow stimulation 
in animal models. This systematic review aimed to provide an overview of 
currently existing knowledge and identify knowledge gaps, to provide 
transparency on the quality of performed in vivo studies, and to aid the design of 
future animal studies and clinical trials. 
 In chapter 3, a systematic search of literature including a meta-analysis was 
conducted to assess the efficacy of implanting cell-seeded versus cell-free implants 
on cartilage regeneration. 
 In chapter 4, an adjustable directional freezing method to develop porous 
collagen scaffolds with aligned unidirectional pores is described. 
 In chapter 5, the effect of pore orientation in collagen scaffolds on cartilage 
regeneration in vitro is described. 
 In chapter 6, 3D topographical features were incorporated in collagen 
scaffolds by lyophilization, and the effect on cell differentiation is described.
 In chapter 7, the bioactivity of unidirectional collagen scaffolds was improved 
by the incorporation of BMP2.
 In chapter 8, we changed gears, and focused on another organ, the bladder, 
where we introduced unidirectional pores using a different methodology, allowing 
the construction of a large acellular spherical hollow construct.
 In chapter 9, the findings of this thesis are summarized and future perspectives 
are indicated.
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Abstract
Microfracture surgery may be applied to treat cartilage defects. During the 
procedure the subchondral bone is penetrated, allowing bone marrow-derived 
mesenchymal stem cells to migrate towards the defect site and form new cartilage 
tissue. Microfracture surgery generally results in the formation of mechanically 
inferior fibrocartilage. As a result, this technique offers only temporary clinical 
improvement. Tissue engineering and regenerative medicine may improve the 
outcome of microfracture surgery. Filling the subchondral defect with a 
biomaterial may provide a template for the formation of new hyaline cartilage 
tissue. In this study, a systematic review and meta-analysis were performed to 
assess the current evidence for the efficacy of cartilage regeneration in preclinical 
models using acellular biomaterials implanted after marrow stimulating 
techniques (microfracturing and subchondral drilling) compared to the natural 
healing response of defects. The review aims to provide new insights into the 
most effective biomaterials, to provide an overview of currently existing 
knowledge, and to identify potential lacunae in current studies to direct future 
research. A comprehensive search was systematically performed in PubMed and 
EMBASE (via OvidSP) using search terms related to tissue engineering, cartilage 
and animals. Primary studies in which acellular biomaterials were implanted in 
osteochondral defects in the knee or ankle joint in healthy animals were included 
and study characteristics tabulated (283 studies out of 6688 studies found). For 
studies comparing non-treated empty defects to defects containing implanted 
biomaterials and using semi-quantitative histology as outcome measure, the risk 
of bias (135 studies) was assessed and outcome data were collected for meta-analysis 
(151 studies). Random-effects meta-analyses were performed, using cartilage 
regeneration as outcome measure on an absolute 0-100% scale. Implantation of 
acellular biomaterials significantly improved cartilage regeneration by 15.6% 
compared to non-treated empty defect controls. The addition of biologics to 
biomaterials significantly improved cartilage regeneration by 7.6% compared to 
control biomaterials. No significant differences were found between biomaterials 
from natural or synthetic origin or between scaffolds, hydrogels and blends. No 
noticeable differences were found in outcome between animal models. The risk of 
bias assessment indicated poor reporting for the majority of studies, impeding an 
assessment of the actual risk of bias. In conclusion, implantation of biomaterials 
in osteochondral defects improves cartilage regeneration compared to natural 
healing, which is further improved by the incorporation of biologics.
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Introduction
Articular cartilage is a specialized tissue that covers joint surfaces and provides a 
low-friction and load-bearing surface for a smooth motion of joints. The structure 
and function of the tissue can be compromised by traumatic injuries and 
degenerative joint diseases. Due to its avascular nature, damaged cartilage tissue 
does not heal spontaneously and it remains a challenge to fully restore tissue 
function [1, 2].
 The surgical options to treat patients with a localized cartilage defect are 
limited to cartilage regeneration approaches such as autologous chondrocyte 
implantation and microfracture surgery [3, 4]. The latter strategy, also known as 
bone marrow stimulation, is relatively simple, minimally invasive and inexpensive. 
During this procedure the subchondral bone plate below the cartilage lesion is 
perforated to initiate bleeding and induce a reparative response. The principle 
behind this regenerative resurfacing strategy is the migration of non-differenti-
ated bone marrow-derived multipotent stem cells from the subchondral bone 
into the defect site leading to the formation of new cartilage tissue [5-7]. Patients 
treated with bone marrow stimulation generally show clinical improvements up 
to 1.5 - 3 years after surgery. However, five years after surgery higher incidences of 
clinical failures are observed [8, 9]. The newly formed tissue generally consists of 
fibrocartilage repair tissue rather than hyaline cartilage, has limited filling of the 
defect, integrates poorly with the surrounding tissue and has inferior mechanical 
properties compared to hyaline cartilage [10]. Therefore, the need for regeneration 
of more durable cartilage tissue persists.
 Regenerative medicine and tissue engineering may offer promising alternatives 
and/or additions to clinical strategies that aim to restore damaged cartilage 
tissue. The construction of biomaterials and the incorporation of cells and 
biologics in these implants have been widely investigated for this purpose. 
Biomaterials can be implanted in osteochondral defects created by applying 
marrow stimulating techniques (microfracture and subchondral drilling [11]) to 
guide and stimulate the formation of cartilage tissue [12]. During microfracture 
surgery an arthroscopic awl is used to penetrate the subchondral bone, while 
with subchondral drilling a high speed drill is applied to penetrate the trabecular 
bone. Different strategies have been applied including the implantation of 
biomaterials with and without cells. Acellular biomaterials offer various 
advantageous properties such as lack of donor-site morbidity, absence of cell 
culture costs, off the shelf availability, fewer regulatory issues, and application of 
one-stage surgical procedures [13, 14]. Many researchers have explored the 
approach of implanting acellular biomaterials and investigated the use of various 
biomaterials in vivo, such as natural (e.g. collagen [6, 15-17], chitosan [18-21], 
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alginate [22-24] and hyaluronic acid [4, 25-27]) and synthetic polymers (e.g. poly-
caprolactone [28-30], polyvinyl alcohol [31-33] and poly(lactic-co-glycolic acid) 
[34-37]). To combine the advantageous properties of these materials, multilayered 
biomaterials (e.g. β-tricalcium phosphate-hydroxyapatite/hyaluronate-atelocollagen 
[2], ceramic bovine bone-gelatin/gelatin-chondroitin sulfate-sodium hyaluronate 
[38]), blends (e.g. poly(glycolic acid)-hyaluronic acid [7] and type I  collagen- 
hyaluronic acid-fibrinogen hydrogel [39]) have been constructed. Biologics are 
natural factors that can be used to stimulate tissue regeneration, e.g. by inducing 
proliferation and differentiation of cells. Biologics such as growth factors of 
the transforming growth factor β (TGF-β) superfamily and others have been 
incorporated in biomaterials to guide and stimulate the formation of hyaline 
cartilage tissue [40]. Moreover, it has been reported that the animal model of 
choice may have a significant impact on study outcome of articular cartilage 
regeneration [41]. Currently, there is no systematic overview of the current 
Figure 1  Illustration of cartilage regeneration by implantation of biomaterials after bone 
marrow stimulation. The implanted biomaterials provide a template to guide cartilage 
regeneration by bone marrow derived mesenchymal stem cells.
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literature assessing the effect of various parameters (e.g. applied biomaterials, 
incorporated biologics and animal models) on cartilage regeneration. 
 The aim of this systematic review and meta-analysis is to assess all current 
evidence for the efficacy of articular cartilage regeneration using acellular 
biomaterials implanted in the knee and ankle joint after microfracture and 
subchondral drilling in animal models. Additionally, we strive to provide 
transparency on the quality of performed in vivo studies, in order to aid the design 
of future animal experiments and clinical trials. We provide a systematic and 
unbiased overview of the current literature addressing regeneration of articular 
cartilage using a wide range of acellular biomaterials containing various 
biological cues (as illustrated in Fig. 1). Results of semi-quantitative histological 
scoring systems are used as a quantitative outcome parameter for outcome 
assessment of cartilage regeneration. Although microfracture surgery and 
subchondral drilling strive to stimulate cartilage and osteochondral regeneration, 
respectively, both are generalized in this study as cartilage regeneration. 
Moreover, the evaluation of different subgroups (natural and synthetic origin of 
the biomaterials, structure of the materials (scaffolds vs. hydrogels), incorporated 
biological cues, and animal models) was included to gain insights in which 
parameters affect cartilage regeneration and to what extent. 
Materials and Methods
Search strategy
To identify relevant peer-reviewed articles, a comprehensive search of the 
literature using PubMed and EMBASE (via OvidSP) was conducted, using the 
methods defined by de Vries et al. [42] and Leenaars et al. [43]. The last search date 
was April 3rd 2015. In both databases, a tissue engineering search component 
developed by Sloff et al. [44], consisting of equivalents for tissue engineering (e.g. 
tissue regeneration, regenerative medicine, bio-engineering or biomatrices), was 
combined with a cartilage search component, consisting of equivalents for 
cartilage and cartilage-related surgeries (e.g. chondral, chondrogenic, surgery, mi-
crofracturing or implants). The search components were constructed using MeSH 
terms (PubMed) and EMTREE terms (EMBASE) and additional free-text words 
from titles or abstracts ([tiab] or ti,ab). The obtained tissue engineering-related 
and cartilage-related results were filtered for animal studies using previously 
described animal search filters [45, 46]. The complete search strategy is attached 
in Supplementary Information 1. No language restrictions were used.
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Study selection
References from the PubMed and EMBASE search strategies were combined and 
duplicates were manually removed from EndNote, with the preference of PubMed 
over EMBASE. All screening phases were performed by two independent reviewers 
(MP and VG) and reported according to the “Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis” (PRISMA) guidelines [47]. References 
were first screened based on title and were excluded based on the following 
criteria: 1) titles showed no relevance to regeneration of articular (hyaline) 
cartilage, 2) it was specifically stated in the title that the conducted experiment 
was an in vitro study only, 3) osteoarthritis animal models were used, 4) only 
ex vivo studies were performed, and 5) deceased animals were used. In case of 
doubt or disagreement, references were included for further screening. The second 
screening phase consisted of a title/abstract screening in Early Review Organizing 
Software (EROS, Institute of Clinical Effectiveness and Health Policy, Buenos 
Aires, Argentina, www.eros-systematic-review.org). References were included 
based on the following inclusion criteria: 1) primary study, 2) animal model, 3) 
bone marrow stimulation by microfracturing or creation of an osteochondral 
defect, and 4) biomaterial implantation. Articles were only excluded when it was 
specifically stated in the abstract that the study was performed without healthy 
animals or acellular biomaterials, or if biomaterials were not implanted in the 
knee or ankle joint. Articles were not excluded in case important information in 
the abstract was missing. These articles were assessed in the full-text screening 
phase. For the full-text screening, articles were included if they met all of the 
following inclusion criteria: 1) primary study, 2) animal model, 3) healthy animals, 
4) articular cartilage regeneration, 5) knee or ankle joint, 6) bone marrow 
stimulation by microfracturing or creation of an osteochondral defect, and 7) 
implantation of an acellular biomaterial. In general, if results of the two reviewers 
were different, articles were discussed until consensus was reached. In case of 
double publication, one of the studies was removed. During the screening phase, 
no selection was made based on publication language. The risk of bias assessment 
and meta-analysis was applied to studies with a comparison between a 
non-treated empty defect control and biomaterial implantation, and with 
semi-quantitative histological scoring system results as outcome data. 
Study characteristics
From the studies included after the full-text screening, the following details were 
obtained: general information (author and year of publication), animal character-
istics (species, strain, sex, age, weight and the number of animals), information 
related to the surgical defect (size, depth and location), experimental conditions, 
biomaterial, biologics, evaluation time points and all outcome measures used, i.e. 
27
Cartilage regeneration using acellular implants
Ch
ap
te
r  
  2
macroscopic evaluation, semi-quantitative macroscopic evaluation, histology, 
immunohistochemistry, semi-quantitative histological scoring, and biomechanical 
tests. Data from semi-quantitative histological scorings were used in the meta- 
analysis (described in section 2.5). Histological scoring systems applied in different 
studies consisted of scoring parameters like cell morphology, Safranin-O staining, 
integrity of surface, thickness, surface of area filled with cells, chondrocyte clustering, 
degenerative changes, restoration of the subchondral bone and integrity.
Risk of bias assessment
A risk of bias analysis was performed to assess the methodological quality of the 
studies included in the meta-analysis, using an adapted version of the risk of bias 
tool described by Hooijmans et al. [48] (for all included studies containing a 
‘non-treated empty defect’ as control group and studies using semi-quantitative 
histological scoring systems as outcome measure). A flowchart was constructed 
(Supplementary Information 2) to score for selection, performance, detection and 
attrition bias, where the scores ‘-‘, ‘?’ and ‘+’ indicate a low, unknown and high risk 
of bias, respectively. The questions addressed are specified in the Supplementary 
Information 2. Articles were scored independently by MP and VG, and if the results 
of the two reviewers were different, results were discussed until consensus was 
reached. All articles written in Chinese (16 studies) were excluded from the risk of 
bias assessment only, due to limited resources to independently translate these 
articles by two native Chinese speakers. However, the data of these studies were 
extracted and used in the meta-analysis.
Analysis preparations and meta-analysis
Analysis preparations
The statistical analyses were restricted to those studies containing the outcome 
measure semi-quantitative histology, making a comparison between a ‘non- 
treated empty defect’ as control group and implanted biomaterials as experimental 
group. Data (mean, standard deviation (SD) and number of animals) of the control 
and experimental group were extracted from the studies, for all available time 
points. When results were not given numerically, but depicted graphically, the 
mean and SD were measured using ImageJ (1.46r, National Institutes of Health 
USA). For studies presenting results in boxplots, the mean and standard deviation 
were recalculated from the median, range and the sample size according the 
method described by Hozo et al. [49]. When data were described by a mean and 
confidence interval (CI), the CI was recalculated to a standard deviation by the 
following equation for a 95% CI [47]:
standard deviation upper limit – lower limit3.92   
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For some studies, data were unclear and assumptions were made, which are listed in 
Supplementary Information 3. To compare studies with different histological score 
system scales, means and standard deviations were converted to a 100% scale by 
dividing the result by the maximum achievable histological score and multiplying 
by 100%. In case of missing or unclear data, authors were e-mailed to retrieve the 
data. When data could not be obtained, these studies were excluded from the 
meta-analysis (reasons for exclusion are also given in Supplementary Information 
3). Results of studies with several experimental groups were combined, following 
the approach described in the Cochrane Handbook, table 7.7 [47]. The same 
approach was followed to combine results of different animals on several time 
points in the same group in the same study. One study (Hamanishi, 2013 [50]) had 
an SD of zero, which caused problems in the analyses. Therefore, the SD was 
changed to 4.29, equal to the SD of the experimental group of the same study at 
the same time point. The resulting data were used to calculate the treatment 
effect and corresponding standard error (SE) per study.
Meta-analysis
The following main research question was assessed: Does an overall beneficial 
effect exist of implanting acellular biomaterials in osteochondral defects 
compared to non-treated empty defects? 
 First, in order to select the appropriate statistical random-effects meta-analysis 
model, we compared a univariate approach to the bivariate approach. In the 
bivariate approach, separate outcomes for control and experimental group were 
used with their respective SEs. The correlation between these two outcomes was 
modeled with a compound symmetry covariance matrix, as this resulted in a 
much lower Akaike Information Criterion value than the use of an unstructured 
covariance matrix. Results were compared with those of the univariate approach, 
based on the treatment effect and SE per study. Results of the univariate and 
bivariate approaches were very similar and we therefore proceeded with the 
univariate approach, when applicable in combination with likelihood ratio tests. 
 Restricted to the experimental groups, the following sub-questions were 
addressed to evaluate whether the treatment effect depended on specific 
variables: 1) Is there a difference between the use of natural and synthetic 
biomaterials?; 2) Does the structure of the biomaterials affect cartilage 
regeneration?; 3) Do differences among various material subgroups exist?; 4) Does 
incorporation of biologics have a beneficial effect on cartilage regeneration 
compared to control biomaterials?; 5) Do differences among subgroups of biologics 
exist?; 6) Do different animal models result in variations in cartilage regeneration? 
Results are shown as % cartilage regeneration (95% CI: [lower CI, upper CI]. Some 
studies have more than one experimental group. Therefore, the total number of 
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studies and number of experimental groups (no. of studies/groups) are provided.
Sensitivity analyses were performed to evaluate the effect of time (e.g. all time 
points, short (≤ 8 weeks), long time points (> 8 weeks), or the maximum time 
point), outliers (excluding consecutively the studies with the 10% highest / lowest 
pooled SD, and studies with the 10% highest / lowest SE), implant location, bone 
marrow stimulating technique applied (microfracturing vs. subchondral drilling), 
language (excluding studies reported in Chinese as the risk of bias of these studies 
was not assessed), and excluding studies where assumptions had to be made. 
Based on a pilot analysis, data of all time points were used for subgroup analyses. 
Subgroup analyses were only performed for subgroups consisting of more than 
two groups.
 The statistical analyses were performed with SAS/STAT® software version 9.2 
for Windows, copyright© 2002-2008 by SAS Institute Inc., Cary, NC, USA. The 
funnel plot shows the overall outcome of the pooled effect size of each study. I2 
was used as a measure of heterogeneity. The forest plot was created with 
ReviewManager (RevMan, Version 5.3. Copenhagen: The Nordic Cochrane Centre, 
The Cochrane Collaboration, 2014).
Results
Search and study inclusion
The searches conducted in PubMed and EMBASE (Supplementary Information 1) 
resulted in 4401 and 5986 studies, respectively, leaving 6688 studies after removal 
of duplicates. These studies were screened by title and title/abstract, which 
resulted in 1088 included studies after the title screening and 517 included studies 
after the title/abstract screening. Screening articles by full-text and subsequently 
selection for studies with empty defect controls as well as semi-quantitative 
histology as outcome measure resulted in 283 included studies after full-text 
assessment, of which 151 and 135 articles could be used for the meta-analysis and 
risk of bias assessment, respectively (Fig. 2). The studies from Xie et al. [51], Yao et 
al. [52] and Zhou et al. [53] could not be retrieved as a full text and these studies 
were therefore excluded. An overview of all included studies after full-text 
assessment as well as studies included for the risk of bias assessment and 
meta-analysis is provided in Supplementary Information 3. All references and 
abbreviations can be found in Supplementary Information 4. In this table, remarks 
are provided related to exclusion reasons for risk of bias assessment and 
meta-analysis (e.g. duplicate publication and incomplete data). Assumptions 
made for certain studies are also stated in this table.
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Study characteristics
The study characteristics (Supplementary Information 3) clearly show substantial 
variation among studies. A wide range of animal species was used, from small 
(rat and rabbit) to larger animal models (dog, minipig, goat, pig, sheep and horse). 
A large variation was observed between the ages of animals (e.g. the age of rabbits 
ranged from 6 weeks to >2 years). Often ages were not described or specified 
specifically (e.g. as adult or mature). Generally, the animals were older (range of 
years) in large animal models compared to animals used in small animal models 
(range of months). The defects were created at different locations in the knee joint, 
such as the trochlea, condyle (medial and lateral), femur and intercondylar fossa. 
In addition, a large variation was found in the dimensions of the prepared defects, 
e.g. the dimensions of the defects created in rabbits ranged from 4-7 mm in 
diameter and 0.8-9 mm in depth. Microfracture surgery and subchondral drilling 
Figure 2  PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analysis) 
flowchart of the systematic search of literature.
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was performed in 25 and 258 studies, respectively. The implanted biomaterials 
were of natural or synthetic origin or combinations thereof, and consisted of 
single-layered or multilayered implants or blends thereof. Implants were constructed 
from a wide range of materials or combinations thereof, such as collagen, chitosan, 
hyaluronic acid, alginate, fibrin, hydroxyapatite, poly(lactic-co-glycolic acid), 
polycaprolactone, poly(glycolic acid) and poly(ethylene glycol), and used in 
different states: scaffolds, hydrogels, or hybrid mixtures of both. Various biological 
cues were incorporated in the biomaterials prior to implantation or administered 
afterwards by injection into the knee joint, mostly growth factors of the TGF-β 
superfamily such as bone morphogenetic protein 2 (BMP-2) and TGF-β1, but also 
fibroblast growth factor (FGF) and platelet-rich plasma (PRP). The maximum 
follow-up time was 1 year, but studies mainly investigated relatively short-term 
effects of implanted biomaterials on cartilage regeneration (up to 6 months).
Risk of bias assessment
A risk of bias assessment was performed to assess risks of bias (selection, performance 
bias, detection and attrition bias) in studies included for the meta-analysis (Fig. 3). 
An overview of all scores per individual study is provided in Supplementary 
Information 6. 
Figure 3  Risk of bias of all included studies in the meta-analysis. The green, orange and red 
colors depict the percentages of studies with low, unknown or high risk of bias of the total 
number of assessed studies. The risk of bias assessment indicated a general lack of details 
regarding the experimental setup, as indicated by the orange bars. The green bars represent 
a low risk of bias, mainly for the difference between groups at the moment of surgical 
intervention and addressing incomplete outcome data. High risk of bias was infrequently 
scored, as indicated by the red bars. Q4-Q6 are not depicted in the graph, but are described 
in Supplementary Information 6.
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 The risk of bias assessment showed that details with respect to the 
randomization method were not provided (Q1). It was often described that 
animals were randomized across different groups without describing the method 
of randomization, thereby limiting assessment of the adequacy of randomization 
and therefore the actual risk of selection bias. Another notable observation from 
the experimental designs studied was that only in a limited number of studies it 
was described that power calculations were performed, whereas sufficient power 
in animal experiments is a requirement for performing adequate studies. 
The actual power analyses were never provided in the studies. Due to a lack of 
information, it was also difficult to assess possible bias by differences in implantation 
sites (with differences in load-bearing conditions, Q2.1) and differences between 
groups related to the age, sex and weight of the animals at the start of the 
experiment (Q2.2). Generally, baseline characteristics of animals prior to 
implantation of biomaterials (e.g. some animals received additional surgery 
related to harvesting of cells for biomaterials combined with cells, Q2.3) were 
similar. When implanting biomaterials, no details were described on blinding 
different biomaterials (Q3). 
 Blinding of the empty defect and biomaterial conditions should be performed 
to limit bias. However, blinding between the empty defect and biomaterial group 
is impossible in case only one biomaterial is implanted. More than half of the 
studies conducted blinded outcome assessment while performing the histological 
scoring, resulting in low risk of detection bias, whereas the other studies had an 
unknown risk (Q7). For most studies, no incomplete outcome data were described/
found, resulting in low risk of attrition bias. For some studies, dropouts were 
described/found, resulting in differences between groups and high risk of bias 
(Q8). Overall, the risk of bias analysis generally revealed poor reporting of the 
experimental design for the majority of the studies, impeding an assessment of 
the actual risk of bias.
Data synthesis
For an overview of the meta-analysis and results obtained, see Table 1. The 
histological scores of defects implanted with biomaterials and non-treated empty 
defects are presented as a percentage on a 100% scale, where 0% and 100% indicate 
poor and perfect cartilage regeneration, respectively. Data are presented as the 
effect (%) with 95% CI.
Overall effect biomaterial implantation
The meta-analysis indicates a significant improvement of cartilage regeneration 
using acellular biomaterials implanted after applying marrow stimulating 
techniques compared to non-treated empty defects (15.6% (95% CI: [12.6, 18.6], 
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p < 0.0001). The forest plot (Supplementary Information 7) depicts the outcome 
effect of each individual study. In 73 studies cartilage regeneration significantly 
improved by the incorporation of biomaterials. In 48 studies no effect was found, 
whereas in only 6 studies a negative effect on cartilage regeneration was 
observed. A similar significant effect was observed taking into account the 
maximum follow-up only (16.3% [13.1, 19.6], p < 0.0001). Also for short and long 
term follow-up cartilage regeneration was significantly improved (≤ 8 weeks: 
12.5% [9.3, 15.7], > 8 weeks: 17.1% [13.9, 20.2]). No notable differences in cartilage 
regeneration were found between the results based on the maximum follow-up 
time per study versus those based on all time points per study. Therefore, further 
subgroup analyses were made using results from all time points together. 
Natural and synthetic materials
The subgroup analysis assessing cartilage regeneration using materials of different 
origin, natural and synthetic, indicated no significant differences (p = 0.887) 
between natural (53.0% [49.31, 56.63]) and synthetic materials (53.7% [48.75, 58.65]). 
 Dividing the group of materials into subgroups allows comparison of cartilage 
regeneration using different biomaterials. The following subgroups were studied: 
1) collagen, 2) chitosan, 3) hyaluronic acid-based biomaterials), 4) alginate, 5) fibrin), 
6) bone material-based, 7) PLGA, and 8) PAMPS-PDMAAm DN hydrogel. No significant 
differences between the biomaterial subgroups were found (Table 1).
Material structure
Materials were divided in three groups based on their structure: 1) scaffolds, 2) 
hydrogels, and 3) blends. Cartilage regeneration was similar after use of scaffolds 
(53.1% [49.53, 56.74]), hydrogels (54.2% [49.39, 59.07]) and blends (55.7% [42.0, 69.3), 
p = 0.973.
Biologics
Incorporation of biologics in the biomaterials resulted in a statistically significant 
improvement in cartilage regeneration of 7.6% [2.1, 13.0], p = 0.007, compared to 
the implantation of control biomaterials. Including only those studies with a 
direct comparison between control biomaterials and biomaterials loaded with 
biologics resulted in an improved cartilage regeneration of 14.6% [5.9, 23.4], 
p = 0.003. Comparing various biological cues including BMP, FGF, PRP and TGF 
indicated no significant differences in improvement of cartilage regeneration 
between these biologics.
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Animal models
Evaluation of the animal models used showed no significant differences (p = 0.348) 
between the effects of biomaterials implanted in dogs, goats, macaques, minipigs, 
pigs, rabbits, rats or sheep (Table 1).
Sensitivity analyses
Sensitivity analyses were performed to assess the robustness of the meta-analysis 
with respect to the overall effect. The sensitivity analyses indicated that exclusion 
of studies with assumptions and studies written in Chinese (no risk of bias 
assessment analyzed) had no effect on the estimated difference in biomaterial 
regeneration. Moreover, including only studies with SDs or SEs in the 10-90% 
range did not notably change of the overall outcome effect. In a post-hoc analysis, 
we investigated cartilage regeneration using biomaterials implanted at different 
locations including condyles, femur, intercondylar fossa and the trochlea. No 
differences were found comparing these implant sites (p = 0.143). In another 
post-hoc analysis, we compared cartilage regeneration of empty defects or defects 
filled with biomaterials after applying microfracturing or subchondral drilling. 
For empty defects (p = 0.152) and biomaterial implants (p = 0.063) no significant 
differences between the two bone marrow stimulating techniques were found. 
Figure 4  Funnel plot of included studies to assess the overall effect of the implantation of 
acellular biomaterials compared to non-treated empty defect controls. The figure indicates 
no substantial asymmetry.
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Publication bias
A funnel plot (Fig. 4) was prepared for all included studies to analyze the overall 
comparison between acellular biomaterials and non-treated empty defect controls. 
No extensive asymmetry was observed, indicating an absence of considerable 
publication bias.
Discussion
The regeneration of damaged cartilage has been widely investigated using 
preclinical models. However, the efficacy of cartilage regeneration using 
implantation of acellular biomaterials has never been assessed using a systematic 
review and meta-analysis. This systematic review aimed (a) to provide an 
overview of currently existing knowledge and identify knowledge gaps, (b) to 
provide transparency on the quality of performed in vivo studies, and (c) to aid the 
design of future animal studies and clinical trials. The results could provide 
insight in strategies for future (pre) clinical research related to biomaterial 
properties, incorporation of biologics, choice of a suitable animal model, and their 
effects on cartilage regeneration.
 The general findings of this systematic review and meta-analysis are that the 
implantation of biomaterials improves cartilage regeneration compared to 
non-treated osteochondral defects by 16% (95% CI). There were only six out of 151 
studies that showed a negative effect of biomaterial implantation on cartilage 
regeneration. In 48 studies no significant effect on cartilage regeneration was 
found. For those studies with improved cartilage regeneration (73 studies), clinical 
studies will have to confirm the beneficial effect of implantation of biomaterials 
on cartilage regeneration in human patients. Filardo et al. described the 
implantation of an osteochondral biomimetic scaffold consisting of a type I 
collagen cartilage-like layer, a type I collagen/hydroxyapatite intermediate layer, 
and a mineralized blend of type I collagen and hydroxyapatite as a subchondral 
bone compartment, to treat patients with osteochondritis dissecans. For these 
patients, clinical scores improved significantly after the first two years and 
evaluation by MRI indicated good defect filling and implant integration, but also 
heterogeneous tissue regeneration and changes of the subchondral bone [54]. In 
two studies included in this systematic review and meta-analysis, this 
osteochondral biomimetic scaffold was also implanted in sheep. Cartilage 
regeneration after six months was 81.8% ± 8.9% (empty defect: 23.2% ± 20.7%) and 
81.2% ± 5.1% (empty defect: 23.4% ± 6.7%). A direct comparison between the degree 
of cartilage regeneration described in the preclinical studies and clinical study is 
not possible since no histological results were described in the clinical study. In 
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addition, outcome measures used in preclinical studies may not predict the 
clinical outcome. For example, a randomized controlled clinical trial with 
BST-CarGel, a chitosan-based medical device, showed greater lesion filling and 
superior repair tissue quality compared to bone marrow stimulation after twelve 
months implantation, but without notable clinical differences related to pain, 
stiffness and physical function between both groups [55]. A remarkable 
observation is the difference in follow-up between the studies, which may 
explain the good histological scores in the preclinical studies after six months 
and heterogeneous tissue regeneration and changes of the subchondral bone 
after two years in human patients. In general, clinical studies demonstrated 
improved cartilage regeneration by the implantation of biomaterials after bone 
marrow stimulation, but there is still room for improvement regarding clinical 
outcome and tissue quality.
 The only subgroup analysis that showed a statistically significant result 
between the groups was between control biomaterials and biomaterials loaded 
with biologics. In future clinical studies assessment of the beneficial properties of 
implanting biomaterials loaded with biologics is of interest, since a significant 
improvement of 8% (95% CI) compared to control biomaterials was found and 
even 14.6% when using studies that directly compared biomaterials with and 
without biologics. We were not able to perform analyses for the effect of the 
concentration or subtype of the growth factors due to the small size of these 
subgroups, although these factors may have a large effect on the outcome. In the 
study by Ishii et al. a positive effect of FGF-2 was observed by the addition of at 
least 183 ng to the biomaterials [56], while Maehara et al. showed significant 
improvements of impregnating biomaterials in 10 µg/ml and not for 100 µg/ml 
FGF-2 [57]. Loading biomaterials with different BMPs including BMP-2 [4, 58-61] 
and BMP-7 [62], or TGF subtypes including TGF-β [22] and TGF-β1 [58, 59], resulted 
in significantly improved cartilage regeneration. However, for clinical application 
of these medical devices, one should take safety of the products into account as 
side effects of TGF-β in a joint environment, including fibrosis and osteophyte 
formation, have been described [63] and patients suffered from major 
complications after spinal surgery and implantation of high concentrations of 
BMP/INFUSE [64].
 The study characteristics of all included studies were tabulated to provide an 
extensive overview of the available literature. Besides the internal validity of the 
studies, the generalizability (external validity) of the study results is of great 
importance. The latter is affected by factors related to the animal model (species, 
strain, weight, age, and sex), surgery (location and size of the defect) and follow-up, 
resulting in heterogeneity between studies. This was also indicated by the 
relatively high level of heterogeneity (I2) for the main meta-analysis (99.4% [99.4, 
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99.4]), and the heterogeneity was almost similar for subgroup analyses. We chose 
to include only healthy animals receiving biomaterials. The screened studies also 
contained osteoarthritis models that were not included, which may be relevant 
for future applications to treat patients with osteoarthritis. Therefore, results 
from this systematic review and meta-analysis may be different compared to 
results found for osteoarthritis models and future clinical studies with 
osteoarthritis patients. We assumed that in order to assess the effect of implanted 
biomaterials on cartilage regeneration, reduction of the influence of confounding 
parameters would aid the validity of the results and conclusions. In this study, the 
meta-analysis included all available data of the effect of implanting biomaterials 
after applying bone marrow stimulating techniques (microfracture and 
subchondral drilling) compared to empty defects on cartilage regeneration. 
During microfracture surgery the subchondral bone is penetrated using an 
arthroscopic awl, whereas during subchondral drilling the trabecular bone is 
penetrated using a high speed drill, which may result in thermal necrosis [11]. 
Remarkably, more studies applied subchondral drilling (258 studies) compared to 
microfracture surgery (25 studies), while microfracture surgery was developed to 
overcome problems associated with thermal necrosis from subchondral drilling 
in the treatment of human patients [65]. We did perform a post-hoc meta-analysis 
to investigate differences in cartilage regeneration after applying both marrow 
stimulating techniques and subsequent implantation of biomaterials, which 
resulted in no significant differences between microfracturing and subchondral 
drilling. A reason for the larger number of animal studies performing subchondral 
drilling compared to microfracture surgery may be the ease to perform 
subchondral drilling over microfracture surgery in animals. Although in the 
included studies various implant locations (i.e. trochlea and condyles) were used, 
we grouped the results in the meta-analysis. A post-hoc subgroup analysis was 
performed to compare defect locations, but no overall significant differences were 
found for biomaterials implanted at different implant locations. Our analysis did 
not confirm a finding of Chen et al. showing improved chondrogenesis in trochlear 
versus condylar cartilage defects after bone marrow stimulation in rabbits [66]. 
This may be explained by various parameters affecting the degree of cartilage 
regeneration at different implant locations, such as the animal model, follow-up 
period and rehabilitation protocol.
 Different outcome measures such as macroscopic and histological evaluation, 
semi-quantitative macroscopical and histological evaluation using scoring 
systems, histomorphometry, PCR and biochemical assays were used to assess the 
regenerative potential of implanting biomaterials. In this systematic review and 
meta-analysis, only data from semi-quantitative histological scoring systems 
were used as outcome measure. We chose to use these data as most authors 
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presented their results by this method and it allows quantitative comparison of 
different studies in a meta-analysis. Various histological scoring systems have 
been used by the authors of included studies, such as the O’Driscoll, Pineda, 
Wakitani and ICRS scoring system, which were also reviewed by Rutgers et al. 
[67]. Depending on the histological scoring system, parameters such as cell 
morphology, matrix staining, surface regularity, structural integrity, defect 
filling and the restoration of the subchondral bone were evaluated. A limitation of 
this outcome measure is that the specific topics addressed in the scoring systems 
greatly differ, i.e. some studies focus on the regeneration of cartilage only, cartilage 
as well as subchondral bone, or include a biomaterial component (e.g. scoring 
degradation of the implant). Other outcome measures including macroscopic 
evaluation, biochemical analysis and biomechanical aspects of the tissue may 
complete the overview of the tissue quality and provide valuable insights in 
articular cartilage regeneration, but these outcome measures were only used in a 
limited number of studies, and therefore not assessed in this analysis. 
 The risk of bias assessment provided insights in the quality of the experimental 
design of the studies. Most studies scored a low or unknown risk of bias, however, 
also little high risk of bias was scored. Low methodological quality (internal 
validity) may result in an overestimation or underestimation of the intervention 
effect [68]. In general, details regarding the randomization procedure were not 
described. Moreover, an observation during the risk of bias assessment was that 
only few studies included in the systematic review described that power 
calculations were performed, which is a crucial aspect in conducting experimental 
studies to ensure sufficient power of experimental designs. As a consequence, 
studies may lack sufficient power and thereby run the risk of false negative 
results. Due to the poor reporting of the experimental design for the majority of 
the studies the assessment of the adequacy of randomization and power 
calculations, and thus the assessment of the actual risk of selection bias, was 
inadequate. However, it may also hold true that studies were well designed but 
there was only poor reporting of the experimental designs [69]. Most researchers 
scoring the histology sections were blinded and sections were randomized. 
However, when biomaterials are not (completely) degraded, blinding between 
biomaterials and empty defects is practically impossible. A lack of blinding of 
outcome assessors implies the risk of detection/observer bias [70]. Bias may have 
been introduced by the lack of blinding and randomization and detracts from the 
overall validity of the results [71, 72]. There is a risk that the positive results found 
are an overestimation of the true effect of using biomaterials. Introducing 
standardized protocols such as the golden standard publication checklist [73] or 
the ARRIVE guidelines [74] may improve reporting of animal studies. 
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 Funnel plots represent the precision of the measured effects, which increases 
by an increase in study size. Therefore, for small and large studies scatter will be 
relatively large and little, respectively. As a consequence, generally, in the absence 
of bias the plot resembles a symmetrical pyramid (a funnel) [47]. An important 
limitation may be publication bias, since multiple studies were included from the 
same author and negative results may not be published. It was described in a 
study by ter Riet et al. that researchers themselves estimate that only 50% of the 
conducted animal experiments are published. This problem may be solved by 
statistical corrections for publication bias [75]. In our study, the funnel plot did not 
show asymmetry and therefore did not indicate the presence of publication bias. 
 The translational value of animal studies depends on the comparability to 
the clinical situation. One of the limitations of the performed animal experiments 
is the short follow-up times. The maximum follow-up time was one year, but most 
studies investigated cartilage regeneration up to 6 months. This limits the 
translational value since clinical improvements in humans are generally observed 
up to 1.5 - 3 years after microfracture surgery [8, 9]. Moreover, many variations 
were present in the applied animal models, i.e. animal characteristics (species, 
strain, sex, age, weight), surgical defects (size, depth and location), applied 
biomaterials, and incorporated biologics. A review by Chu et al. [76] extensively 
reflects on benefits and limitations of different animal models used in cartilage 
repair studies. They state that for humans the volume of a cartilage defect is 
approximately 550 mm3 and treatment is required for defects with a surface larger 
than 10 mm2. Due to the limited joint size of many animals, larger animal models 
such as minipig, goat and horse therefore offer superior translational value than 
smaller animals such as rats, rabbits and dogs. However, all studies contained 
defect volumes smaller than 550 mm3 and only few studies had defects surfaces 
larger than 10 mm2. Additionally, cartilage thickness differs among various 
species, with goat, rabbit, minipig and dogs having thinner cartilage than 
humans. Another drawback for some animal models is the large endogenous 
repair potential. In humans, untreated defects show little to no regeneration 
while rabbits display a large regenerative potential, limiting clinical translation. 
Dog, goat, minipig and horse do not have this large endogenous repair and the use 
of these animals may therefore be favorable. The maturity of the animals is of 
great importance when designing animal experiments since open growth plates 
can impede with the applied treatment. Animal species are skeletally mature at 
different ages; i.e. rabbits at the age of 16-39 weeks, pigs at 42-52 weeks, dogs at 
12-24 months, sheep and goat at 24-36 months and horses at 60-72 months [76, 77]. 
In this study we did not group studies based on animal maturity. In addition to 
clinical relevance, other reasons to select an animal model are related to logistical, 
financial, and ethical considerations. A systematic review conducted by Ahern et 
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al. [77] investigated the strengths and shortcomings of different animal models 
and compared these with common clinical lesions in clinical studies. They 
remarked that smaller animal models are often used due to feasibility, while large 
animal models may more closely resemble humans. However, no differences 
were found between animal models in this systematic review and meta-analysis, 
which may be explained by various parameters affecting the degree of cartilage 
regeneration such as implant location, defect size, follow-up period and rehabilitation 
protocol. 
 In this systematic review and meta-analysis the efficacy of cartilage 
regeneration using acellular biomaterials was compared to the natural healing 
response of defects treated with microfracture surgery and subchondral drilling. 
The risk of bias assessment indicated poor reporting in animal studies, which 
may be improved in future animal studies. Moreover, to improve the translation 
towards clinical trials animal experiments should be comparable to the clinical 
situation. As described in this systematic review a relatively high level of 
heterogeneity exists between studies related to the animal model, surgery and 
follow-up, with a need to resemble current clinical settings more closely. In this 
study we only addressed bone marrow stimulating techniques (microfracture 
and subchondral drilling) and subsequently the incorporation of biomaterials, 
but also the regeneration of partial thickness cartilage defects may be beneficial 
to prevent progression to full-thickness cartilage defects, limit the progression 
towards osteoarthritis and improve quality of life in patients. In many studies 
also cell-laden biomaterials have been implanted and the beneficial effect of 
cellular biomaterials versus acellular biomaterials and the natural healing response 
has been studied. Although acellular biomaterials offer various advantageous 
properties over cellular biomaterials such as no donor-site, no cell culture, off the 
shelf availability, less regulatory issues, and application of one-stage surgical 
procedures [13, 14], studying the additive value of cellular biomaterials may aid 
further improvement of marrow stimulating techniques.
Conclusion
The systematic review and meta-analysis resulted in a structured, thorough and 
transparent overview of literature related to the current evidence for the efficacy 
of cartilage regeneration using acellular biomaterials implanted after microfrac-
turing in animal models. Cartilage regeneration is more effective by implantation 
of acellular biomaterials in microfracture defects compared to microfracturing 
alone. The efficacy is further improved by the incorporation of biologics.
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Supplementary Information 2. 
Methodological quality assessment: questions and scoring flowchart.
Questions
1)  Randomization: Was the allocation sequence adequately generated and applied 
(selection bias)?
2)  Baseline characteristics: Were the groups similar at baseline (selection bias)? 
 Were all groups implanted in one animal and where there differences in 
load bearing between implantation sites (2.1), and if not all groups were 
in one animal, was randomization adequately performed? 
 How were animal characteristics divided over the groups (2.2)? 
 Where there differences between groups at the moment of surgical 
intervention (2.3)? 
3)  Implantation concealment: Was the allocation adequately concealed (selection 
bias)?
4)  Random housing: Were the animals randomly housed during the experiment 
(performance bias)?
5)  Blinding: Where the caregivers and/or investigators blinded from knowledge 
which intervention each animal received during the experiments (performance 
bias)?
6)  Random outcome assessment: Were the animals selected at random for 
outcome assessment (detection bias)?
7)  Analysis blinding: Was the outcome assessor blinded (detection bias)?
8)  Incomplete outcome data: Were incomplete outcome data adequately addressed 
(attrition bias)?
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Flowchart
1) Was the allocation sequence adequately generated and applied?
2) Were the groups similar at baseline or were they adjusted 
     for confounders in the analysis
Allocation sequence specied?
Yes No
Details?
No
? +
?
Complete Partial
1.1 1.2
1.3
(No information)
Yes, but not random
Yes
- ?1.4 1.5
3) Was the allocation adequately concealed?
4) Were the animals randomly housed during the experiment?
5) Were the caregivers and/or investigators blinded from knowledge 
     which intervention each animal received during the experiment?
6) Were the animals selected at random for outcome assessment?
8) Were incomplete outcome data adequatly addressed?
7) Was the outcome assessor blinded?
- Are all conditions in one animal?
- Not all conditions in one animal?
- One condition per animal?
Part 1: # conditions/animal?
Randomization
adequately performed?
Dierence in load-bearing between conditions?
Answer question 1 (allocation)?
? -1.5 1.6+ 1.4
-?+
Yes Not sure
? -1.2 1.3
No
Yes Not sure
? +1.8 1.1
No
- 1.7
Part 2: Dividing of charactertics over groups (sex, age, weight)?
- Not all conditions in one animal?
- One condition per animal?
- Are all conditions in one animal? - 2.1
Not sure
? -2.3 2.4- 2.2
Extensive informationTable
Part 3: Dierence between groups at moment of surgical intervention?
Yes
- 3.2
No
+ 3.1
+ 1.1 (Impossible to conceal)- Empty defect and 1 scaold condition?
- Empty defect and multiple scaold conditions?
Not enough information
Is there more than 1 scaold condition and an empty defect?
- 1.3? 1.2
Extensive information (e.g. scaolds implanted blinded )
Dropout mentioned?
Do we see: - dropout?
                      - missing data?
Dierence between groups? 
Intervention related?
Yes No
? -1.2 1.3
Yes Not sure No
+ 1.1 - 1.5
Yes No
+ 1.4
Reviewer(s) blinded?
1.3
Yes Not sure No
? +1.2- 1.1
In general, for this type of in vivo studies these domains are not essential to be 
assessed. Therefore, only specic examples were reported in footnotes.
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Supplementary Information 7. Forest plot.
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Augmented cartilage regeneration by 
implantation of cellular versus acellular 
implants after bone marrow stimulation:  
a systematic review and meta-analysis  
of animal studies
Michiel W. Pot | Toin H. van Kuppevelt | Veronica K. Gonzales | Pieter Buma
Joanna in ’t Hout | Rob B.M. de Vries | Willeke F. Daamen
Chapter 3
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Abstract
Bone marrow stimulation may be applied to regenerate focal cartilage defects, 
but generally results in transient clinical improvement and formation of 
fibrocartilage rather than hyaline cartilage. Tissue engineering and regenerative 
medicine strive to develop new solutions to regenerate hyaline cartilage tissue. In 
this systematic review and meta-analysis, we provide a comprehensive overview 
of current literature and assess the efficacy of articular cartilage regeneration by 
implantation of cell-laden versus cell-free biomaterials in the knee and ankle 
joint after bone marrow stimulation in animal models. PubMed and EMBASE (via 
OvidSP) were systematically searched using tissue engineering, cartilage and 
animals search strategies. Included were primary studies in which cellular and 
acellular biomaterials were implanted after applying bone marrow stimulation 
in the knee or ankle joint in healthy animals. Study characteristics of all included 
studies (146 studies out of 7354 studies found) were tabulated and for those studies 
applying semi-quantitative histology as outcome measure, outcome data were 
collected for meta-analysis (117 studies). Cartilage regeneration was expressed on 
an absolute 0-100% scale and random effects meta-analyses were performed. 
Implantation of cellular biomaterials significantly improved cartilage regeneration 
by 18.6% compared to acellular biomaterials. No significant differences were 
found between biomaterials loaded with stem cells and those loaded with somatic 
cells. Culture conditions of cells did not affect cartilage regeneration. Cartilage 
formation was reduced with adipose-derived stem cells compared to other cells, 
but still improved compared to acellular scaffolds. Assessment of the risk of bias 
was impaired due to incomplete reporting for most studies. Implantation of 
cellular biomaterials improves cartilage regeneration compared to acellular 
biomaterials.
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Introduction
Articular cartilage facilitates joint loading and movement by resisting compressive 
and shear forces [1]. For patients, localized cartilage defects can have detrimental 
long term effects such as joint dysfunction, pain, and degenerative osteoarthritis. 
Once cartilage is damaged, the tissue does not heal spontaneously due to its 
avascular nature [2]. Clinical treatments to heal full-thickness cartilage defects 
and osteochondral lesions include bone marrow stimulation techniques, such as 
microfracture and subchondral drilling, and autologous chondrocyte implantation. 
The defect size generally determines the treatment applied, where microfracture 
and autologous chondrocyte implantation can be used to treat small (< 2.5 cm2) 
and large lesions (> 2.5 cm2), respectively [3]. Microfracture surgery is an attractive 
procedure as it is a relatively simple, minimally invasive and inexpensive one-step 
approach. During the procedure multiple perforations, so-called microfractures, 
are made in the subchondral bone plate to induce bleeding and provoke a 
reparative response in the cartilage defect. The formed blood clot consists of bone 
marrow-derived mesenchymal stem cells (BM-MSCs), growth factors and other 
proteins, providing an environment supportive of cartilage formation [4]. The 
repaired tissue, however, generally consists of fibrous cartilage, which lacks the 
mechanical properties of native hyaline cartilage [5]. Microfracture only results 
in temporary clinical improvement [6], and the demand for improved cartilage 
regeneration persists.
  Cartilage regeneration may be improved by applying tissue engineering and 
regenerative medicine (TERM) approaches in addition to bone marrow stimulating 
techniques. TERM encompasses the development of biomaterials, which can be 
loaded with cells and biologics [7]. Upon implantation of these biomaterials and 
infiltration of BM-MSCs, the biomaterial may act as a template to guide and stimulate 
cartilage regeneration [3]. In a previous systematic review and meta-analysis, 
we showed that in animal models the implantation of acellular biomaterials in 
addition to bone marrow stimulation was more effective in regenerating cartilage 
in vivo than bone marrow stimulation alone, and the efficacy was further 
improved by the incorporation of biologics [8]. 
 Bone marrow stimulation may be even more effective in case the biomaterials 
are loaded with cells. Implantation of biomaterials loaded with cells after applying 
bone marrow stimulation has been widely investigated in vivo, and included 
loading of chondrocytes [9-11], BM-MSCs [12-14], synovium-derived mesenchymal 
stem cells (SD-MSCs) [15-17], adipose-derived stem cells (ADSCs) [18-20], periosteal 
cells [21, 22], fibroblasts [23], umbilical cord stem cells (UCSC) [23, 24] and embryonic 
stem cells (ESC) [25]. Cells are either used directly after harvesting [26, 27] or after 
an additional in vitro step to expand [28, 29] and/or differentiate the cells [30, 31]. 
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In this systematic review and meta-analysis, we present a comprehensive, 
unbiased overview of all current literature regarding the regeneration of articular 
cartilage by implantation of cell-laden versus cell-free biomaterials in the knee 
and ankle joint after bone marrow stimulation in animal models (as illustrated in 
Fig. 1). At present, a complete overview is lacking and the efficacy of cartilage 
regeneration by these approaches has not been investigated using a systematic 
review and meta-analysis. Since strategies to heal cartilage defects are in theory 
also applicable for osteochondral lesions [3], microfracture and subchondral 
drilling were in the context of this SR both regarded as cartilage regeneration. 
Figure 1  Illustration of articular cartilage regeneration by implantation of cellular and 
acellular biomaterials after applying bone marrow stimulation. The figure was adapted 
from Pot et al. [8].
Consideration: addition of cells to implants
Evaluation in animal models
Strategies related to cellular/acellular approaches 
- Acellular implants; attract autologous cells
- Cell-laden implants; loaded with e.g.:
 - Chondrocytes
 - Mesenchymal stem cells (MSCs)
 - Adipose-derived stem cells (ADSCs)
Chondrocytes MSCs ADSCsAcellular
Deep zone
Cancellous bone
Step 2: Scaold implanted
(Cellular/acellular)
Step 1: Bone marrow stimulation
(Subchondral drilling/microfracture)
Middle zone
Supercial zone
Tidemark
Subchondral bone plate
Calcied cartilage
Mesenchymal stem cells
Osteochondral environment
Chondrocytes
Collagen
Cartilage Subchondral bone
Reparative approach:
1) Bone marrow stimulation
  Subchondral drilling or microfracturing
2) Scaold implantation
 Cellular or acellular
Implant
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We further investigated the effect of loading biomaterials with (1) stem cells 
versus somatic (differentiated) cells, (2) different cell types (e.g. chondrocytes, 
MSCs and ADSCs), and (3) culture conditions of cells (e.g. direct use after 
harvesting, in vitro expansion and/or differentiation). In the meta-analysis, 
histological scores from semi-quantitative histological scoring systems were used 
as outcome data to assess the effect on cartilage regeneration. Moreover, we 
aimed to provide transparency on the quality of included in vivo studies, to make 
suggestions on how to improve the design of future animal studies and eventually 
clinical trials, and to provide insights in strategies for future (pre) clinical research 
related to cellular or acellular approaches.
Materials and Methods
Search strategy
An extensive literature search was performed in PubMed and EMBASE (via 
OvidSP) to identify relevant peer-reviewed articles, according to the methods 
described by de Vries et al. [32] and Leenaars et al. [33]. Articles were searched until 
June 29, 2016. The search strategy consisted of search components for tissue 
engineering [34] and cartilage [8]. The search components were developed using 
synonyms for tissue engineering and cartilage, and were constructed using MeSH 
terms (PubMed) and EMTREE terms (EMBASE), as well as free-text words from 
titles or abstracts ([tiab] or /ti,ab.) [8]. Subsequently, results were refined for 
animal studies by applying animal search filters [35, 36]. No language restrictions 
were applied.
Study selection
After obtaining all references through searches in PubMed and EMBASE, 
duplicates were manually removed in EndNote X7 (Thomson Reuters, Philadelphia, 
Pennsylvania) by one review author (MP). Resulting references were screened for 
their relevance by two independent reviewers (MP and VG/WD) based on (1) title, 
(2) title/abstract and (3) full-text using Early Review Organizing Software (EROS, 
Institute of Clinical Effectiveness and Health Policy, Buenos Aires, Argentina, 
www.eros-systematic-review.org). In case of disagreement between both reviewers 
or any doubt, references were included for further screening. An overview of all 
exclusion criteria applied per screening phase is provided in Supplementary 
Information 1.
 Studies were included for risk of bias assessment and meta-analysis when 
semi-quantitative histological scoring was used as outcome measure.
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Study characteristics
Study characteristics were extracted from the studies by MP. Basic information 
(author and year of publication), animal model characteristics (species, strain, 
sex, etc.), experimental characteristics (surgery, biomaterial, follow-up, etc.), cell 
characteristics (cell type, culture conditions, etc.) and outcome characteristics 
(macroscopic evaluation, histology and semi-quantitative histological scoring, 
etc.) were obtained. 
Risk of bias assessment
The methodological quality was assessed for all studies included in the meta- 
analysis (studies that evaluated cartilage regeneration using semi-quantitative 
histological scoring as outcome data). A risk of bias analysis was performed 
according to an adapted version [8] of the tool described by Hooijmans et al. [37]. 
Selection, performance, detection and attrition bias were scored independently by 
MP and VG/WD using questions and a flowchart [8], with ‘-‘, ‘?’ and ‘+’, indicating low, 
unknown and high risk of bias, respectively. In case of differences between both 
reviewers, results were discussed until consensus was reached. Unfortunately, 
16 articles were published in Chinese and we did not have the resources to obtain 
certified translations of these articles. We were, however, able to successfully 
extract the data of these studies using Google Translate and used the data in the 
meta-analysis. A sensitivity analysis was performed to evaluate the effect of 
language (exclusion of articles published in Chinese, see section 2.5.2).
Analysis preparations and meta-analysis
Analysis preparations
Meta-analyses were performed for the outcome measure semi-quantitative histology; 
data were used from studies that compared biomaterials with (experimental 
group) and without cells (control group). In general, these histological scoring 
systems evaluate the degree of cartilage regeneration by scoring parameters 
including e.g. Safranin-O staining, surface integrity and cartilage thickness [38].
 Outcome data (mean, standard deviation (SD) and number of animals) were 
extracted from the studies for all time points as follows: 1) numerical data were 
obtained from the text or tables, 2) results depicted graphically were obtained by 
measuring the mean and SD using ImageJ (1.46r, National Institutes of Health 
USA), 3), results presented in boxplots were recalculated from the median, range 
and the sample size to the mean and SD [39], and 4) in case results were presented 
as mean and confidence interval (CI) per group, the following equation was used
to recalculate the CI to a standard deviation for a 95% CI [40]:
SD = upper limit – lower limit3.92   
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If data were missing or unclear, authors were contacted to provide the data. 
Studies were excluded from the meta-analysis in case data could not be retrieved 
or remained unclear (i.e. missing SD, all SD similar to corresponding mean, and 
histological scores exceeding maximum), unless data were sufficiently clear to 
make assumptions (i.e. group size and number of animals per time point and 
analyses, see Supplementary Information 2). A sensitivity analysis was performed 
to evaluate the effect of assumptions (exclusion of articles where assumptions 
were made, see section 2.5.2). Histological scoring systems describe the degree of 
cartilage regeneration, however with different scoring scales. To compare data 
from different studies, all data was converted to a 100% cartilage regeneration 
scale by dividing both the mean and SD by the maximum score of the scoring 
system applied and subsequently multiplying the outcome by 100%. In our SR, 
healthy tissue is represented as 100% cartilage regeneration (highest score). 
Lower percentages indicate less regenerated cartilage tissue. When results of 
experimental groups could be combined per study (i.e. outcome of various 
biomaterials seeded with one cell type), we followed the approach described in 
the Cochrane Handbook, table 7.7 [40]. Time points of treatment groups were 
combined using the same approach. Subsequently, per study the mean and 
corresponding standard error (SE) per treatment group were calculated.
Meta-analysis
The following main research question was assessed: Is there an overall beneficial 
effect on cartilage regeneration (expressed as histological score) of implanting 
biomaterials loaded with cells compared to acellular biomaterials?
 We used a bivariate approach to model a random effects meta-analysis, i.e. 
separate outcomes for the control and experimental group were used with their 
respective SEs. The correlation between these two outcomes was modeled with a 
compound symmetry covariance matrix, as this resulted in a the lowest Akaike 
Information Criterion value. 
 To evaluate the effect of specific variables on the treatment outcome for the 
experimental group (biomaterials loaded with cells), the following sub-questions 
were addressed: 1) Is there a difference between the use of stem cells and somatic 
(differentiated) cells (stem cells vs. somatic cells)?; 2) Do differences among 
various cell subgroups exist (e.g. chondrocytes vs. other cells)?; 3) Is there a 
difference between biomaterials loaded with cells which were not cultured in 
vitro, were expanded in vitro or were differentiated in vitro (during surgery vs. 
expansion, surgery vs. differentiation, and expansion vs. differentiation)? Results 
are depicted as % cartilage regeneration (95% CI: [lower CI, upper CI]. The mean 
difference (% [95% CI]) is presented as condition A – condition B (e.g. ’stem cells - 
somatic cells’ or ‘surgery – differentiation’). Based on a previous study, data of all 
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time points were used [8]. Subgroup analyses were performed, in case subgroups 
consisted of more than five experimental groups in 3 studies. Most studies 
contained more than one experimental group, therefore the total number of 
studies and number of experimental groups (no. of studies/groups) is also 
provided in the analysis. No adjustment for multiple testing was applied in the 
analyses for the sub-questions.
 Sensitivity analyses were performed on the main research question to 
evaluate the effect of language (exclusion of articles published in Chinese, 
because for these articles the risk of bias was not investigated), and the effect of 
assumptions (exclusion of articles for which assumptions were made) in the 
meta-analysis.
 SAS/STAT® software version 9.2 for Windows, copyright© 2002-2008 by SAS 
Institute Inc., Cary, NC, USA, was used to perform statistical analyses. R software 
version 3.0.1 [41] with package meta [42] was used to create the funnel plot, which 
illustrates effect sizes of all studies versus their precision. I2 was used as a measure 
of heterogeneity. ReviewManager (RevMan, Version 5.3. Copenhagen: The Nordic 
Cochrane Centre, The Cochrane Collaboration, 2014) was used to create the forest 
plot.
Results
Search and study inclusion
Searching the PubMed and EMBASE databases [8] for references regarding 
cartilage regeneration by implantation of cellular and acellular biomaterials in 
the knee and ankle joint in combination with bone marrow stimulation resulted 
in a total of 11,248 references, of which 4,743 came from PubMed and 6,505 from 
EMBASE. After removal of duplicates, 7,354 references were screened by title and 
title/abstract, which resulted in the exclusion of 6,744 references. Subsequently, 
610 studies were screened by full-text, resulting in 146 included studies. From 
some studies ([43-45]), the full-text could not be retrieved and these studies were 
excluded.
 In the meta-analysis, studies were used which applied semi-quantitative 
histology as outcome measure, resulting in 117 included studies. A risk of bias 
assessment (Fig. 2) was performed for 101 of the 117 studies (excluding Chinese 
studies). Supplementary Information 2 provides an overview of all included 
studies after the full-text screening, risk of bias assessment and meta-analysis, as 
well as detailed information regarding reasons for exclusion and assumptions 
made for some studies. Supplementary Information 3 contains the reference list 
and abbreviations of studies used in Supplementary Information 2. 
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Study characteristics
A large variation between studies was observed regarding animal model charac-
teristics (species, strain, sex, etc.), experimental characteristics (surgery, biomaterial, 
follow-up, etc.), cell characteristics (cell type, culture conditions, etc.) and outcome 
characteristics (macroscopic evaluation, histology and semi-quantitative histological 
scoring, etc.), as can be appreciated from Supplementary Information 2. Various 
animal species were used including rabbit, dog, sheep, pig, rat, horse, minipig, 
goat and macaques. A large range was found in animal age, e.g. the age of rabbits 
ranged from 6 weeks to >2 years. Small animals were generally younger (in the 
range of months) compared to larger animals (in the range of years). In many 
studies, no detailed information was provided regarding the absolute age of the 
animal, but ages were described as e.g. adult or mature. 
 The method used for bone marrow stimulation was mostly subchondral 
drilling (142 studies), where only 4 studies used microfracture to connect the 
cartilage defect to the underlying bone marrow stroma for the recruitment of 
pluripotential cells. Defects were created at various locations (trochlea, condyles, 
femur and intercondylar fossa) and with diverse dimensions (e.g. for rabbits: 4-7 
mm in diameter and 0.8-9 mm in depth). 
 Implanted biomaterials were prepared from natural (e.g. alginate and 
collagen), synthetic (e.g. poly(lactic-coglycolic acid) and polycaprolactone) or 
mixtures of both natural and synthetic materials. Additionally, in 27 studies 
biologics, such as bone morphogenetic protein 2 and transforming growth factor 
beta, were loaded in the biomaterials. Different cell types were applied, including 
chondrocytes, bone marrow-derived mesenchymal stem cells (BM-MSCs), bone 
marrow-derived progenitor cells, synovium-derived stem cells (SD-MSCs), bone 
marrow-derived mononuclear cells, adipose-derived stem cells, adipose-derived 
stromal vascular fraction cells, endothelial progenitor cells, embryonic stem cells, 
umbilical cord blood stem cells, fibroblasts, and periosteal cells, while in some 
studies undefined cell populations like bone marrow aspirate concentrate were 
used. Cells were either seeded on biomaterials and implanted in the created defect 
or cultured in vitro to expand and/or differentiate the cells, followed by seeding 
on biomaterials and implantation. In some studies, cells were cultured as a 
monolayer (without biomaterial), followed by seeding of the cells onto the 
biomaterial and implantation, while in other studies cells were directly cultured 
on biomaterials in vitro prior to implantation.
 In most studies, short-term cartilage regeneration was investigated: the 
follow-up time was generally less than 6 months and the maximum follow-up 
time was 12 months.
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Risk of bias assessment
The methodological quality was assessed for all studies included in the meta- 
analysis except Chinese articles. The overview of the results in Figure 3 indicates 
a general lack of information regarding the experimental setup of the studies, 
limiting the assessment of the actual risk of bias. Please see Supplementary 
Information 4 for all scores per individual study.
 In the assessed studies, details regarding the application and method of 
randomization (Q1) were generally lacking. As a result, assessment of the actual 
risk of selection bias was nearly impossible. Assessment of the actual risk of bias 
due to differences in baseline characteristics was difficult since no details 
regarding randomization were described. Differences may have been present in 
Figure 2  PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analysis) 
flowchart of the systematic search of literature. Of the 117 studies included for the 
meta-analysis, a risk of bias assessment was performed for 101 studies, excluding Chinese 
articles.
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Embase: n = 6505Pubmed: n = 4743
Full-text screening:
n = 146 included
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- No cartilage: n = 15
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- No osteochondral defect: n = 52
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old implanted: n = 15
- No acellular scaold implanted: n = 82
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- Article could not be obtained: n = 3
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- Other: n = 2
Included for: 
- Meta-analysis: n = 117 
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Excluded:
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load-bearing between implantation sites (Q2.1) and age, sex and weight of animals 
(Q2.2). In most studies, few differences were found between animals at the 
moment of surgical intervention since animals were treated similarly. For 
example, harvesting of cells was mostly performed by obtaining cells from all 
animals (Q2.3). Details regarding blinding of experimental conditions at the 
moment of implantation were generally not provided, which may have resulted 
in bias (Q3). Random housing of animals was generally not (well) described (Q4). 
Caregivers and/or investigators did not know which intervention each animal 
received during the experiment (Q5). No details were presented regarding the 
random selection of animals for outcome assessment (Q6). The method of blinding 
during analysis, however, was well described in most studies (Q7). Incomplete 
outcome data were identified or described in a few studies only, where these 
resulted in studies with high risk of bias (Q8). Generally, most studies lacked 
reporting of important details and therefore an adequate assessment of the actual 
risk of bias was difficult.
Data synthesis
Semi-quantitative histological scores were used as outcome data to compare 
biomaterials with cells (experimental group) and without cells (control group) 
Figure 3  Results of the risk of bias analysis. Low, unknown or high risk of bias are presented 
in green, orange and red, respectively, where the percentages indicate the percentage of 
studies scoring low, unknown or high risk of bias of the total number of investigated studies 
per question. Low risk of bias was mainly found for addressing incomplete outcome data 
and baseline characteristics at the moment of surgical intervention. Unknown risk of bias 
was generally the result of limited details described in the studies regarding the 
experimental set-up. High risk of bias was only occasionally scored. Questions 4-6 are not 
depicted graphically, but are described and explained in Supplementary Information 4.
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Table 1   Overview meta-analysis results; the effect on cartilage regeneration of (1) 
the addition of cells to biomaterials, (2) loading of stem cells vs. somatic cells, (3) 
loading of specific cell types, e.g. chondrocytes vs. all cells except chondrocytes, 
and (4) culture conditions.
Meta-analysis No. of  
studies/ groups 
Subgroups Cartilage regeneration  
(% [95% CI)] 
Mean difference (% [95% CI]) 
p-value 
1.  Overall effect 98/26598/208
Cellular scaffolds 
Acellular scaffolds 
61.5 [58.5, 64.5] 
43.0 [40.0, 46.0] 
18.6% [15.2, 22.0]
p < 0.0001 
2.  Stem cells or somatic cells 57/14836/101
Stem cells 
Somatic cells 
61.5 [58.1, 65.0] 
62.8 [58.5, 67.1] 
-1.28 [-6.5, 4.0] 
p = 0.622 
3.  Type of cells 
30/81
44/117
3/6
11/19
8/14
3/7
Chondrocytes
Bone marrow-derived MSCs
Synovium-derived MSCs
Adipose-derived stem cells
Bone marrow aspirate
Bone marrow-derived mononuclear cells
63.6 [58.1, 69.0]
61.5 [57.1, 65.9]
67.4 [36.7, 98.2]
56.3 [49.9, 62.6]
54.7 [39.8, 69.6]
74.1 [27.9, 100.0]
2.7 [-3.4, 8.9] 
p = 0.373
-0.3 [-6.0, 5.4] 
p = 0.919
-6.0 [-8.5, 20.5] 
p = 0.412
-5.9 [-11.3, -0.4] 
p = 0.036
-7.6 [-20.5, 5.2] 
p = 0.239
12.9 [-8.6, 34.3] 
p = 0.238
4.  Cell manipulation 
14/27
59/180 
27/58 
During surgery: harvesting, implantation 
Expansion: harvesting, expansion in vitro, implantation 
Differentiation: harvesting, differentiation in vitro, implantation 
58.9 [51.3, 66.5]
61.4 [57.6, 65.1]
63.1 [57.6, 68.6]
Surgery vs. Expansion 
-2.4 [-10.8, 5.9] 
p = 0.564
Surgery vs. Differentiation 
-4.2 [-13.5,  5.1] 
p = 0.374
Expansion vs. Differentiation 
-1.7 [-8.2, 4.7] 
p = 0.594 
The total number of studies and number of groups included in the meta-analysis are depicted (studies 
may have >1 experimental group, no. of studies/groups). Results are presented on a 100% cartilage 
regeneration scale, where 100% indicates ‘maximum’ cartilage regeneration. The addition of cells to 
biomaterials significantly improved cartilage regeneration compared to acellular biomaterials. The use 
of stem cells or somatic cells resulted in comparable cartilage regeneration. Cartilage regeneration was 
significantly lower for biomaterials seeded with adipose-derived stem cells compared to other cell 
types. Cartilage regeneration was not affected by the method of cell manipulation.
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types. Cartilage regeneration was not affected by the method of cell manipulation.
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and to address sub-questions related to the use of type of cells and culture 
conditions. An overview of all meta-analysis results is provided in Table 1; an 
overview of all raw data is given in Supplementary Information 5. 
 Data are presented as the effect (%) with 95% CI, where 100% cartilage 
regeneration represents healthy tissue and lower percentages indicate less 
regenerated cartilage tissue.
Overall effect implantation of cellular and acellular biomaterials
The meta-analysis indicates that implantation of cellular and acellular biomaterials 
resulted in 61.5% (95% CI: [58.5, 64.5]) and 43.0% (95% CI: [40.0, 46.0]) cartilage 
regeneration, respectively. The addition of cells to biomaterials significantly 
improved cartilage regeneration by 18.6% (95% CI: [15.2, 22.0], p < 0.0001). An overview 
of the results of each individual study is displayed in the forest plot (Supplementary 
Information 6), presenting improved cartilage regeneration by loading biomaterials 
with cells in 66 studies, similar cartilage regeneration in 30 studies, and a negative 
effect on cartilage regeneration in 2 studies. The heterogeneity (I2) was very high 
for the comparison between cellular and acellular biomaterials (99.4% [95% 
CI 99.3%; 99.4%]).
Stem cells and somatic cells
No significant differences (p = 0.622) were found between biomaterials loaded 
with stem cells (61.5% (95% CI: [58.1, 65.0] and somatic cells (62.8% (95% CI: [58.5, 
67.1]).
Cell type
Biomaterials were loaded with various cell types, including chondrocytes, bone 
marrow-derived MSCs, synovium-derived MSCs, adipose-derived stem cells, bone 
marrow aspirate, periosteal cells, fibroblasts, adipose-derived stromal vascular 
fraction cells, endothelial progenitor cells, bone marrow mononuclear cells, 
cartilage, umbilical cord stem cells, embryonic stem cell, or bone marrow aspirate. 
Subgroup analyses were only performed when subgroups consisted of more than 
five experimental groups in 3 studies. Seeding biomaterials with adipose-derived 
stem cells significantly decreased cartilage regeneration, while for the rest of the 
cell types no significant differences were observed (Table 1). 
Cell manipulation
Comparing differences in cartilage regeneration between biomaterials loaded 
with cells which were not cultured in vitro (thus implanted immediately after 
harvesting of cells), or were expanded and/or differentiated in vitro, indicated that 
the method of cell manipulation did not affect cartilage regeneration (Table 1).
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Sensitivity analyses
To investigate the robustness of the meta-analysis, sensitivity analyses were 
performed regarding the overall effect of the addition of cells to biomaterials. The 
overall outcome effect for cellular scaffolds was not notably affected by the 
exclusion of studies (1) with assumptions (2) or written in Chinese (no risk of bias 
assessment performed). Also for acellular biomaterials, the exclusion of both 
types of studies had no effect on cartilage regeneration. 
Publication bias
Publication bias was assessed for all studies included in the meta-analysis 
comparing cartilage regeneration using acellular versus cell-laden biomaterials. 
Although the funnel plot (Fig. 4) is rectangular in shape, no major asymmetry 
was observed, giving no indication for publication bias.
Figure 4  Funnel plot of the studies included in the meta-analysis comparing cartilage 
regeneration using cell-laden and acellular biomaterials. No substantial asymmetry was 
found.
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Discussion
Bone marrow stimulation can be applied to induce cartilage regeneration. In a 
previous systematic review, it has been demonstrated that in animals the quality 
of newly formed cartilage was improved by the implantation of biomaterials 
after bone marrow stimulation, which is further enhanced by loading biomaterials 
with biologics [8]. The aim of this systematic review was (a) to provide a comprehensive, 
systematic and unbiased overview of all current literature regarding animal 
studies on cartilage regeneration using cellular versus acellular biomaterials and 
to identify knowledge gaps, (b) to assess the efficacy of cartilage regeneration 
using cellular versus acellular biomaterials and to investigate the effect of various 
parameters (i.e. stem/somatic cells, cell source, cell culture conditions), (c) to gain 
insight in the methodological quality of animal studies, and (d) to improve the 
design of future animal models and eventually clinical trials.
 In animal studies, the implantation of cellular biomaterials significantly 
improved cartilage regeneration by 18.6% (95% CI 15.2, 22.0) compared to acellular 
biomaterials in animal models. This may be explained by the difference in the 
number of cells and the different contribution of various cell types in the 
regenerative process. For acellular biomaterials, cartilage matrix is deposited by 
bone marrow-derived mesenchymal stem cells, while for cellular biomaterials 
matrix deposition is additionally stimulated by the seeded cells. In the 
meta-analysis, the heterogeneity (I2) was very high for the comparison between 
cellular and acellular biomaterials (99.4% [95% CI 99.3%; 99.4%]), and the 
heterogeneity was approximately similar in the subgroup analyses. Therefore, all 
results should be interpreted with caution, especially for subgroup analyses with 
a relatively limited number of studies. Further clinical studies are required to 
assess the potential beneficial effect of cellular biomaterials versus acellular 
biomaterials in patients. Marcacci et al. [46] published promising results of a 
multicenter clinical phase III retrospective cohort study in which patients were 
treated with an implant consisting of autologous chondrocytes grown on 
Hyalograft C, a hyaluronic acid derivative, with a 3-year follow-up. Histological 
assessment of neotissue indicated hyaline-like cartilage for the majority of 
biopsies as well as major clinical improvements. The therapy was considered safe 
and effective for the treatment of articular cartilage lesions. 
 In a subgroup analysis, no significant differences were found between 
somatic cells (e.g. chondrocytes) and stem cells (e.g. mesenchymal stem cells 
(MSCs) and adipose-derived stem cells (ADSCs)). Differences were found between 
various cell types. ADSCs reduced cartilage regeneration in the subgroup analysis. 
However, cartilage regeneration using biomaterials seeded with ADSCs was still 
superior to biomaterials without cells. As compared to other cell types, it may be 
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that the origin of ADSCs from fatty tissue resulted in significantly reduced 
cartilage regeneration compared to cells derived from cartilage and the 
subchondral bone. A major drawback of the subgroup analysis evaluating the 
seeding of various cell types on biomaterials was the limited number of studies, 
as endothelial progenitor cells, embryonic stem cells, umbilical cord stem cells 
and fibroblasts were each only researched in one study. The use of MSCs may be 
favorable since these cells overcome limitations associated with the use of 
chondrocytes, including donor-site morbidity and limited matrix production 
after expansion in vitro [47]. Moreover, MSCs can be harvested from numerous 
sources, maintain their multipotency after expansion in vitro, can differentiate 
into chondrocytes that produce cartilage matrix and may suppress proinflamma-
tory cytokines by their immunoregulatory properties. A drawback of MSCs may 
be their potency to terminally differentiate after chondrogenic differentiation, 
resulting in bone formation [47]. Additionally, MSCs are more difficult to 
manipulate and regulate than chondrocytes [48]. In clinical trials, the addition of 
MSCs to biomaterials did not result in a large improvement compared to 
autologous chondrocyte implantation or microfracture surgery [49, 50]. Besides 
MSCs, other cell sources are of interest for combined use with biomaterials, 
including embryonic stem cells and induced pluripotent stem cells (iPSCs). The 
use of embryonic stem cells, however, is at present associated with ethical issues, 
and although iPSCs provide pluripotency with less ethical issues and can be 
derived from various tissues, their safety in vivo has not been proven yet. It has 
been demonstrated, however, that newly formed cartilage by iPSCs integrates 
with native cartilage and subchondral bone in rats [47]. 
 Study characteristics were collected from all included studies (also for studies 
not included in the meta-analysis) to provide a comprehensive overview of all 
literature regarding the effect of cellular versus acellular biomaterials on cartilage 
regeneration. A large heterogeneity was found between studies due to differences 
in animal model (species, strain, weight, age, and sex), performed surgery (bone 
marrow stimulation technique, implant location and defect size), biomaterials 
implanted (e.g. natural and synthetic origin) and follow-up period (short-term 
and long-term). To reduce the influence of possible confounding parameters, we 
excluded studies using healthy animals in which created defects were not filled 
during the first surgery (e.g. some studies implanted biomaterials 3 weeks after 
applying bone marrow stimulation) and osteoarthritis animal models, despite 
their greater relevance for future applications to treat patients with osteoarthritis. 
Bone marrow stimulation can be performed by subchondral drilling using a high 
speed drill or by microfracture surgery using arthroscopic awls [51]. It was 
remarkable that many more studies applied subchondral drilling (142 studies) 
compared to microfracture surgery (4 studies), especially since microfracture 
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surgery overcomes problems associated with thermal necrosis from subchondral 
drilling [52]. It may be that in animal models subchondral drilling is easier to 
perform than microfracture surgery. In a previous systematic review and 
meta-analysis, we found that the applied bone marrow stimulation technique 
had no effect on cartilage regeneration [8].
 Various outcome measures have been used to investigate cartilage regeneration, 
including MRI, macroscopic and histological evaluation, semi-quantitative 
macroscopical and histological evaluation using scoring systems, histomorphom-
etry, biomechanical analysis, polymerase chain reaction, biochemical assays, 
microCT and scanning electron microscopy. We selected data from semi-quanti-
tative histological scoring systems as outcome measure, because histological 
scores are often used and it allow for quantitative comparisons between studies. 
However, different histological scoring systems to evaluate histological sections 
are available (extensively reviewed by Rutgers et al. [37]), including the O’Driscoll 
and ICRS scoring system, which evaluate cartilage regeneration using different 
parameters (e.g. cell morphology, matrix staining and defect filling) and looking 
at different processes, e.g. cartilage regeneration only, cartilage and subchondral 
bone regeneration, and additionally biomaterial degradation. A limitation of this 
review and meta-analysis may be that we did not discriminate between these 
parameters. On the other hand, the use of all data may provide an extensive and 
complete overview of all aspects affecting the regenerative process.
 The methodological quality assessment was performed to evaluate the 
experimental designs and the reliability of the results of the studies included in 
the meta-analysis. The methodological quality (internal validity) is of great 
importance since a low methodological quality may result in an overestimation 
or underestimation of the effect size [53]. No studies were included in or excluded 
from the meta-analysis based on methodological quality assessment results. ‘Low 
risk of bias’ and ‘unknown risk of bias’ were the most found scores, but some 
studies were marked as having a high risk of bias. Generally, the possibility of 
assessing of the actual risk of bias was limited due to the absence of important 
details regarding the experimental set-up in most studies. No details were 
described related to the method of randomization. It may be that the animal 
studies were performed well, but that experimental designs were only reported 
poorly [54]. For the analysis of the histological sections, however, it was described 
in most studies that sections were randomized and that outcome assessors were 
blinded. Detection/observer bias may be introduced in case blinding was not 
performed and can result in an overestimation of the actual effect of the therapy 
[55]. The overall validity of the study results may be impaired by bias due to the 
lack of blinding and randomization [56, 57]. Reporting of animal studies may be 
improved by using standardized protocols, including the ARRIVE guidelines [58] 
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or golden standard publication checklist [59]. Publication bias may be the result of 
omission to publish negative results and the inclusion of multiple studies of the 
same author, and can result in an overestimation of the results. Publication bias 
can be detected using a funnel scatter plot, but for the data used in the 
meta-analysis of this study, no asymmetry was observed and no indications for 
publication bias found.
 The power of experimental designs is important when performing experimental 
studies and insufficient power may result in false negative results. Many studies 
(30 out of 98) in the meta-analysis with a large CI showed a neutral effect of the 
implantation of biomaterials loaded with cells on cartilage regeneration. Only in 
some studies, it was described that power calculations were performed but the 
actual calculations were never provided, while sufficient power is required to 
avoid false negative results.
 A high translational value of animal studies is crucial to successfully take 
treatments forward to clinical practice. Therefore, validated and predictive 
animal models are required. Many challenges and limitations are associated with 
the use of animal models for cartilage defects. Chu et al. [60] and Ahern et al. [61] 
extensively described the strengths and shortcomings of different animal models 
related to e.g. joint size, cartilage thickness, defect size, intrinsic healing potential 
and animal maturity, in comparison to lesions in clinical studies. In most animal 
experiments, the follow-up period was maximally 6 months, while in patients 
clinical improvements are generally observed up to 1.5 - 3 years after microfracture 
surgery [62, 63]. The translational value and considerations to select animal 
models were extensively discussed before [8].
 In future studies, improved reporting of animal studies is required and 
studies should strive to resemble the clinical situation to facilitate translation of 
the results. For clinical application of new regenerative medicine and tissue 
engineering strategies, including the use of biomaterials, biologics and cells, the 
effectiveness needs to be proven both in animal models and clinical studies [64]. 
Moreover, the cost-effectiveness of new interventions in clinical practice may be 
assessed using early health economic models [65]. Considerations for the addition 
of cells to biomaterials are of great importance and limitations (including 
donor-site morbidity, cell culture costs, regulatory issues, limited off the shelf 
availability, and potentially multiple-stage surgical procedures [8, 66]) should be 
weighed against potentially superior cartilage regeneration by applying cellular 
biomaterials. Difficulties in controlling cell culture and the development of novel 
materials stimulating tissue regeneration may justify the use of acellular 
biomaterials. Future research focusing on the properties of biomaterials, the 
source and manipulation of cells, and potentially patient profiling, may allow 
selection of the best treatment for each individual patient [67].
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Conclusion
This systematic review and meta-analysis provides an extensive overview of all 
studies applying regenerative medicine and tissue engineering approaches to 
regenerate articular cartilage by implantation of cellular versus acellular 
biomaterials after applying bone barrow stimulation in animal models. Cartilage 
regeneration was more effective by implantation of cellular biomaterials 
compared to acellular biomaterials. The use of stem cells or somatic cells gave 
comparable results. Only seeding of adipose-derived stem cells negatively 
affected cartilage regeneration in cell-seeded biomaterials. 
Acknowledgements
We thank Jie An (Department of Biomaterials, Radboud Institute for Molecular 
Life Sciences, Radboud university medical center) and Chunling Tang (Department 
of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud 
university medical center) for their contribution to the paper. Gerrie Hermkens 
from the Radboud university medical center library is greatly acknowledged for 
help retrieving full-text studies.
Supplemental Information
All supplemental Information will be available upon publication. 
77
Cartilage regeneration using cellular implants
Ch
ap
te
r  
  3
References
1. Swieszkowski W, Tuan BH, Kurzydlowski KJ, Hutmacher DW. Repair and regeneration of 
osteochondral defects in the articular joints. Biomol Eng, 2007. 24: p. 489-495.
2. Buckwalter JA, Saltzman C, Brown T. The impact of osteoarthritis: implications for research. Clin 
Orthop Relat Res, 2004. 427 Suppl: p. S6-15.
3. Cucchiarini M, Madry H, Guilak F, Saris DB, Stoddart MJ, Koon Wong M, Roughley P. A vision on the 
future of articular cartilage repair. Eur Cell Mater, 2014. 27: p. 12-16.
4. Steadman JR, Rodkey WG, Rodrigo JJ. Microfracture: surgical technique and rehabilitation to treat 
chondral defects. Clin Orthop Relat Res, 2001. 391 Suppl: p. S362-369.
5. Dai L, He Z, Zhang X, Hu X, Yuan L, Qiang M, Zhu J, Shao Z, Zhou C, Ao Y. One-step repair for cartilage 
defects in a rabbit model: a technique combining the perforated decalcified cortical-cancellous bone 
matrix scaffold with microfracture. Am J Sports Med, 2014. 42: p. 583-591.
6. Saris D, Price A, Widuchowski W, Bertrand-Marchand M, Caron J, Drogset JO, Emans P, Podskubka A, 
Tsuchida A, Kili S, Levine D, Brittberg M; SUMMIT study group. Matrix-applied characterized 
autologous cultured chondrocytes versus microfracture: two-year follow-up of a prospective 
randomized trial. Am J Sports Med, 2014. 42: p. 1384-1394.
7. Seo SJ, Mahapatra C, Singh RK, Knowles JC, Kim HW. Strategies for osteochondral repair: focus on 
scaffolds. J Tissue Eng, 2014. 5: p. 2041731414541850.
8. Pot MW, Gonzales VK, Buma P, IntHout J, van Kuppevelt TH, de Vries RBM, Daamen WF. Improved 
cartilage regeneration by implantation of acellular biomaterials after bone marrow stimulation: a 
systematic review and meta-analysis of animal studies. PeerJ, 2016. 4: p. e2243-2269.
9. Ahn JH, Lee TH, Oh JS, Kim SY, Kim HJ, Park IK, Choi BS, Im GI. Novel hyaluronate-atelocollagen/be-
ta-TCP-hydroxyapatite biphasic scaffold for the repair of osteochondral defects in rabbits. Tissue Eng 
Part A, 2009. 15: p. 2595-2604.
10. Caminal M, Peris D, Fonseca C, Barrachina J, Codina D, Rabanal RM, Moll X, Morist A, García F, Cairó 
JJ, Gòdia F, Pla A, Vives J. Cartilage resurfacing potential of PLGA scaffolds loaded with autologous 
cells from cartilage, fat, and bone marrow in an ovine model of osteochondral focal defect. 
Cytotechnology, 2016. 68: p. 907-919.
11. Christensen BB, Foldager CB, Hansen OM, Kristiansen AA, Le DQ, Nielsen AD, Nygaard JV, Bünger CE, 
Lind M. A novel nano-structured porous polycaprolactone scaffold improves hyaline cartilage repair 
in a rabbit model compared to a collagen type I/III scaffold: in vitro and in vivo studies. Knee Surg 
Sports Traumatol Arthrosc, 2012. 20: p. 1192-1204.
12. Araki S, Imai S, Ishigaki H, Mimura T, Nishizawa K, Ueba H, Kumagai K, Kubo M, Mori K, Ogasawara 
K, Matsusue Y. Improved quality of cartilage repair by bone marrow mesenchymal stem cells for 
treatment of an osteochondral defect in a cynomolgus macaque model. Acta Orthop, 2015. 86: p. 
119-126.
13. Igarashi T, Iwasaki N, Kawamura D, Kasahara Y, Tsukuda Y, Ohzawa N, Ito M, Izumisawa Y, Minami 
A. Repair of articular cartilage defects with a novel injectable in situ forming material in a canine 
model. J Biomed Mater Res A, 2012. 100: p. 180-187.
14. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM. Mesenchymal 
cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am, 1994. 76: 
p. 579-592.
15. Pei M, He F, Boyce BM, Kish VL. Repair of full-thickness femoral condyle cartilage defects using 
allogeneic synovial cell-engineered tissue constructs. Osteoarthritis Cartilage, 2009. 17: p. 714-722.
16. Lee JC, Min HJ, Park HJ, Lee S, Seong SC, Lee MC. Synovial membrane-derived mesenchymal stem cells 
supported by platelet-rich plasma can repair osteochondral defects in a rabbit model. Arthroscopy, 
2013. 29: p. 1034-1046.
17. Shimomura K, Moriguchi Y, Ando W, Nansai R, Fujie H, Hart DA, Gobbi A, Kita K, Horibe S, Shino K, 
Yoshikawa H, Nakamura N. Osteochondral repair using a scaffold-free tissue-engineered construct 
derived from synovial mesenchymal stem cells and a hydroxyapatite-based artificial bone. Tissue 
Eng Part A, 2014. 20: p. 2291-2304.
78
18. Xie XT, Wang Y, Zhao CJ, Guo SC, Liu S, Jia WT, Tuan RS, Zhang C. Comparative evaluation of MSCs 
from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. 
Biomaterials, 2012. 33: p. 7008-7018.
19. Masuoka K, Asazuma T, Hattori H, Yoshihara Y, Sato M, Matsumra K, Matsui T, Takase B, Nemoto K, 
Ishihara M. Tissue engineering of articular cartilage with autologous cultured adipose tissue-derived 
stromal cells using atelocollagen honeycomb-shaped scaffold with a membrane sealing in rabbits. J 
Biomed Mater Res B Appl Biomater, 2006. 79B: p. 25-34.
20. Kang HJ, Peng J, Lu SB, Liu SY, Zhang L, Huang JX, Sui X, Zhao B, Wang A, Xu W, Luo Z, Guo Q. In vivo 
cartilage repair using adipose-derived stem cell-loaded decellularized cartilage ECM scaffolds. J 
Tissue Eng Regen Med, 2014. 8: p. 442-453.
21. Perka C, Schultz O, Spitzer RS, Lindenhayn K. The influence of transforming growth factor beta 1 on 
mesenchymal cell repair of full-thickness cartilage defects. J Biomed Mater Res, 2000. 52: p. 543-552.
22. Schagemann JC, Erggelet C, Chung HW, Lahm A, Kurz H, Mrosek EH. Cell-laden and cell-free 
biopolymer hydrogel for the treatment of osteochondral defects in a sheep model. Tissue Eng Part A, 
2009. 15: p. 75-82.
23. Yan H, Yu CL. Repair of full-thickness cartilage defects with cells of different origin in a rabbit model. 
Arthroscopy, 2007. 23: p. 178-187.
24. Chung JY, Song M, Ha CW, Kim JA, Lee CH, Park YB. Comparison of articular cartilage repair with 
different hydrogel-human umbilical cord blood-derived mesenchymal stem cell composites in a rat 
model. Stem Cell Res Ther, 2014. 5: p. 39-52.
25. Cheng A, Kapacee Z, Hardingham T, Lucas R, Kimber S. Cartilage Repair using Human Embryonic 
Stem Cell-derived Chondroprogenitors. Stem Cells Transl Med, 2014. 3: p. 1287-1294.
26. Betsch M, Thelen S, Santak L, Herten M, Jungbluth P, Miersch D, Hakimi M, Wild M. The role of 
erythropoietin and bone marrow concentrate in the treatment of osteochondral defects in mini-pigs. 
PLoS One, 2014. 9: p. e92766.
27. Getgood A, Henson F, Skelton C, Herrera E, Brooks R, Fortier LA, Rushton N. The augmentation of a 
collagen/glycosaminoglycan biphasic osteochondral scaffold with platelet-rich plasma and 
concentrated bone marrow aspirate for osteochondral defect repair in sheep: a pilot study. Cartilage, 
2012. 3: p. 351-363.
28. Guo X, Park H, Young S, Kretlow JD, van den Beucken JJ, Baggett LS, Tabata Y, Kasper FK, Mikos AG, 
Jansen JA. Repair of osteochondral defects with biodegradable hydrogel composites encapsulating 
marrow mesenchymal stem cells in a rabbit model. Acta Biomater, 2010. 6: p. 39-47.
29. Dorotka R, Bindreiter U, Macfelda K, Windberger U, Nehrer S. Marrow stimulation and chondrocyte 
transplantation using a collagen matrix for cartilage repair. Osteoarthritis Cartilage, 2005. 13: p. 655-664.
30. Sosio C, Di Giancamillo A, Deponti D, Gervaso F, Scalera F, Melato M, Campagnol M, Boschetti F, Nonis 
A, Domeneghini C, Sannino A, Peretti GM. Osteochondral repair by a novel interconnecting colla-
gen-hydroxyapatite substitute: a large-animal study. Tissue Eng Part A, 2015. 21: p. 704-715.
31. Necas A, Plánka L, Srnec R, Crha M, Hlucilová J, Klíma J, Starβ D, Kren L, Amler E, Vojtová L, Jancár J, Gál 
P. Quality of newly formed cartilaginous tissue in defects of articular surface after transplantation 
of mesenchymal stem cells in a composite scaffold based on collagen I with chitosan micro- and 
nanofibres. Physiol Res, 2010. 59: p. 605-614.
32. de Vries RB, Buma P, Leenaars M, Ritskes-Hoitinga M, Gordijn B. Reducing the number of laboratory 
animals used in tissue engineering research by restricting the variety of animal models. Articular 
cartilage tissue engineering as a case study. Tissue Eng Part B Rev, 2012. 18: p. 427-235.
33. Leenaars M, Hooijmans CR, van Veggel N, ter Riet G, Leeflang M, Hooft L, van der Wilt GJ, Tillema A, 
Ritskes-Hoitinga M. A step-by-step guide to systematically identify all relevant animal studies. Lab 
Anim, 2012. 46: p. 24-31.
34. Sloff M, Simaioforidis V, de Vries R, Oosterwijk E, Feitz W. Tissue engineering of the bladder-reality or 
myth? A systematic review. J Urol, 2014. 192: p. 1035-1042.
35. Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M. Enhancing search efficiency by means of 
a search filter for finding all studies on animal experimentation in PubMed. Lab Anim, 2010. 44: 
p. 170-175.
79
Cartilage regeneration using cellular implants
Ch
ap
te
r  
  3
36. de Vries RB, Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M. A search filter for increasing 
the retrieval of animal studies in Embase. Lab Anim, 2011. 45: p. 268-270.
37. Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE’s 
risk of bias tool for animal studies. BMC Med Res Methodol, 2014. 14: p. 43-52.
38. Rutgers M, van Pelt MJ, Dhert WJ, Creemers LB, Saris DB. Evaluation of histological scoring systems 
for tissue-engineered, repaired and osteoarthritic cartilage. Osteoarthritis Cartilage, 2010. 18: p. 12-23.
39. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the 
size of a sample. BMC Med Res Methodol, 2005. 5: p. 13-23.
40. Higgins JPT, Green, S. Cochrane handbook for systematic reviews of interventions, 2011. London: The 
Cochrane Collaboration.
41. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical 
Computing 2011, Vienna, Austria. http://www.R-project.org/.
42. Schwarzer G. meta: General package for meta-analysis. R package version 4.1-0. http://
CRAN.R-project.org/package=meta
43. Xie A, Nie L, Shen G, Cui Z, Xu P, Ge H, Tan Q. The application of autologous plateletrich plasma gel in 
cartilage regeneration. Mol Med Rep, 2014. 10: p. 1642-1648.
44. Yao X, Ma X, Zhang Z. Chondrocyte allografts for repair of full-thickness defects in the condylar 
articular cartilage of rabbits. Chin J Dent Res, 2000. 3: p. 24-30.
45. Zhou M, Yu D. Cartilage tissue engineering using PHBV and PHBV/Bioglass scaffolds. Mol Med Rep, 
2014. 10: p. 508-514.
46. Marcacci M, Berruto M, Brocchetta D, Delcogliano A, Ghinelli D, Gobbi A, Kon E, Pederzini L, Rosa D, 
Sacchetti GL, Stefani G, Zanasi S. Articular cartilage engineering with Hyalograft C: 3-year clinical 
results. Clin Orthop Relat Res, 2005. 435: p. 96-105.
47. Bernhard JC, Vunjak-Novakovic G. Should we use cells, biomaterials, or tissue engineering for 
cartilage regeneration? Stem Cell Res Ther, 2016. 7: p. 56-65.
48. Deng Z, Jin J, Zhao J, Xu H. Cartilage defect treatments: with or without cells? Mesenchymal stem 
cells or chondrocytes? Traditional or matrix-assisted? A systematic review and meta-analyses. Stem 
Cells Int, 2016. 2016: p. 9201492.
49. Nejadnik H, Hui JH, Feng Choong EP, Tai BC, Lee EH. Autologous bone marrow-derived mesenchymal 
stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports 
Med, 2010. 38: p. 1110-1116.
50. Lee KB, Wang VT, Chan YH, Hui JH. A novel, minimally-invasive technique of cartilage repair in the 
human knee using arthroscopic microfracture and injections of mesenchymal stem cells and 
hyaluronic acid--a prospective comparative study on safety and short-term efficacy. Ann Acad Med 
Singapore, 2012. 41: p. 511-517.
51. Falah M, Nierenberg G, Soudry M, Hayden M, Volpin G. Treatment of articular cartilage lesions of the 
knee. Int Orthop, 2010. 34: 9. p. 621-630.
52. Kane P, Frederick R, Tucker B, Dodson CC, Anderson JA, Ciccotti MG, Freedman KB. Surgical restoration/
repair of articular cartilage injuries in athletes. Phys Sportsmed, 2013. 41: p.75-86.
53. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne 
JA; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration’s 
tool for assessing risk of bias in randomised trials. BMJ, 2011. 343: p. d5928.
54. Hooijmans CR, de Vries RB, Rovers MM, Gooszen HG, Ritskes-Hoitinga M. The effects of probiotic 
 supplementation on experimental acute pancreatitis: a systematic review and meta-analysis. PLoS 
One, 2012. 7: p. e48811.
55. Bello S, Krogsboll LT, Gruber J, Zhao ZJ, Fischer D, Hrobjartsson A. Lack of blinding of outcome assessors 
in animal model experiments implies risk of observer bias. J Clin Epidemiol, 2014. 67: p. 973-983.
56. Bebarta V, Luyten D, Heard K. Emergency medicine animal research: does use of randomization and 
blinding affect the results? Acad Emerg Med, 2003. 10: p. 684-687.
57. Hirst JA, Howick J, Aronson JK, Roberts N, Perera R, Koshiaris C, Heneghan C. The need for 
randomization in animal trials: an overview of systematic reviews. PLoS One, 2014. 9: p. e98856.
80
58. Kilkenny C, Browne WJ, Cuthi I, Emerson M, Altman DG. Improving bioscience research reporting: 
the ARRIVE guidelines for reporting animal research. PLoS Biol, 2012. 41: p. 27-31.
59. Hooijmans C, de Vries R, Leenaars M, Ritskes-Hoitinga M. The Gold Standard Publication Checklist 
(GSPC) for improved design, reporting and scientific quality of animal studies GSPC versus ARRIVE 
guidelines. Lab Anim, 2011. 45: p. 61. 
60. Chu CR, Szczodry M, Bruno S. Animal models for cartilage regeneration and repair. Tissue Eng Part B 
Rev, 2010. 16: p. 105-115. 
61. Ahern BJ, Parvizi J, Boston R, Schaer TP. Preclinical animal models in single site cartilage defect 
testing: a systematic review. Osteoarthritis Cartilage, 2009. 17: p. 705-713.
62. Hoemann CD, Chen G, Marchand C, Tran-Khanh N, Thibault M, Chevrier A, Sun J, Shive MS, Fernandes 
MJ, Poubelle PE, Centola M, El-Gabalawy H. Scaffold-guided subchondral bone repair: implication of 
neutrophils and alternatively activated arginase-1+ macrophages. Am J Sports Med, 2010. 38: p. 
1845-1856.
63. van der Linden MH, Saris D, Bulstra SK, Buma P. Treatment of cartilaginous defects in the knee: rec-
ommendations from the Dutch Orthopaedic Association. Ned Tijdschr Geneeskd, 2013. 157: p. A5719. 
64. Cousin MA, Greenberg AJ, Koep TH, Angius D, Yaszemski MJ, Spinner RJ, Windebank AJ. The value of 
systematic reviews in estimating the cost and barriers to translation in tissue engineering. Tissue 
Eng Part B Rev, 2016. 22: p. 430-437.
65. de Windt TS, Sorel JC, Vonk LA, Kip MM, Ijzerman MJ, Saris DB. Early health economic modelling of 
single-stage cartilage repair. Guiding implementation of technologies in regenerative medicine. J 
Tissue Eng Regen Med, 2016, in press.
66. Efe T, Theisen C, Fuchs-Winkelmann S, Stein T, Getgood A, Rominger MB, Paletta JR, Schofer MD. 
Cell-free collagen type I matrix for repair of cartilage defects-clinical and magnetic resonance 
imaging results. Knee Surg Sports Traumatol Arthrosc, 2012. 20: p. 1915-1922.
67. Kon E, Roffi A, Filardo G, Tesei G, Marcacci M. Scaffold-based cartilage treatments: with or without 
cells? A systematic review of preclinical and clinical evidence. Arthroscopy, 2015. 31: p. 767-775.
81
Cartilage regeneration using cellular implants
Ch
ap
te
r  
  3
Supplementary Information 1. Screening exclusion criteria.
Title screening
1. 
2. 
3. 
4. 
5. 
6. 
No primary study
No animal study
No bone marrow stimulation performed
Osteoarthritis models
Ex vivo studies
Deceased animals
Title/abstract screening
1. 
2. 
3. 
4. 
5. 
6. 
No primary study
No animal study
No bone marrow stimulation performed
Osteoarthritis models
Ex vivo studies
Deceased animals
Full-text screening
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
No primary study
No animal study
No ‘healthy’ animals (i.e. arthritis models)
No cartilage (i.e. bone or other tissue)
No articular cartilage (i.e. elastic cartilage)
Not in the knee or ankle joint (i.e. ear, rib)
No bone marrow stimulation performed
No scaffold implanted
No cell-free scaffold implanted
No cell-laden scaffold implanted
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Supplementary Information 6.  
The forest plot illustrates the difference in cartilage regeneration 
between cellular and acellular biomaterials of each individual study.
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Abstract
Aligned unidirectional collagen scaffolds may aid regeneration of those tissues 
where alignment of cells and extracellular matrix is essential, as for instance in 
cartilage, nerve bundles and skeletal muscle. Pores can be introduced by ice 
crystal formation followed by freeze-drying, the pore architecture reflecting the 
ice crystal morphology. In this study we developed a wedge-based system 
allowing the production of a wide range of collagen scaffolds with unidirectional 
pores by directional freezing. Insoluble type I collagen suspensions were frozen 
using a custom-made wedge system, facilitating the formation of a horizontal as 
well as a vertical temperature gradient and providing a controlled solidification 
area for ice dendrites. The system permitted the growth of aligned unidirectional 
ice crystals over a large distance (> 2.5 cm), an insulator prolonging the freezing 
process and facilitating the construction of crack-free scaffolds. Unidirectional 
collagen scaffolds with tunable pore sizes and pore morphologies were constructed 
by varying freezing rates and suspension media. The versatility of the system 
was indicated by the construction of unidirectional scaffolds from albumin, 
poly(vinyl alcohol) (a synthetic polymer), and collagen-polymer blends producing 
hybrid scaffolds. Macroscopic observations, temperature measurements and 
scanning electron microscopy indicated that directed horizontal ice dendrite 
formation, vertical ice crystal nucleation and evolutionary selection were the 
basis of the aligned unidirectional ice crystal growth, and hence the aligned 
unidirectional pore structure. In conclusion, a simple, highly adjustable freezing 
system has been developed allowing the construction of large (hybrid) bioscaffolds 
with tunable unidirectional pore architecture.
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Introduction
Tissue engineering and regenerative medicine aim to restore the structure and 
function of damaged tissues and organs. A commonly used strategy is the 
incorporation of cells and effector molecules into supporting structures, also 
referred to as scaffolds, to induce tissue regeneration. An important parameter for 
the guidance of tissue formation is the pore architecture of scaffolds. Typical 
isotropic scaffolds show uniformity in all orientations, but isotropy may be 
undesirable in tissues displaying an anisotropic extracellular matrix (ECM). In 
this case, application of isotropic scaffolds may result in structural and mechanical 
discordance with the surrounding tissue, and the use of scaffolds with anisotropic 
architecture is therefore favored [1].
 Construction of unidirectional scaffolds has been widely investigated, since 
they provide cues to direct growth of tissues along the aligned structures [2-4]. 
Aligned growth is important during, e.g., the formation of nerve bundles, skeletal 
muscle fibers, and cartilaginous tissue. In addition, longitudinal microchannels 
have been reported to increase cellular influx [5]. Anisotropic pore organization in 
scaffolds has been applied for the regeneration of a number of tissues, such as 
intervertebral disc [6], cartilage [7], muscle [8], tendon [9], and nerves [10]. Besides 
the pore orientation, physical parameters as intrinsic surface topographies 
influence cellular behavior [11].
 ECM proteins are appropriate substrates for scaffolding material because of 
their biocompatibility, biodegradability, bioactive properties, and, in case of 
collagen, low antigenicity. Type I collagen is the most abundant scaffolding 
material in the body, and can be used to construct scaffolds of different 
architectures [12]. Several methods have been developed to produce anisotropic 
unidirectional porous collagen-based scaffolds, such as lyophilization [13], electro-
spinning [14], and application of electrochemical gradients [15] and magnetic 
fields [16]. The requirement for complex equipment restricts wide applicability of 
most of these strategies. Moreover, many techniques require harsh operating 
conditions that can limit the use of biologicals, and the remaining organic solvents 
may cause in vivo toxicity [17]. From these techniques, lyophilization is a widely 
established method [18]. The pore architecture of scaffolds obtained by 
lyophilization reflects the ice crystal morphology obtained during freezing. 
Controlled growth of ice crystals forms the basis of the development of collagen 
scaffolds with a unidirectional structure and the final pore structure can be 
modified by adjusting the freezing regime [12]. Generally, comprehensive setups 
are employed to obtain unidirectional scaffolds by lyophilization [19]. For those 
studies reporting simple freezing strategies, one strategy is to dip collagen 
suspensions in freezing media [20], which may limit control over the freezing 
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process. Another simple approach is to fill a mold with collagen suspension and 
subsequently cool the mold with freezing media. Such simple molds typically 
consist of a metal surface and isolation, but generally result in limited homogeneity 
due to the lack of constant slow cooling [21]. To our knowledge the construction of 
collagen scaffolds with unidirectional pores over long distances (>2.5 cm) by 
controlled unidirectional freezing conditions have not been described before. 
The development of a simple adjustable system for the production of high quality 
tailor-made unidirectional collagen scaffolds may allow easy access to unidirectional 
scaffolds. Porous collagen scaffolds generally have rather weak mechanical strength. 
An improvement of (unidirectional) collagen scaffolds would be an increase in 
mechanical strength, such as tensile strength, fracture strength and compressive 
strength. Reinforced hybrid scaffolds prepared from premixed collagen and water- 
soluble polymers such as poly(vinyl alcohol) may aid interesting characteristics 
for tissue engineering applications [22]. In this study, we describe an adjustable 
directional freezing method to develop porous collagen scaffolds with aligned 
unidirectional pores, taking into account the physics of ice crystal growth. 
A custom-made wedge system was developed to aid controlled solidification, 
especially in the initial phases of the freezing process. The influence of freezing 
temperature, solvents, collagen concentration, and use of synthetic polymers are 
described.
Materials and methods
Preparation of scaffolds with aligned pores
Fibrillar insoluble type I collagen was isolated from bovine achilles tendon. The 
general procedure for scaffold construction comprised the preparation of a 0.7% 
(w/v) collagen suspension by incubating collagen fibrils overnight at 4 °C in 0.25 
M acetic acid (pH 2.7, Scharlau, Spain). The collagen suspension was homogenized 
on ice using a Teflon glass Potter-Elvehjem device (Louwers Glass and Ceramic 
Technologies, Hapert, The Netherlands) with an intervening space of 0.35 mm (10 
strokes). Air bubbles were removed by centrifugation at 117 g for 30 min at 4 °C. 
Unidirectional porous collagen scaffolds were produced by directional freezing of 
the collagen suspension using a custom-made wedge system (for an overview of 
the system, including dimensions, see Fig. 1).
 The system consisted of two wedges of anodized aluminum and polyurethane 
(Obomodulan®, type 652, Vink, Didam, The Netherlands) with thermal conductivities 
of 205 and 0.03 W/m·K, respectively. A 16 mm high reservoir of Scotch® tape was 
attached to the aluminum wedge. Styrofoam insulation (outer dimensions: W x L 
x H (mm): 45 x 70 x 40; inner dimensions: W x L x H (mm): 15 x 45 x 40) was placed 
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around the wedge system and reservoir to ensure a vertical temperature gradient 
without external disturbances. The wedge system was applied to induce a 
horizontal temperature gradient (see Figure 2B). The collagen suspension was 
pipetted into the reservoir. The wedge system was placed on a plateau of 
aluminum in a container and the collagen suspension was subsequently frozen 
using liquid nitrogen (-196 °C). The freezing medium was only in contact with 
Obomodulan and not with the aluminum (Fig. 1B). The system was left at ambient 
temperature during freezing. Scaffolds were prepared by freezing 10 ml of a 
collagen suspension followed by lyophilization for 2 days in a Zirbus freeze-dryer 
(Sublimator 500 II, Bad Grund, Germany). Next, scaffolds were stabilized using 
vapor fixation with 37% formaldehyde under vacuum for 30 min [5]. 
 The effect of different parameters on the pore structure was investigated, i.e., 
freezing temperature, collagen concentration, acetic acid concentration, addition 
of detergent, use of other components than collagen, and collagen/PVA blends 
(see Table 1). To investigate the effect of the freezing temperature and speed, 
the collagen suspension was also frozen using a mixture of dry ice and ethanol 
Figure 1  Experimental setup of the wedge system to construct unidirectional scaffolds. A) 
Wedge system used for the preparation of lyophilized unidirectional scaffolds. The gray and 
brown wedges represent aluminum and Obomodulan, respectively. The suspension is 
present in the blue reservoir made from Scotch tape. B) Front view of the wedge system in 
its experimental setup. The wedge system is placed on a plateau of aluminum in a styrofoam 
container. Styrofoam insulation surrounds the wedge system. The freezing medium is in 
direct contact with the wedge-shaped Obomodulan but not with the wedge-shaped 
aluminum.
45 mm
16 mm
3 mm
4 mm
16 mm
15 mm
16 mm
A
Level of freezing medium 
Styrofoam 
insulation
Styrofoam 
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ReservoirB
2 mm2 mm
Obomodulan wedge 
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Styrofoam container
Legend
90
(-78 °C). To study the effect of the volume of the applied collagen suspension, 
scaffolds were made using volumes up to 30 ml collagen suspension in 0.25 M 
acetic acid. Additional Scotch® tape was attached to the wedge system for a 32 mm 
high reservoir. To examine the effect of collagen concentration on pore structure, 
collagen suspensions of 0.4, 1.0, and 2.0% (w/v) were used. Collagen suspensions 
of 0.4% and 1% (w/v) were prepared similarly as 0.7% (w/v) while the 2.0% (w/v) 
collagen suspensions were homogenized by passing the suspension five times 
through a 50 ml syringe, followed by centrifugation at 2538 g for 45 min to remove 
air bubbles. To investigate the effect of a lowered surface free energy during ice 
crystal formation, a solution of 15 mM octyl β-D-glucopyranoside (Sigma-Aldrich), 
a nonionic detergent, in 0.25 M acetic acid was prepared, after which collagen 
fibrils were added. The effect of the suspension medium was further studied by 
altering the concentration of the acetic acid used. Preparation of collagen in 0.025 M 
acetic acid (0.15 wt%, pH 3.5), 0.25 M acetic acid (1.5 wt%, pH 2.7), and 2 M acetic acid 
(12 wt%, pH 2.5) were studied. As a reference, collagen fibrils were suspended in 
Milli-Q water. To investigate the versatility of the system for use of components 
other than collagen, scaffolds were prepared from 7% (w/v) bovine serum albumin 
(BSA, PAA Laboratories GmbH, Pasching, Austria) and 5, 10, 15, and 20% (w/v) 
poly(vinyl alcohol) (PVA, Sulkey of America, Kennesaw, GA, USA), all in 0.25 M 
acetic acid. Moreover, to investigate reinforcement of collagen scaffolds with 
synthetic polymers (hybrid scaffolds), mixtures of collagen and PVA (0.7% w/v 
collagen combined with 0.5, 1.0, 2.5, and 5.0% (w/v) PVA), in 0.25 M acetic acid, 
were prepared. All suspensions were homogenized using the Potter-Elvehjem 
device. 
Process of directional solidification
The process of planar ice dendrite formation was visualized by video capture 
using a Sony Cybershot DSC-H10 camera. To visualize the process, 10 ml of a 
solution of 0.25 M acetic acid was frozen using liquid nitrogen. A solution without 
collagen was used to circumvent interference caused by the cloudy appearance of 
the collagen suspension. 
 Temperature measurements were performed to characterize the freezing 
process. The temperature differences in the collagen suspension during the 
freezing process with liquid nitrogen and a mixture of dry ice and ethanol were 
measured n=3, in triplicate, at nine different locations (Fig. 2B) using thermocouples 
(Testo 922 and 925, Testo AG, Lenzkirch, Germany). Sensors were placed at three 
locations on the aluminum surface, from the thick aluminum part to the thin 
aluminum part (left: 0.5 cm, middle: 2.25 cm, right: 4 cm). Sensors were also placed 
at three heights from the surface of the aluminum (bottom: 0 mm, middle: 5 mm, 
top: 10 mm) at three different locations (left: 0.5 cm, middle: 2.25 cm, right: 4 cm). 
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As a control, sensors were placed on the aluminum surface (left: 0.5 cm, middle: 
2.25 cm, right: 4 cm) of a non-wedge, flat system (aluminum: W x L x H (mm): 15 x 
45 x 15; Obomodulan: W x L x H (mm): 15 x 45 x 3), and measurements were 
performed during freezing with liquid nitrogen. Temperature measurements 
were performed for 10 min with time intervals of 10 s for freezing at -196 °C and for 
45 min with 1 min time intervals for freezing at -78 °C. The duration of the freezing 
process was measured from the start of the measurement until collagen 
suspensions were macroscopically frozen. Freezing times are represented as mean 
± standard deviation (min). Cooling rates were calculated from 0 °C until -20 °C for 
temperature measurements at different heights. Cooling rates are represented as 
mean ± standard deviation (°C/min). Horizontal temperature differences between 
the left and the right sensor were calculated from 0 °C until -30 °C and are 
represented as mean ± standard deviation. The measured temperature difference 
between the left and the right sensor was divided by the distance between both 
sensors (3.5 cm) to calculate the temperature difference per cm (°C/cm).
Scaffold morphology
The morphology of the scaffolds was evaluated using scanning electron 
microscopy (JEOL SEM6340F, Tokyo, Japan). Samples were mounted on stubs and 
sputtered with a thin layer of gold using a Polaron E5100 Coating System [23]. 
Images were recorded using an accelerating voltage of 10 kV. Scaffolds were cut 
longitudinally and perpendicularly. High magnification images were taken from 
the lower parts of scaffolds to assess the development of unidirectional pores. 
Pilot experiments showed homogeneity in pore size distribution throughout the 
scaffolds. In a pilot study three scaffolds were extensively analyzed with respect 
to pore size. The following data were obtained from nine samples per scaffold at 
three locations - left, middle, right (see figure 2) and heights - 2, 6 and 10 mm. Pore 
sizes were 54 ± 9 µm, 50 ± 9 µm and 55 ± 9 µm. On the basis of these data we used 
one longitudinal and cross-section per scaffold for further analysis. Four images 
were recorded from random locations per cross-section and the lengths of the 
shortest axis of 50 pores were measured using ImageJ. This experiment was 
performed n=3 in triplicate. 
Statistics
Statistical analyses were performed using GraphPad Prism (GraphPad Software, 
Inc., version 5, La Jolla, CA, U.S.A.). Horizontal temperature differences between 
the left and the right sensor were determined by paired t-tests. The effect of the 
various experimental conditions was assessed by a repeated measures ANOVA 
with Tukey’s post-hoc test. Pore sizes are shown as mean ± standard deviation. 
P-values < 0.05 were considered statistically significant.
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Results
Construction of unidirectional collagen scaffolds
Collagen scaffolds with unidirectional pore architecture were constructed by 
directional freezing using the custom-made wedge system (Fig. 1). The system 
consists of two opposite wedges of aluminum (upper layer) and Obomodulan 
(lower layer) that differ in thermal conductivity. The Obomodulan wedge is a poor 
thermal conductor, acting as a mediator between the freezing medium and the 
aluminum wedge, resulting in slower freezing compared to the situation when 
the aluminum layer would be in direct contact with liquid nitrogen. After completion 
of the freezing process, frozen suspensions could easily be removed from the 
Scotch tape reservoir. No cracks were observed before or after lyophilization. 
 Temperature measurements during the freezing process indicated a large 
vertical temperature gradient (Fig. 2), resulting in freezing of the collagen 
suspension from the aluminum surface upward to where the collagen suspension 
was exposed to ambient temperature. Freezing at -196 °C and -78 °C resulted in 
cooling rates of 6.4 ± 1.2 °C/min and 0.3 ± 0.1 °C/min, respectively. Collagen 
suspensions were frozen after 11 ± 1 min and 50 ± 5 min for freezing at -196 °C for 
and -78 °C respectively. Macroscopic observations showed that the wedge system 
induced horizontal dendrite formation by the growth of ice dendrites over the 
aluminum surface of the wedge (Supporting Information 1, video). To evaluate 
the presence of a horizontal temperature gradient sensors were placed on the 
aluminum surface at three different locations. The sensor located on the thick 
aluminum part of the wedge always showed a lower temperature compared to 
sensors placed midway and on the thin aluminum part. The temperature 
difference between the left and right sensor was 1.1 ± 0.9 °C (p <0.0001) and 0.3 ± 
0.1 °C (p <0.0001) for -196 °C and -78 °C, respectively, resulting in temperature 
differences of 0.3 ± 0.3 °C/cm and 0.1 ± 0.0 °C/cm. This indicates the presence of a 
significant horizontal temperature gradient from left to right over the aluminum 
surface of the wedge system during the freezing process, for freezing at -196 °C as 
well as at -78 °C. Temperature measurements performed using the non-wedge, flat 
system did not reveal an obvious temperature differences between different 
horizontal locations. 
Scaffold characterization 
Directional freezing and lyophilization was applied to construct scaffolds with 
unidirectional pores. The collagen scaffolds constructed using the standard 
method (with 10 ml collagen suspension) comprised a height of 12 mm. In the 
lower parts of the scaffolds, SEM images (Fig. 3A) indicated a small area of round 
pores at the base of the freeze-dried scaffolds. Above this area, there was a small 
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Figure 2  Experimental setup of the wedge system to construct unidirectional scaffolds. 
Temperature gradients observed during construction of unidirectional scaffolds using 
the wedge system. Liquid nitrogen or dry ice/ethanol were used as freezing medium. 
The position of the sensors is indicated. See Fig. 1 for color coding of the wedge system. 
Data from representative measurements are shown. A) Vertical temperature gradient with 
cooling rates of 6.4 ± 1.2 °C/min and 0.3 ± 0.1 °C/min for liquid nitrogen and dry ice/ethanol 
respectively. B) Horizontal temperature gradient measured during the entire freezing 
process. The temperature difference between the left and right sensor was 1.1 ± 0.9 °C 
(p <0.0001) and 0.3 ± 0.1 °C (p <0.0001) for -196 °C and -78 °C, respectively. C) Horizontal 
temperature measurements performed using a non-wedge system indicated no obvious 
temperature differences between the left, middle and right part of the wedge.
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area where elongated pores were present in multiple directions. These observations 
indicate an initial process of nucleation and evolutionary selection (see the 
discussion). The height of the non-unidirectional area was less for higher freezing 
speeds, i.e., 2 and 3 mm for -196 °C and -78 °C, respectively. Above the non- 
unidirectional area (2 mm in height), unidirectional pores were present throughout 
the scaffold from base to top over a distance of 10 mm (Fig. 3B). The cross-sections 
of scaffolds (Fig. 3B) showed a honeycomb-like morphology of the pores with 
small openings in the pore walls. These openings provide interconnectivity 
between adjacent pores. Furthermore, thin thread-like struts bridging opposite 
pore walls were observed in both longitudinal and cross-sections.
 Scaffolds with a height of over 30 mm were constructed from a 30 ml collagen 
suspension using freezing at -196 °C and -78 °C (Fig. 3C). These scaffolds contained 
unidirectional pores over a length of about 28 mm. 
Control of pore morphology
For an overview of the parameters examined and results obtained see Table 1.
Table 1   Overview of parameters examined and results obtained with respect to pore 
size/structure.
Parameters Results
Freezing temperature 
   Liquid nitrogen
   Dry ice/ethanol
Pore size smaller  for  lower freezing temperatures
Collagen concentration 
   0.4% - 2.0 % (w/v)
Pore size smaller for increased collagen concentration
Detergent
   No
    15 mM octyl β-D-glycopyranoside
Pore size smaller by incorporation of a detergent
Acetic acid concentration
   0 - 2 M
Pore size larger  and wall structure more closed for 
increased acetic acid concentration
(Bio)molecule
   Bovine serum albumin
   Polyvinyl alcohol
    Collagen + polyvinyl alcohol
Unidirectional scaffolds with  morphology  dependent 
on type  and concentration of molecule
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Figure 3  Scanning electron microscopical characterization of scaffolds constructed by 
freezing with liquid nitrogen or a mixture of dry ice and ethanol. A) Round pores (arrows) 
were present at the base of the scaffolds, indicating ice crystal nucleation. Elongated pores 
in different directions were present above the area of nucleation, indicating evolutionary 
selection. The area of nucleation and evolutionary selection appears smaller in the case of 
freezing with liquid nitrogen compared to a mixture of dry ice and ethanol. B) High 
magnification of the unidirectional pore structures in a longitudinal and cross-sectional 
view. The pores have a hexagonal/elliptic morphology, and are smaller with higher freezing 
speed (-196 °C: 66 ± 11 µm and -78 °C: 146 ± 30 µm, p <0.0001). C) Panorama views of 
longitudinal sections of unidirectional scaffolds made using a 30 ml collagen suspension. 
Unidirectional pores run from bottom to top over a length of > 25 mm. Scale bars in main 
figure A are 1 mm and in close-ups 300 µm, in B 100 µm and in C 1 mm.
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Freezing temperature
Pore sizes in scaffolds could be affected by freezing temperature: a fast freezing 
process using liquid nitrogen resulted in smaller pores compared to freezing using 
a mixture of dry ice and ethanol (66 ± 11 µm for -196 °C: 146 ± 30 µm for -78 °C, 
p < 0.0001). 
Collagen concentration
Scaffolds with aligned unidirectional pores were constructed using four collagen 
concentrations. Pore diameters were affected by collagen concentration (Fig. 4), 
and were 74 ± 13, 66 ± 11, 63 ± 9, and 50 ± 10 µm in 0.4, 0.7, 1.0, and 2.0% scaffolds, 
respectively (p < 0.0001). For all collagen concentrations, honeycomb-like pores 
were observed in the scaffolds with no apparent differences in wall thickness. 
Figure 4  Scaffolds constructed from suspensions with different collagen concentrations. 
Scaffolds with unidirectional pores could be prepared for all applied collagen concentrations. 
Hexagonal/elliptic pores in the scaffolds were observed, with no apparent differences in 
wall thickness. An increase in collagen concentration resulted in an increase in the number 
of pores and a decrease in pore size (***: p < 0.0001). Scale bars represent 100 µm.
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Although no mechanical tests were performed, handleability of the scaffolds 
improved with increased collagen concentration.
Incorporation of detergents
Production of scaffolds from a collagen suspension in 15 mM octyl β-D-glycopyra-
noside in 0.25 M acetic acid also resulted in unidirectional collagen scaffolds after 
freezing and lyophilization. The wall structure was similar to scaffolds prepared 
using 0.25 M acetic acid without this non-ionic detergent, but a decrease in pore 
size from 66 ± 11 µm to 57 ± 10 µm was noted (p < 0.0001, results not shown). 
Concentration of acetic acid
Unidirectional collagen scaffolds could be constructed from collagen suspensions 
Figure 5  Unidirectional collagen scaffolds prepared from collagen suspensions with 
different concentrations of acetic acid. An increase in the concentration of acetic acid 
resulted in scaffolds with a less thread-like more closed wall structure and increased pore 
sizes (***: p < 0.0001). Scale bars represent 100 µm.
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with different concentrations of acetic acid. For reference, collagen fibrils were 
incubated in Milli-Q water. The pores in these scaffolds consisted of thread-like 
structures and thin walls. SEM images indicated that the unidirectional pore 
structure was present, although somewhat masked by the highly thread-like 
structure. Morphologically, scaffolds prepared using collagen suspended in 
0.025 M acetic acid resembled the structure of scaffolds prepared using collagen 
suspended in Milli-Q water (Fig. 5). When increasing the concentration of acetic 
acid from 0.025 M to 0.25 M acetic acid, scaffolds became less filamentary and the 
wall structure was more closed. A further increase of the acetic acid concentration 
from 0.25 M to 2 M acetic acid further reduced the fibrillar nature of the scaffolds 
with an even more closed wall structure. The scaffolds showed no obvious 
differences in wall thickness. The pore sizes in the scaffolds were 32 ± 7 µm, 49 ± 
9 µm, 66 ± 11 µm and 87 ± 15 µm for Milli-Q water, 0.025 M, 0.25 M and 2 M acetic 
acid (p < 0.0001), respectively.
Application of system to other (bio)molecules
To evaluate the general applicability of the system, scaffolds with unidirectional 
pores were constructed using another protein (albumin), a synthetic polymer 
Figure 6  Versatility of the wedge system: unidirectional scaffolds prepared from 
poly(vinyl alcohol) (PVA, a synthetic polymer), and collagen + PVA. A) Longitudinal sections 
of unidirectional scaffolds prepared with various concentrations of PVA. The unidirectional 
pore structure was observed for all concentrations. Pore sizes decreased with increasing 
concentrations of PVA. B) Longitudinal sections of unidirectional hybrid collagen-PVA 
scaffolds. A mixed morphology resembling features from both collagen and PVA scaffolds 
was observed. Scale bars represent 100 µm.
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(PVA), or a mixture of a protein + polymer (collagen + PVA). The unidirectional 
pore orientation was clearly observed in scaffolds constructed from albumin. 
Albumin-based scaffolds displayed similar characteristics as those made from 
collagen, including a small area at the base of the scaffold of rounded pores and 
elongated pores in different directions (data not shown). Above this non-unidi-
rectional area, unidirectional pores were present. The cross-sections showed that 
the pores were irregular and oblong shaped. In general, albumin scaffolds 
consisted of smooth wall structures with additional globular structures. 
 Freezing of PVA suspensions at varying polymer concentration also resulted 
in scaffolds with unidirectional pores (Fig. 6A). Morphologically, the wall 
structure resembled a fishbone-like arrangement, and an increase in polymer 
concentration resulted in a decrease in pore size with an increase in wall thickness.
 Hybrid unidirectional scaffolds were constructed using 0.7% (w/v) collagen 
in combination with different concentrations of PVA: 0.5%, 1.0%, 2.5%, and 5% 
(w/v) (Fig. 6B). The structure of hybrid scaffolds containing 5% PVA showed a 
mixed morphology combining the architecture observed for 5% PVA and 0.7% 
collagen scaffolds. The walls of hybrid scaffolds were thicker compared to those 
seen in collagen-only scaffolds. Moreover, a more fibred morphology was present 
in hybrid scaffolds compared to polymer-only scaffolds due to the addition of 
collagen, especially in the fibers crossing the pores. With lowered concentrations 
of PVA, the structure shifted to that observed for collagen scaffolds. The 
handleability of the scaffolds was improved by the incorporation of PVA compared 
to collagen scaffolds.
Discussion
Large collagen scaffolds with unidirectional pore architecture were constructed 
by freezing collagen suspensions using liquid nitrogen or a mixture of dry ice and 
ethanol, applying a wedge-like construct consisting of both a thermal conductor 
and insulator. The delayed freezing process by the insulator may have aided in the 
development of crack-free scaffolds, whereas cracks were observed after fast 
freezing of collagen suspensions in metal casts in direct contact with liquid 
nitrogen. Moreover, changing the materials of the metal wedge and insulator to 
materials with different thermal conductivities may allow adaptation of ice 
crystal growth [24]. The wedge shape induced a small but significant horizontal 
temperature gradient, likely facilitating local nucleation at the coldest point, 
followed by laterally directed ice crystal growth over the metal surface which 
stabilizes unidirectional crystal growth. The horizontal temperature gradient 
may have introduced small differences in height between adjacent upward 
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growing ice crystals, thereby blocking inclined growing of ice crystals, and 
resulting in a stabilized upward growth of ice crystals (Fig. 7). A steeper angle of 
the wedge may give rise to a larger horizontal temperature gradient and thus 
improved stabilized unidirectional crystal growth.
 Four steps can be identified during the formation of unidirectional collagen 
scaffolds as based on optical observations, temperature measurements and SEM 
analyses (Fig. 7): (1) formation of a horizontally oriented network of ice dendrites, 
(2) development of vertical protrusions and/or nuclei, (3) evolutionary selection of 
the vertical growth direction, and (4) unidirectional (mainly cellular) ice crystal 
growth. Step 1: At the interface between the aluminum surface and collagen 
suspension, the ice nuclei that rapidly become dendrites protrude horizontally. 
The dendrites initially form at the coldest part of the wedge (the thick aluminum 
part) and spread over the aluminum surface, owing to the horizontal temperature 
Figure 7  Proposed physical principles underlying the formation of aligned unidirectional 
scaffolds. A) Schematic representation of the physical processes occurring during directional 
solidification, resulting in unidirectional ice crystal growth. The direction of the growing 
ice front is facilitated by the wedges, providing a controlled solidification area for ice 
dendrites. Nucleation sites develop, which merge into ice crystals by evolutionary selection 
[27], and grow upward due to the vertical temperature gradient. The horizontal temperature 
gradient, facilitated by the wedge shape, may stabilize the formation of aligned 
unidirectional ice crystals. B) The planar ice surface progresses into an unstable surface as 
the result of physical disturbances in freezing media. Ice crystals grow out from protrusions 
or nuclei formed by these instabilities. Growth of ice crystals is guided by the vertical 
temperature gradient. Collagen fibrils and other particles are entrapped between the 
growing ice crystals. Figure 7B was adapted from Deville et al. [30]. Copyright Wiley‐VCH 
Verlag GmbH & Co. KGaA. Reproduced with permission.
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gradient realized by the wedge-shaped metal. The horizontal temperature 
gradient thus provides a controlled solidification area for ice dendrites. Step 2: 
On top of the initial planar layer of dendrites, upward pointing protrusions may 
form on the ice dendrite arms as a result of morphological (so-called Mullins- 
Sekerka) instabilities [25]. An alternative possibility is a preferential heterogeneous 
nucleation of upward pointing ice crystallites on the dendrite arms. These 
nucleation sites left a mark as round pored structures at the base of the scaffolds 
(Fig. 3). The nucleation mechanisms and crystal growth phenomena have recently 
been reviewed by Pawelec and co-workers [26]. Step 3: Evolutionary selection 
takes place in which only a selection of growing ice crystals will continue and 
form the structure of the unidirectional scaffold, protruding upward from the 
aluminum surface [27]. During evolutionary selection non-perpendicular 
growing ice crystal needles collide with perpendicular growing needles and stop 
growing. Only perpendicular growing ice crystals survive and continue growing. 
This process is likely the result of the combined vertical and horizontal temperature 
gradient. A similar mechanism was observed by Pawelec et al., demonstrating 
the transformation from isotropic (nucleation sites), via evolutionary selection, 
to growth of aligned pores upward. The non-unidirectional area was present 
throughout the whole sample, which may be addressed to the slow freezing 
applied, while in our experiments relatively fast-freezing was used [28]. 
 Step 4: the further unidirectional upward cellular growth of the ice crystals 
after evolutionary selection is supported by the vertical temperature gradient. 
During freezing of the collagen suspension, ice and collagen/acetic acid/water 
compartments are formed. Aqueous acetic acid is a eutectic system (eutectic 
point: -26.7 °C, at a 60% (v/v) acetic acid to water ratio) [29], which results in com-
partmentalization during the freezing process: a compartment of frozen water 
and a compartment with concentrated liquid acetic acid in which the collagen 
fibers can be found (we assume that the collagen fibrils do not affect the eutectic 
point or the freezing process).
 After lyophilization, pores showed a honeycomb-like morphology with thin 
bridging structures and openings in the wall. The development of the 
honeycomb-like structure can be explained by stacking of dendrites during 
cellular growth and the bridging structures by dendrite growth [19]. Openings in 
the wall structure are explained by the formation of side branches of ice crystals 
(branching phenomenon). These ice protrusions result in a continuous-interpene-
trating network of ice crystals intertwined with collagen [31]. The characteriza-
tion of the scaffolds indicated homogeneous pore size distributions throughout 
the scaffolds, whereas other studies often describe a gradual increase in pore size 
upward [28, 32]. Since the basis of the unidirectional collagen scaffolds preparation 
is the formation and growth of ice crystals, manipulation of ice crystal growth 
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offers possibilities to control scaffold parameters such as pore size and wall 
morphology, thus facilitating the construction of a range of collagen scaffolds 
with different characteristics.
 Fast freezing using liquid nitrogen resulted in smaller pore sizes compared to 
slower freezing using a mixture of dry ice and ethanol. This complies with the 
well-known fact that dimensions of growing ice crystals generally decrease with 
increasing growth velocity [33]. Similar effects of the freezing rate on pore size 
have been reported extensively in literature [9, 12]. The thermal conductivity of 
the materials used is an important parameter. For instance, Schoof et al. [19] 
reported pore sizes of approximately 23 µm for collagen in 1.5 wt% acetic acid 
(resembling approximately 0.25 M acetic acid) frozen using copper blocks at a 
temperature of -180 °C, whereas Madaghiele et al. [2] reported pore sizes of 33 µm 
for collagen in hydrochloric acid frozen using liquid nitrogen-cooled copper blocks, 
while we measured pore sizes of 66 µm for freezing with liquid nitrogen. The 
insulator applied in our experiments delayed the freezing process and attributed 
to the larger pore size. 
 Unidirectional collagen scaffolds were constructed with various collagen 
concentrations where an increase in collagen concentration resulted in a slight 
decrease in pore size. Similar trends were shown by Madaghiele et al. where an 
increase in collagen concentration from 0.5% to 2% (in hydrochloric acid) frozen 
with liquid nitrogen resulted in a decreased pore size from 33 to 23 µm after 
lyophilization [2]. This result is in agreement with data shown by Pawelec et al. 
where 0.5% and 1% collagen scaffolds contained respectively pore sizes of 120 - 
170 µm and 90 - 160 µm [28]. 
 Next to freezing temperature and collagen concentration, ice crystal growth 
was influenced by detergents, such as octyl β-D-glycopyranoside, which tend to 
accumulate at the interface between the two phases (the solid (ice) and liquid 
(suspension) phases) where they decrease the surface energy (tension) to facilitate 
nucleation, resulting in smaller pores [34].
 The properties of the suspension medium also influenced pore size in 
unidirectional scaffolds. Collagen scaffolds made from increasing concentrations 
of acetic acid resulted in scaffolds with larger pore sizes, in line with observations 
made by Schoof et al. who also showed that an increase in acetic acid concentration 
resulted in an increase in pore size (20 – 40 um for 1.5 - to 3.8 wt%) [19].
 Unidirectional scaffolds have been constructed from other proteins than 
collagen and albumin, e.g. Zhang et al. prepared unidirectional scaffolds from silk 
fibroin and showed that an increase in silk fibroin concentration resulted in a 
decreased pore size, an improved pore orientation and an increased wall thickness 
[10]. Similar trends were described regarding PVA scaffolds by Gutiérrez et al. [35]. 
In our experiments, the increased wall thickness was only observed for scaffolds 
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prepared using BSA and PVA but not for collagen scaffolds, suggesting that 
different proteins/particles can be present varying compactness that influences 
ice crystal formation.
 In this study, hybrid collagen/polymer scaffolds were prepared by mixing 
collagen and PVA prior to freezing and lyophilization. This method allows the 
freezing process to be the determining parameter for the final scaffold 
architecture. Other studies have created hybrid constructs by combining polymer 
meshes with hydrogels [36] or with a collagen/chitosan suspension prior to 
freeze-drying [37]. A limitation of such a strategy is that the meshes may have an 
effect on ice crystal growth during freezing and thus on the final pore structure 
of the freeze-dried scaffold.
 Tissue engineering strategies generally encompass the use of scaffolds as 
cell-carriers and the incorporation of effector molecules to direct cellular ingrowth 
and differentiation [24, 38]. Unidirectional collagen scaffolds may provide 
improved cellular ingrowth as the result of the unidirectional architecture [1, 31]. 
An application for these scaffolds may be the regeneration of articular cartilage. 
Stimuli such as SDF-1α and growth factors of the BMP family may be coupled 
to the scaffold to attract mesenchymal stromal cells from the underlying 
subchondral bone and induce chondrogenesis, while the architecture facilitates 
migration of cells throughout the scaffold [39, 40].
 The incorporation of (biodegradable) polymers is an option to improve the 
mechanical strength of collagen scaffolds, as indicated in this study for PVA, a 
FDA approved, biocompatible, and water-soluble polymer. Especially for 
load-bearing applications, an improvement of the mechanical strength is required 
to develop long-lasting implants [36]. 
 The custom-made wedge system presented here allows a wide range of 
unidirectional scaffolds to be created in a simple manner and at low cost.
Conclusion
Porous scaffolds with unidirectional anisotropic pores were constructed by 
directional freezing using a custom-made wedge system. The mechanism of 
unidirectional ice crystal growth was elucidated, and ice crystal growth was 
manipulated to develop a wide range of unidirectional collagen scaffolds with 
distinctive pore structures.
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Abstract
Porous scaffolds constructed from type I collagen fibrils by freezing and 
lyophilization are frequently used for tissue engineering applications. Varying 
freezing conditions can adjust pore architecture, e.g. isotropic (random-oriented) 
vs. anisotropic (aligned) pores. A typical drawback of collagen scaffolds in vitro is 
the limited cell infiltration which hampers the development of cellular constructs. 
In this study, we evaluated cell seeding procedures for both isotropic and 
anisotropic collagen scaffolds and investigated the effect of pore orientation on 
cell seeding efficacy, distribution and infiltration, and on tissue formation using 
C2C12 murine skeletal muscle myoblasts and human adipose-derived stem cells. 
Larger seeding volumes could only be applied for anisotropic scaffolds and 
resulted in a more equally distributed population of cells. For isotropic scaffolds 
cells resided more at the scaffold surface, while in anisotropic scaffolds they 
infiltrated further into the scaffold. Tissue formation, as judged by e.g. extracellular 
matrix formation, was also observed deeper in anisotropic scaffolds compared to 
isotropic scaffolds, and was deposited according to the scaffold template provided. 
In conclusion, anisotropic scaffolds allow increased cell infiltration, better cell 
distribution and result in more tissue formation in the scaffold in vitro.
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Introduction
Tissue engineering aims to restore structure and function of damaged tissues. 
The general approach encompasses the development of scaffolds, which act as 
extracellular matrix (ECM) and provide a 3D environment for cells stimulating 
tissue regeneration [1]. Scaffolds can be constructed from various materials of 
which type I collagen, the main scaffolding material of the body, offers a number 
of valuable properties including biocompatibility, biodegradability, bioactivity 
and low antigenicity [2]. Type I collagen can be used to prepare hydrogels and 
porous scaffolds. The application of porous scaffolds prepared from insoluble 
collagen fibrils may be favorable since they generally provide better mechanical 
characteristics than hydrogels and collagen fibrils are the structural elements 
used by nature. For the construction of hydrogels, type I collagen needs to be 
solubilized [3], allowing homogeneous cell encapsulation [4], which is generally 
not observed in isotropic collagen scaffolds in vitro [5]. The use of anisotropic 
rather than isotropic collagen scaffolds may improve cellular infiltration [2], and 
allow improved development of cellular constructs in vitro. Anisotropic scaffolds 
can be constructed by freezing and lyophilization, resulting in aligned pores [2]. 
The pore orientation is crucial for proper functioning of tissues and plays an 
important role in the biomechanical properties of scaffolds [6]. In addition, the 
direction of newly formed ECM is dependent on the structure of the provided 
scaffold template [7, 8]. 
 In this study, we directly compared isotropic and anisotropic collagen scaffolds 
with respect to cell seeding efficacy, cell distribution and tissue formation. 
Materials and methods
Isotropic collagen scaffolds were prepared by freezing 0.7% (w/v) collagen 
suspensions (in 0.25 M acetic acid) in 6-well plates (7.5 ml/well) at -20 °C, followed 
by lyophilization [8] (Fig. 1A). To construct anisotropic collagen scaffolds, collagen 
suspensions were frozen by directional freezing (10 ml/scaffold) using liquid 
nitrogen [2]. Scaffolds were strengthened by vapor fixation with formaldehyde 
under vacuum (Fig. 1B), processed into their final dimensions (diameter: 12 mm, 
height: 4 mm, Fig. 1C), and further crosslinked using N-ethyl-3-(3-dimethylamino-
propyl)-carbodiimide (EDC) and N-hydroxysuccinimide (NHS, Fig. 1B). Scaffolds 
were sterilized with 25 kGy γ-irradiation [9].
 Scaffold morphology was assessed using scanning electron microscopy. 
Sample preparations and recordings were performed as described [2].
112
 C2C12 murine skeletal muscle myoblasts were used to evaluate cell seeding 
procedures, while both C2C12 cells and human adipose-derived stem cells (ADSCs) 
were employed to investigate the effect of pore orientation. Cell culture 
experiments were performed n=3 with each condition in triplicate. 
 C2C12 myoblasts were expanded [10] and harvested (P23-24) [9], followed by 
assessing optimal cell seeding volumes and efficacies. Cell suspensions (100 µl 
and 250 µl, both with 2.5 x 106 cells) were dripped on scaffolds placed on autoclaved 
Whatman paper to allow infiltration by capillary force (Fig. 1C, [9]). Scaffolds were 
incubated at 37 °C for 3 h and transferred to new 12-well plates, prior to adding 
proliferation medium [10] and harvesting for DNA analysis. As controls for DNA 
analysis, cell pellets (2.5 x 106 cells) were prepared by centrifugation at 104g for 
5 min. Unless stated otherwise, 100 µl cell suspensions (2.5 x 106 cells) were used 
for further experiments. Seeded scaffolds were cultured for 14 days (7 days 
proliferation medium and 7 days differentiation medium [10]), with medium 
refreshed every 3 days. 
 Human ADSCs were obtained from healthy donors undergoing reconstructive 
procedure (Radboud university medical center, Nijmegen, The Netherlands) and 
expanded [11]. Cells (P4) were seeded as described above and cultured with 
scaffolds for 21 days in α-MEM and chondrogenic medium [12], with medium 
refreshed every 3 days. 
 DNA analysis was performed after papain digestion and measured with 
Hoechst 33342 solution using calf thymus DNA as standard [9] and cell pellets as 
a reference for the total number of cells. qPCR analysis was performed as described 
previously [9], using primers for glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), perinatal myosin heavy chain (pMHC), myogenin and actinin [13]. 
Results were expressed as quantification cycle (Cq) and normalized to GAPDH. 
Cells cultured in monolayer (5,000 cells/well in 12-wells plate) were used as a 
reference. For (immuno)cytochemistry, scaffolds were processed [9] and stained 
with hematoxylin and eosin (H&E) and Alcian blue [12], or with antibodies 
against myosin (1:400, MY-32, Sigma-Aldrich) [13] and chondroitin sulfate [9]. 
Cell infiltration depth was determined using ImageJ using two methods: 1) by 
measuring the maximum depth where three single cells were located (linear 
intercept) and 2) by measuring the depth where three groups of at least 5 cells 
were observed.
 GraphPad Prism (GraphPad Software, Inc., version 5, La Jolla, CA, U.S.A.) was 
used to perform statistical analysis. Results are shown as mean ± standard 
deviation. Repeated measures ANOVA with Tukey’s post-hoc tests was performed 
to compare groups, where p-values < 0.05 are considered statistically significant.
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Results
Random and directional freezing of collagen suspensions and lyophilization 
yielded collagen scaffolds with isotropic and anisotropic pore architectures (Fig. 
1A). Pore diameters were 89 ± 24 µm [8] and 66 ± 11 µm [2] for isotropic and 
anisotropic scaffolds, respectively. 
 Placing scaffolds on Whatman paper prior to cell seeding enhanced the influx 
of cells into the scaffolds. Without Whatman paper, cell seeding was difficult for 
both isotropic and anisotropic scaffolds because the scaffolds were wet after the 
scaffold processing techniques causing cell suspensions to spill over the edges of 
the scaffolds. Drying of scaffolds by freeze-drying was unfavorable since the 
additional freezing step damages the pore architecture formed during the initial 
freezing process.
 For both isotropic and anisotropic scaffolds, the distribution of cells over the 
scaffold surface during the seeding procedure was more equal with larger 
volumes. Comparing seeding volumes of 250 µl to 100 µl, cells distributed better 
over the scaffold surface in case of 250 µl, whereas cells were unequally distributed 
with local high cell densities with 100 µl. For isotropic scaffolds seeded with a 
volume of 250 µl, the uptake of the cell suspension was limited, while anisotropic 
scaffolds did allow the infiltration of the whole cell suspension. DNA content was 
therefore significantly lower (p < 0.001) for isotropic scaffolds (18 ± 4 µg, Fig. 2A) 
compared to anisotropic scaffolds (51 ± 7 µg) and control cell pellets (2.5 x 106 cells; 
46 ± 4 µg). For a seeding volume of 100 µl, cell suspensions could fully enter both 
scaffold types. No differences were found in cell seeding efficiency between 
isotropic scaffolds (56 ± 5 µg, Fig. 2A), anisotropic scaffolds (54 ± 8 µg) and control 
cell pellets (56 ± 7 µg). In order to compare isotropic and anisotropic scaffolds, 
100 µl was applied as cell seeding volume for in vitro experiments.
 Seeded C2C12 myoblasts and ADSCs penetrated further into the anisotropic 
scaffolds, while the cells mainly resided at the seeding side for isotropic scaffolds 
(Fig. 2B). Consequently, higher cell densities were present on top of isotropic 
scaffolds compared to anisotropic scaffolds. Linear depth intercept was 1.4 ± 
0.2 mm and 0.9 ± 0.3 mm in anisotropic and isotropic scaffolds, respectively 
(p < 0.001). Groups of five cells were found almost twice as deep (p < 0.01) in 
anisotropic (0.9 ± 0.4 mm) compared to isotropic scaffolds (0.5 ± 0.2 mm).
 For ADSCs, cartilage matrix formation was deposited according to the 
provided template. Most staining was found at the seeding side of the scaffolds 
(control staining were negative, data not shown), and deeper into anisotropic 
scaffolds compared to isotropic scaffolds (Fig. 2C). Therefore, the use of anisotropic 
scaffolds may be beneficial in vivo for the regeneration of aligned tissues, including 
tendon, muscle, nerves and cartilage [2].
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Figure 1  Schematic illustration of the process from scaffold construction to cell seeding. 
A) Collagen suspensions were frozen by random or directional freezing (A1), yielding 
scaffolds with isotropic or anisotropic pores (A2). Scale bars represent 100 µm. B) Scaffolds 
were strengthened by vapor fixation with formaldehyde (B1), processed into their final 
dimensions (B2), and crosslinked using EDC/NHS (B3). C) Cell suspensions were dripped on 
top of wet, sterilized scaffolds, while the scaffolds were placed on Whatman paper, to allow 
infiltration of the cell suspension in the scaffold by capillary force.
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For C2C12 myoblasts, the anisotropic pore architecture facilitated the formation of 
aligned elongated cellular structures, indicating fusion of myoblasts, while only 
randomly-oriented staining was observed in isotropic scaffolds (Fig. 2D). PCR 
analysis, however, indicated no differences in actinin, myogenin and pMHC gene 
expressions between isotropic and anisotropic scaffolds (data not shown).
 In conclusion, anisotropic scaffolds facilitated cell infiltration best, and may 
be the scaffolds of choice to develop cellular constructs in vitro. Additionally, the 
anisotropic pore architecture enabled aligned tissue formation, important for the 
regeneration of tissues with an anisotropic extracellular matrix.
Figure 2  Seeding volume affects seeding efficacy, pore orientation affects cell infiltration 
and matrix deposition. A) The number of cells seeded was significantly (***: p < 0.001) 
reduced for isotropic scaffolds using 250 µl as seeding volume. Cell pellet reflects the total 
number of cells seeded. B) The anisotropic pore orientation facilitated the influx of cells, 
while cells seeded on isotropic scaffolds were largely present at the scaffold surface. C) 
Cartilage matrix produced by ADSCs was deposited deeper in anisotropic scaffolds 
compared to isotropic scaffolds. D) Using C2C12 myoblasts, alignment of cells (indicated by 
arrows) was observed in anisotropic scaffolds only. Scale bars represent 400 µm in (B) and 
100 µm in (C) and (D). ADSCs: adipose-derived stem cells.
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Abstract
The construction of scaffolds and subsequent incorporation of cells and biologics 
have been widely investigated to regenerate damaged tissues. Scaffolds act as a 
template to guide tissue formation and their properties have considerable impact 
on the regenerative process. Whereas many technologies exist to induce specific 
2D morphologies into biomaterials, the introduction of 3D micro-morphologies 
into scaffolds produced from biological molecules poses a challenge. Scaffolds 
based on collagen are generally prepared by freezing and lyophilization. Variation 
in the speed of freezing allows for specific overall pore architecture, but cannot be 
used for the introduction of specific micro-morphologies into each individual pore 
wall. We here report the use of dicarboxylic acids to induce specific micro- 
morphologies in collagen scaffolds, and evaluate the effect of micro-morphologies 
on cellular migration and differentiation. Insoluble type I collagen fibrils were 
suspended in monocarboxylic acids and dicarboxylic acids of different concentrations, 
and unidirectional and random scaffolds were constructed by freezing/ 
lyophilization. Scanning electron microscopy was used to investigate scaffold 
morphology and pore sizes. C2C12 cells were seeded on scaffolds with smooth and 
frayed-like pores and cultured for two weeks. Readout parameters included 
(immuno)cytochemistry and molecular biological analysis. Applying various acids 
and concentrations resulted in variations in 3D micro-morphologies, including 
wall structure, wall thickness and pore size. The use of dicarboxylic acids resulted 
in acid specific differences in pore structures, whereas monocarboxylic acids did 
not result in remarkable structural differences. Dicarboxylic acids with an odd or 
even number of C-atoms resulted in frayed or smooth wall structures, respectively, 
although with varying appearances. Formation of micro-morphologies was 
concentration dependent. In vitro analysis indicated cytocompatibility of scaffolds 
and enhanced myosin staining and myosin heavy chain gene expression levels 
for C2C12 cells cultured on scaffolds with frayed-like micro-morphologies compared 
to smooth micro-morphologies. In conclusion, porous collagen scaffolds with 
various 3D micro-morphologies can be constructed, acid crystal formation is key 
to the specific micro-morphologies observed and modulation of crystal growth by 
dicarboxylic acids allows generation of micrometer-defined topographies. These 
3D micro-morphologies may be used as a screening platform to select optimal 
substrates for the regeneration of specific tissues.
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Introduction
The field of tissue engineering strives to reconstruct structural and functional 
properties of damaged, diseased or lost tissues [1]. The general strategy includes 
the fabrication of supportive biomaterials, so-called scaffolds, which provide a 
template guiding tissue formation, and subsequently loading of these scaffolds 
with biological compounds and cells [2]. The selection of appropriate scaffolding 
materials is key since scaffolds have considerably impact in the regenerative 
process [3]. The interaction between cells and scaffolds is a complex interplay 
where both affect one another: the cells by remodeling the microenvironment 
and the scaffold by influencing cell fate. Properties such as mechanical strength, 
degradation rate, pore size and interconnectivity steer cellular growth and 
function [4, 5]. Moreover, micro-morphologies in the scaffold may regulate cellular 
behavior since 3D topographical features have been shown to regulate cellular 
migration, attachment, viability and differentiation [6, 7]. It has for instance been 
shown that bone marrow-derived mesenchymal stem cells preferentially adhere 
to ridged surfaces [8], that embryonic stem cells differentiate towards the 
neuronal lineage without the use of any differentiation-inducing agents on 
ridged or grooved surfaces [9], and that attachment and proliferation of 
chondrocytes is enhanced by incorporation of ridged or grooved surfaces [10]. 
Currently, several physical and chemical micro- and nanofabrication patterning 
techniques are available to introduce morphologies (e.g. ridges, pillars, pits and 
grooves) and distributions (e.g. random and regular features). These techniques 
encompass e.g. soft lithography, photolithography, electrospinning, polymer 
phase separation, layer-by layer microfluidic patterning, three-dimensional 
printing, chemical vapor deposition, ion milling, salt leaching and reactive ion 
etching [11-13]. These techniques are generally not applicable to vulnerable 
biological molecules. Therefore, the construction of scaffolds consisting of 
biological structures as collagen fibrils, the structural elements used by nature, 
and the incorporation of micro-morphologies is limited by these techniques, but 
crucial to develop biologically relevant biocompatible systems for regeneration of 
tissues in vitro and in vivo.
 Type I collagen is a promising biomaterial due to its biocompatibility, bio-
degradability, and bioactivity. Porous collagen scaffolds can be constructed by 
freezing-lyophilization, the ice crystals formed during the freezing process 
forming a negative blueprint for the final pore architecture [14]. Variations in the 
overall architecture of collagen scaffolds prepared by lyophilization have 
generally been introduced by adjustments of the freezing conditions, such as the 
freezing temperature, which are known to affect pore sizes [15-17]. Moreover, the 
pore orientation and structure can be adapted by applying temperature gradients 
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and changing the concentration of acetic acid in which collagen fibrils were 
suspended, respectively. An increase in acetic acid concentration resulted in less 
thread-like and more closed wall structures [18]. Pawelec et al. showed that the 
incorporation of ionic or non-ionic solutes in a suspension of collagen in aqueous 
acetic acid changed pore size and influenced cell attachment [19]. These results 
imply that variations in crystal formation, due to the solute in which collagen 
fibrils are suspended, may result in adaptable micro-morphologies. Therefore, we 
hypothesize that scaffolds prepared using different acids (monocarboxylic acids 
and dicarboxylic acids) and concentrations may result in scaffolds with various 
micro-morphologies. Adjustable collagen scaffolds with variations in micro- 
morphology may be used as a screening platform to study the effect of such 
properties on cellular behavior in order to select optimal substrates for the 
regeneration of specific tissues.
Materials and methods
Scaffold construction
Type I collagen fibrils were isolated from bovine achilles tendon as described [20]. 
Collagen suspensions of 0.7% (w/v) were prepared using monocarboxylic and 
dicarboxylic acids. Monocarboxylic acids included formic acid (Merck, Darmstadt, 
Germany), acetic acid (Scharlau, Barcelona, Spain) and propionic acid (Merck). 
Dicarboxylic acids included oxalic acid (Merck), malonic acid (Sigma-Aldrich, 
St. Louis, MO, USA), succinic acid (Sigma-Aldrich), glutaric acid (Sigma-Aldrich), 
maleic acid (Sigma-Aldrich), and fumaric acid (Sigma-Aldrich). An overview of 
used acids (including their IUPAC names and chemical formula) and molarities is 
provided in Table 1. The acid solubility determined the maximum acid concentration 
applied to prepare collagen suspensions. After overnight incubation at 4 °C, 
collagen suspensions were homogenized on ice using a Teflon glass Potter-Elvehjem 
(Louwers Glass and Ceramic Technologies, Hapert, The Netherlands) with an 
intervening space of 0.35 mm (10 strokes), and deaerated by centrifugation at 
117g for 30 min at 4 °C [18].
 To investigate the effect of the various diluted acids on the micro-morphology 
of collagen scaffolds, scaffolds with unidirectional and random-oriented pores 
were constructed. Briefly, unidirectional collagen scaffolds were prepared by 
freezing collagen suspensions by directional freezing (10 ml/scaffold) using liquid 
nitrogen and a custom-made wedge system, followed by lyophilization in a Zirbus 
freeze dryer (Sublimator 500 II, Bad Grund, Germany) [18]. Random collagen 
scaffolds were prepared by freezing collagen suspensions in 6-wells plates (5 ml/
well) at -20 °C, followed by lyophilization [16]. Scaffolds were then strengthened 
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by vapor fixation crosslinking using 37% formaldehyde (Scharlau) under vacuum 
for 30 min to improve the handling [18].
Scanning electron microscopy
Scanning electron microscopy (SEM; JEOL SEM6340F, Tokyo, Japan) was used to 
investigate scaffold morphology. Scaffolds were cut longitudinally and perpen-
dicularly and samples were placed on stubs and sputtered with a thin layer of 
gold using a Polaron E5100 Coating System [18]. Images were recorded using an 
accelerating voltage of 10 kV. For pore size quantifications, images were recorded 
from four random locations of perpendicular samples. The lengths of the shortest 
axis of 50 pores were measured using ImageJ [18].
Cell culture
To evaluate the effect of micro-morphologies on the differentiation of C2C12 
murine skeletal muscle myoblasts, unidirectional collagen scaffolds with 
frayed-like (prepared using 0.25 M oxalic acid) and smooth (prepared using 0.25 M 
malonic acid) micro-morphologies (based on the SEM results) were selected. 
 Scaffolds were prepared as above and processed as described [21]. Briefly, 
scaffolds were strengthened by vapor fixation with 37% formaldehyde (Scharlau) 
under vacuum for 30 min, processed into their final dimensions (diameter: 12 mm, 
height: 4 mm, top and bottom were removed), then remaining aldehydes were 
quenched, and scaffolds were crosslinked using 33 mM N-ethyl-3-(3-dimethyl-
aminopropyl)-carbodiimide (Fluka Chemica AG, Buchs, Switzerland) and 6 mM 
N-hydroxysuccinimide (Fluka Chemica AG) in 50 mM 2-morpholinoethane 
sulfonic acid (MES buffer, pH 5.0; Sigma-Aldrich) containing 40% (v/v) ethanol for 
4 h. Subsequently, scaffolds were washed with 0.1 M Na2HPO4 (Merck), 1 M NaCl 
(Merck), 2 M NaCl, demineralized water and phosphate buffered saline (PBS, pH 
7.4), and sterilized while wet with 25 kGy γ-irradiation [21]. 
 Cell culture experiments were performed n=4 with each condition in 
triplicate. C2C12 murine skeletal muscle myoblasts were expanded in monolayer 
until 90% confluency in proliferation medium; Dulbecco’s Modified Eagle’s 
Medium (DMEM; Gibco, Carsbad, CA, USA), supplemented with 10% fetal calf 
serum (FCS, Pan-Biotech, Aidenbach, Germany) and 100 IU/ml penicillin and 100 
µg/ml streptomycin (Amresco, Solon, OH, USA). C2C12 cells were trypsinized using 
0.05% trypsin-EDTA (Corning, Manassas, VA, USA), followed by seeding of 2.5 x 106 
cells per scaffold. In short, 100 µl cell suspensions (25 x 106 cells/ml) were dripped 
on the scaffolds while the scaffolds were placed on autoclaved Whatman™ 
chromatography paper (3030-917, GE Healthcare Life Sciences, Pittsburg, PA, USA) 
to allow the cell suspension to infiltrate the scaffold by capillary force. Scaffolds 
were then incubated at 37 °C for 3 h to let the cells adhere to the scaffolds, after 
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which scaffolds were transferred to new 12-well plates and proliferation medium 
was added. The scaffolds were cultured for 7 days in proliferation medium and 
subsequently for 7 days in differentiation medium (DMEM, supplemented with 
1% horse serum (PAA Laboratories, Cölbe, Germany) and 100 IU/ml penicillin and 
100 µg/ml streptomycin. Cells cultured in monolayer (5,000 cells/well in 12-wells 
plate) were used as a reference for quantitative polymerase chain reaction (qPCR). 
Medium was changed every 3 days. Scaffolds were harvested after 14 days and 
divided as follows: ½ scaffold for histological analysis and ½ scaffold for qPCR.
Histology and immunohistochemistry
For histological evaluation, samples were washed in 0.1 M PBS pH 7.4, fixed in 4% 
formaldehyde in 0.1 M PBS pH 7.4, dehydrated through graded ethanol series, 
cleared in xylene, embedded in paraffin, and cut into 5 µm thick sections. Sections 
were stained with haematoxylin and eosin (H&E) and immunofluorescent 
staining against myosin [22]. Briefly, sections were incubated in 0.1 M citrate 
buffer for 60 min, blocked in 0.15% glycine in 0.1 M PBS pH 7.4 for 30 min and in 1% 
(w/v) bovine serum albumin (BSA), 5% (v/v) normal goat serum, 0.1% (w/v) cold 
water fish gelatin (Sigma-Aldrich), 0.1% (v/v) Triton X-100 in 0.1 M PBS pH 7.4 for 
another 30 min. Sections were incubated with a primary antibody against myosin 
(1:400, MY-32, Sigma-Aldrich) for 60 min, secondary antibody goat anti-mouse 
IgG (H+L) Alexa 488 for 60 min, and 10 µg/ml 4′,6-diamidino-2-phenylindole 
(DAPI; Roche Diagnostics GmbH, Mannheim, Germany) to stain nuclei. Control 
sections were incubated with secondary antibody only. After each step, sections 
were washed with PBS. Sections were enclosed in Mowiol mounting medium 
(Sigma-Aldrich).
qPCR 
Isolation of RNA, evaluation of RNA quality, synthesis of cDNA and qPCR analysis 
were performed as described previously [21]. Briefly, RNA was isolated in TRIzol® 
(Life Technologies, Carlsbad, CA, USA) using the RNeasy Mini Kit (Qiagen GmbH., 
Hilden, Germany, 74106), followed by measuring RNA quality using a NanoDrop 
instrument (Thermo Scientific, Rockford, IL, USA). Then, the iScript cDNA Synthesis 
Kit (Bio-Rad Laboratories, Inc., Hercules, CA, USA) was used to convert 500 ng RNA 
into cDNA, using a T100™ Thermal Cycler (Bio-Rad Laboratories, Inc.) for 5 min at 
25 °C, 30 min at 42 °C and 5 min at 85 °C. MilliQ water was included as no template 
control (NTC). Obtained cDNA (20 µl) was diluted 20 times in Milli-Q water. Gene 
expressions were measured using SYBR Green qPCR, using iQ™ SYBR® Green 
Supermix (Bio-Rad Laboratories, Inc.) and 2 µL cDNA as a template, including NTC 
and MilliQ water controls. The following primer sequences were used in real-time 
PCR analyses: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) forward 
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5’-TGATGGGTGTGAACCACGAG-3’; reverse 5’-GGGCCATCCACAGTCTTCTG-3’; actinin 
forward 5’-TCATCCTCCGCTTCGCCATTC-3’; reverse 5’-CTTCAGCATCCAACATCTT-3’; 
and Myosin Heavy Chain (pMHC) forward 5’-TCGCTGGGCTGGGTGTTAG-3’; reverse 
5’-TGTCTGTCAGGCTGGGTGTG-3’. qPCR was performed on a CFX96™ Real-Time 
System (Biorad). The following amplification settings were used: 5 min at 95 °C, 
followed by 45 cycles of 10 s at 95 °C, 20 s at 60°C and 20 s at 72 °C. Crossing-point 
(Cp) values, expressed as quantification cycle (Cq), were obtained using Bio-Rad 
CFX Manager 3.1 software (Bio-Rad) [21]. Gene expressions were normalized to 
GAPDH and were expressed as 2-ΔCq.
Statistics
Results of pore size measurements and qPCR are shown as mean ± standard 
deviation. Statistical differences were assessed using GraphPad Prism (GraphPad 
Software, Inc., version 5, La Jolla, CA, USA) by unpaired t-tests and repeated measures 
ANOVA with Tukey’s post-hoc tests to compare different groups, where p-values 
< 0.05 were considered statistically significant.
Results
Scaffold characterization
Collagen scaffolds constructed with dicarboxylic acids
Construction of unidirectional collagen scaffolds using various dicarboxylic acids 
resulted in different micro-morphologies of the pore wall (Fig. 1A). Scaffolds 
constructed using oxalic acid and succinic acid showed morphologically open 
inter- connective frayed-like wall structures, while the morphology in scaffolds 
constructed from malonic acid and glutaric acid showed smooth wall surfaces. 
Differences in frayed-like wall structures were observed, where scaffolds prepared 
using oxalic acid and succinic acid resulted in honeycomb-like and fibrillar micro- 
morphologies, respectively. Wall thickness also varied among the applied acids, 
where oxalic acid and succinic acid resulted in thick walls, whereas the use of 
malonic acid and glutaric acid resulted in thinner walls.
 For random collagen scaffolds constructed using dicarboxylic acids with 
different concentrations (0.05-2 M, see Table 1), an increase in acid concentration 
resulted in more fibrillar wall structures (Fig. 2A). For dicarboxylic acids with an 
even number of C-atoms, oxalic acid (C2) and succinic acid (C4), the pore structure 
became more fibrillar from 0.25 M acid onwards. For dicarboxylic acids with an 
odd number of C-atoms, malonic acid (C3) and glutaric acid (C5), fibrillar structures 
appeared when using 1 M acid to construct scaffolds, which became even more 
apparent for acid concentrations of 2 M. SEM images showed smooth wall 
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Figure 1  Unidirectional scaffolds prepared using dicarboxylic acids. A) Scanning electron 
micrographs of unidirectional collagen scaffolds prepared using different dicarboxylic acids 
(all 0.25 M) showed variations in micro-morphologies. The use of oxalic acid and succinic 
acid resulted in a frayed-like morphology, while malonic acid and glutaric acid resulted in 
smooth wall structures. Differences in frayed-like micro-morphologies, honeycomb-like 
and fibrillar, were observed for scaffolds prepared using oxalic acid and succinic acid, 
respectively. B) Scanning electron micrographs of longitudinal cross-sections of unidirectional 
collagen scaffolds prepared using 0.05 M and 1 M oxalic acid indicated that the pore 
morphology depends on applied concentration, where a higher acid concentration increased 
wall thickness and fibrillarity. All scale bars represent 50 µm.
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structures in scaffolds prepared using 0.05 M oxalic acid, malonic acid, succinic 
acid and glutaric acid. These results indicate that the formation of smooth or 
fibrillar structures depends on the type of dicarboxylic acid and acid concentration 
used (also see 3.1.3). An increase in acid concentration from 0.05-2 M significantly 
reduced pore size in scaffolds (Fig. 2B).
Figure 2  Effect of dicarboxylic acid concentration on the formation of micro-morphologies 
in random collagen scaffolds. A) Scanning electron micrographs showed that all scaffolds 
prepared using 0.05 M dicarboxylic acid have smooth wall structures. The pore wall became 
more fibrillar upon an increase in acid concentration. For dicarboxylic acids with an even 
number of C-atoms (oxalic acid and succinic acid), the pore structure became more fibrillar 
at 0.25 M already, while for ‘odd’ acids (malonic acid and glutaric acid) fibrillar structures 
were observed starting at 1 M and were most apparent at 2 M. Scale bars represent 100 µm. 
B) An increase in acid concentration resulted in decreased pore sizes (*: p < 0.05, ***: p < 0.0001). 
Note: scaffolds prepared using 1 M oxalic acid were too heterogeneous to determine pore sizes.
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Unidirectional collagen scaffolds constructed with monocarboxylic acids
No morphological differences in pore wall structure and wall thickness were found 
between scaffolds prepared using formic acid, acetic acid and propionic acid 
(Fig. 3A; 0.25 M acid concentration). An increase in acid concentration generally 
increased the pore size (Fig. 3B) and scaffolds became less fibrillar with a more 
closed wall structure. Differences in pore size between acid concentrations applied 
were more apparent for higher acid concentrations. For 1 M acid concentrations, 
pore sizes were significantly different between formic acid, acetic acid and 
propionic acid (***: p < 0.0001). For 0.05 M and 0.25 M acid concentrations, pore 
sizes were significantly larger in scaffolds prepared using formic acid compared to 
acetic acid and propionic acid (*: p <0.05, ***: p < 0.0001). Pore sizes of scaffolds 
prepared using acetic acid were obtained from a previous study [18].
Figure 3  Unidirectional scaffolds prepared using monocarboxylic acids. A) Scanning electron 
micrographs of unidirectional collagen scaffolds prepared using different monocarboxylic 
acids (all 0.25 M) showed no variations in micro-morphologies. Scale bars represent 50 µm. 
B) Pore sizes of scaffolds prepared from formic acid differed from those made with acetic 
acid [18] and propionic acid (*: p < 0.05, ***: p < 0.0001). For scaffolds constructed using 1 M 
acids, pore sizes were significantly different between formic acid, acetic acid and propionic 
acid (***: p < 0.0001).
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Effect of acid solubility on micro-morphology formation in random collagen 
scaffolds 
To further investigate the effect of acid solubility, independently of carbon chain 
length, random collagen scaffolds were constructed using dicarboxylic acids 
maleic acid (cis) and fumaric acid (trans), both C4. For maleic acid, smooth pore 
walls were visible, while a more thread-like morphology was observed for fumaric 
acid (Fig. 4). 
Cytocompatibility and cellular differentiation
General morphology and immunocytochemistry
To evaluate cytocompatibility of the scaffolds and to investigate the effect of 
incorporated micro-morphologies on cell differentiation, C2C12 cells were cultured 
on unidirectional collagen scaffolds prepared using 0.25 M oxalic acid (frayed-like 
morphology) and 0.25 M malonic acid (smooth morphology) for 14 days. C2C12 
cells infiltrated deeply into the scaffolds, which was facilitated by the 
unidirectional pore architecture. Cells resided more at the outside of scaffolds 
prepared using oxalic acid, while they infiltrated further into scaffolds prepared 
using malonic acid (Fig. 5A). Myosin staining (Fig. 5B) indicated aligned elongated 
cellular structures for C2C12 cells cultured in scaffolds with both smooth and 
frayed-like pores, but the staining was more intense for C2C12 cells cultured in 
scaffolds prepared using oxalic acid (frayed morphology).
Figure 4  Effect of acid solubility on the formation of micro-morphologies. Scanning 
electron micrographs of the pore structure of scaffolds prepared from cis/trans isomers 
(both C4) maleic acid (A, cis) and fumaric acid (B, trans) showed smooth and a more fibrillar 
pore structure for maleic acid and fumaric acid, respectively. Scale bars represent 100 µm.
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Figure 5  Differentiation of C2C12 cells seeded on scaffolds prepared using oxalic acid and 
malonic acid. A) The unidirectional pore architecture facilitated infiltration of cells, but 
cells were found deeper in scaffolds prepared using malonic acid compared to oxalic acid. 
Scale bars represent 200 µm (top panel) and 100 µm (bottom panel). B) Myosin staining 
indicated aligned elongated cellular structures for C2C12 cells cultured in oxalic acid and 
malonic acid scaffolds. Staining was more intense for oxalic acid. Scale bars represent 
50 µm. C) Analysis of gene expression levels of actinin (p = 0.081), myogenin (p = 0.064) 
and pMHC indicated that only pMHC gene expression levels were significantly increased 
(p = 0.013) for C2C12 cells cultured on scaffolds prepared using oxalic acid (frayed morphology) 
compared to malonic acid (smooth morphology). A general trend was higher gene expression 
levels for C2C12 cells cultured on frayed morphologies compared to smooth morphologies.
132
mRNA analysis
Gene expressions of actinin, myogenin and perinatal myosin heavy chain (pMHC) 
were analyzed in C2C12 cells and compared to the expression of the C2C12 cells 
cultured in monolayer as positive control. mRNA analysis indicated that pMHC 
gene expression was significantly upregulated for C2C12 cells cultured on scaffolds 
prepared using oxalic acid (frayed morphology) compared to malonic acid (smooth 
morphology). No differences were observed in actinin (p = 0.081) and myogenin 
(p = 0.064) gene expression levels between scaffolds prepared using oxalic acid 
and malonic acid, and positive controls (Fig. 5C). A general trend of higher gene 
expression levels of C2C12 cells was found when cultured on frayed morphologies 
compared to smooth morphologies.
Discussion
In general, in vitro studies have investigated the effect of micro-morphologies 
using 2D monolayer culture models, where substrates have been modified with 
topographical features, including morphologies (e.g. ridges, pillars, pits and 
grooves) and distributions (e.g. random and regular features) [11-13]. Although this 
is informative for the effect of specific micro-morphologies on cellular behavior, 
the ability to incorporate specific 3D micro-morphologies in scaffolds is key to 
steer cell behavior. The novel methodology developed here allows both the use of 
biological macromolecules and the incorporation of 3D micro-morphologies in 
scaffolds, to guide tissue formation in collagen scaffolds.
 It was observed that dicarboxylic acids with an even number of C-atoms 
(referred to as “even acids”) led to fibrillar scaffold wall structures, whereas 
dicarboxylic acids with an odd number of C-atoms (referred to as “odd acids”) led 
to scaffolds with a solid wall structure. It is known that series of alkane derivatives 
often show alternating physicochemical characteristics between compounds 
with an even and odd number of carbon atoms, e.g. with respect to solubility [23]. 
The use of dicarboxylic acids resulted in acid specific differences in pore structures, 
whereas monocarboxylic acids did not result in remarkable differences in micro- 
morphology. Dicarboxylic acids with an even or odd number of C-atoms resulted 
in frayed or smooth wall structures, respectively, although with different 
appearances, which was dependent on the acid concentration applied. The scaffold 
morphology is likely related to the formation of crystals. In our experiments, 
the use of poorly soluble acids resulted in a higher degree of fibrillarity. The effect 
of acid solubility was confirmed by constructing scaffolds using dicarboxylic 
acids maleic acid and fumaric acid, which both contain four carbon atoms 
including a double bond between C2 and C3, representing the well dissolvable cis 
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and poorly dissolvable trans isomer, respectively. For the cis and trans isomer, a 
smooth and thread-like micro-morphology were observed, respectively, which 
could be explained by the cis-conformation enabling the formation of an 
intramolecular hydrogen bond in maleic acid between the two carboxylic acid 
groups, which is not present in fumaric acid [24]. This results in a strongly 
increased solubility (6.16 mol/kg at 298.15 K [25]) for maleic acid compared to 
fumaric acid (0.05 - 0.06 mol/kg) [26]. Based on these observations, the scaffold 
Figure 6  Relation between the number of C-atoms and dicarboxylic acid solubility, and 
crystal packing of even and odd acids. A) Solubility of dicarboxylic acids in water. There is 
an even-odd effect with respect to the number of C-atoms on solubility [27, 28]. The effect of 
solubility was also found by comparing fumaric acid and maleic acid (both 4 C-atoms), 
which have a low and high solubility, respectively. For poorly soluble acids, readily forming 
crystals, frayed surface structures were observed in the collagen scaffolds, whereas for 
highly soluble acids smooth wall structures were found. B) Overall structure of acids with 
an even and odd number of C-atoms (parallelogram versus trapezoid-like). The difficulty to 
form crystals in case of trapezoid shaped acids results in smooth pore walls, while the ease 
of crystallization of parallelogram shaped acids results in frayed pore walls.
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structure at a given acid concentration appears to correlate to the length of the 
carbon skeleton of the dicarboxylic acid (Fig. 6A). The solubility of a compound is 
inversely correlated to the ease of crystal formation. The crystal structures of both 
even and odd dicarboxylic acids were shown to be mainly based on a combination 
of intermolecular hydrogen bonding and hydrophobic interactions [23]. The 
carboxylic acid groups on each side of the molecule form hydrogen-bonded dimers 
with successive molecules, resulting in the formation of continuous acid chains. 
Furthermore, the hydrophobic methylene backbones stack on top of each other, 
perpendicular to the chain axis. Starting from glutaric acid (C5), the packing 
modes of the acids were shown to be regular within both series of odd and even 
acids. Thalladi et al. [23] proposed a model which explains the lower packing 
stability of odd acids by the repulsive effect of carboxylic acid groups of adjacent 
chains. In even acids, the distance between these moieties can be increased by 
slightly shifting each chain along the chain axis. In odd acids, shifting the chain 
would increase the distance on one side of each molecule, but decreases the 
distance on the other side. The crystal packing of odd dicarboxylic acids therefore 
cannot be stabilized in this way. Although this model is not directly translatable 
to the lower dicarboxylic acids (< C5), similar mechanisms may account for the 
solubility alternation found for these acids. Also the morphology of the crystal 
lattice of odd and even acids may be responsible for the micro-morphologies 
observed. Acids with an odd and even number of C-atoms have a trapezoid-like 
and parallelogram-like structure, respectively (Fig. 6B). The ease or difficulty to 
form crystals from even (parallelogram) and odd (trapezoid) acids, respectively, 
gives rise to the formation of micro-morphologies observed in this study. 
 In vitro analysis was performed to investigate cytocompatibility and the 
effect of different micro-morphologies on cellular differentiation. C2C12 cells 
were cultured on unidirectional type I collagen scaffolds, since these scaffolds 
facilitate cell infiltration due to the aligned pore architecture [18]. Incorporation 
of frayed-like micro-morphologies in unidirectional collagen scaffolds was 
favorable over the use of smooth micro-morphologies, as indicated by myosin 
staining and pMHC gene expression levels, confirming the preference of cells for 
irregular structures [8-10]. The underlying mechanism of the effect of frayed-like 
micro-morphologies on cell differentiation may be explained by focal adhesion 
formation and subsequent signal transduction cascades. Yang et al. [29] described 
that micro-morphologies play important roles in the formation and dissociation 
of focal adhesions, which connect intracellular compartments of the cell with the 
extracellular matrix. Adaptation of focal adhesions due to the provided scaffold 
template, as a result of mechanotransduction, may result in physical changes and 
reorganization of intracellular compartments [30, 31]. Subsequently, this may 
result in differences in protein expression, interaction and concentration, and 
135
3D micro-morphologies in collagen scaffolds
Ch
ap
te
r  
  6
intracellular signaling, including of focal adhesion kinase [32, 33]. As a proof-of- 
principle, we investigated the differentiation of C2C12 cells on frayed-like and 
smooth scaffolds, for which we selected scaffolds prepared using 0.25 M oxalic 
acid and malonic acid. Further investigations of other dicarboxylic acids and 
concentrations, and intra- and extracellular mechanisms resulting in specific cell 
responses to the micro-morphologies applied may provide insights in the selection 
of substrates for specific purposes. 
 Unidirectional collagen scaffolds with incorporated micro-morphologies may be 
applied for the regeneration of various tissues. Screening for the effect of micro- 
morphologies on cellular behavior can be performed with the knowledge gained 
here, thereby making it possible to select optimal substrates for the regeneration 
of specific tissues.
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Abstract
Microfracture surgery may be improved by implantation of unidirectional 
collagen scaffolds that provide a template for mesenchymal stem cells to 
regenerate cartilage. Incorporation of growth factors in unidirectional scaffolds 
may further enhance cartilage regeneration. In scaffolds, immobilization of 
growth factors is required to prolong in vivo activity, to limit diffusion and to 
reduce the amount of growth factor needed for safe clinical application. We 
investigated the immobilization of bone morphogenetic protein 2 (BMP2) to 
unidirectional collagen scaffolds and the effect on chondrogenesis in vitro. 
C3H10T1/2 cells were seeded on unidirectional collagen scaffolds with and 
without covalently attached heparin, and with and without incubation with 
BMP2 (1 and 10 µg), or with BMP2 present in the culture medium (10-200 ng/ml). 
Culturing was for 2 weeks and readout parameters included histology, immuno-
histochemistry, biochemical analysis and molecular biological analysis. The 
unidirectional pores facilitated the distribution of C3H10T1/2 cells and matrix 
formation throughout scaffolds. The effective dose of medium supplementation 
with BMP2 was 100 ng/ml (total exposure 1 µg BMP2), and similar production of 
cartilage-specific molecules chondroitin sulfate and type II collagen was found 
for scaffolds pre-incubated with 10 µg BMP2. Pre-incubation with 1 µg BMP2 
resulted in less cartilage matrix formation. The conjugation of heparin to the 
scaffolds resulted in more chondroitin sulfate and less type II collagen deposition 
compared to scaffolds without heparin. In conclusion, unidirectional collagen 
scaffolds pre-incubated with 10 µg BMP2 supported chondrogenesis in vitro and 
may be suitable for prolonged cartilage matrix synthesis in vivo.
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Introduction
Articular cartilage covers bone surfaces within synovial joints and provides a 
low-friction and load-bearing surface for efficient and flexible joint motion [1]. 
Traumatic injuries and osteoarthritis can result in cartilage damage. Restoring 
cartilage defects is challenging due to the limited self-renewal capacity. Patients 
with cartilage defects often suffer from progressive joint dysfunction and pain 
[2]. To treat patients with localized cartilage defects, microfracture surgery [3], 
mosaicplasty [4] and autologous chondrocyte implantation [5] are applied. 
Although satisfactory short-term clinical results have been described [6], these 
treatments can result in donor site morbidity [4] and fibrocartilage formation [7]. 
Consequently, newly formed tissue often lacks the mechanical and biological 
properties of native hyaline cartilage and gradually degenerates over time [8]. 
 Regenerative medicine and tissue engineering strive to find alternatives to 
restore the structure and function of damaged articular cartilage. A promising 
strategy may be the implantation of scaffolds in combination with microfracture 
surgery, making use of bone marrow-derived mesenchymal stem cells (MSCs) 
that penetrate into the scaffold and produce new cartilage tissue [9, 10]. The use of 
unidirectional collagen scaffolds is promising for this application since the 
anisotropic pore organization facilitates the influx of cells [11] and steers the 
arrangement of cells in vertical columns, resembling the organization of 
chondrocytes in native articular cartilage [12]. Additionally, immobilization of 
growth factors to the scaffolds may allow for sustained delivery of growth factors 
to stimulate cartilage regeneration in vivo [13]. The efficacy of the implantation of 
scaffolds and incorporation of biologics have been studied before; implantation of 
scaffolds resulted in improved cartilage regeneration, which was further 
enhanced by loading the scaffolds with biologics [14]. Because cartilage tissue 
mainly consists of type II collagen, the use of scaffolds prepared from type II 
collagen seems a logical choice, but Ohno et al. [15] showed similar type I, type II 
and aggrecan gene expressions for chondrocytes cultured in type I and type II 
collagen scaffolds in vitro. Moreover, the ability for dedifferentiated chondrocytes 
to redifferentiate has been described in PLGA-type I collagen hybrid meshes [16], 
suggesting that type I collagen scaffolds are suitable for cartilage regeneration. 
This was confirmed by Buma et al. [17], who found less cell migration in type II 
collagen scaffolds in vivo because cells were directed into a chondrogenic 
phenotype upon arrival in the scaffolds, while type I collagen scaffolds facilitated 
the influx of progenitor cells from the subchondral bone towards the defect site 
and throughout the implanted scaffolds. These scaffolds may be further improved 
by bioactive molecules that stimulate cartilage regeneration.
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 Bone and cartilage development are guided by various growth factors, in a 
distinct spatiotemporal setting [18]. Bone morphogenetic protein (BMP), transforming 
growth factor beta (TGF-β) and fibroblast growth factor (FGF) have been used to 
stimulate cartilage regeneration in vitro [19]. These growth factors are generally 
added to the culture medium to induce a cellular response, but for in vivo 
applications growth factors need to be immobilized since no biologics can be 
added after implantation of scaffolds and diffusion of growth factors away from 
the defect should be prevented. For clinical application, the use of growth factors 
is constrained by rapid degradation and clearance and therefore excessive doses 
exceeding 10,000 times the physiological dose have been applied. However, these 
high doses resulted in side effects including infections, hematomas and cancer 
[20]. Immobilization may reduce the amount of growth factors needed, necessary 
for safe clinical application. Growth factors can be incorporated in collagen 
scaffolds by non-covalent interaction with glycosaminoglycans (GAGs), which 
can be covalently immobilized to collagen scaffolds [21]. In vivo, GAGs are 
important for growth factor signaling, controlling the dose and bioactivity, and 
protecting growth factors from degradation [22, 23]. Heparin is a highly negatively 
charged glycosaminoglycan that has been used for sustained delivery of BMP2 
[13, 24]. Therefore, heparin-conjugated scaffolds were applied as sustained delivery 
vehicles for the release of growth factors. 
 The aim of this study was to enhance the bioactivity of unidirectional type I 
collagen scaffolds for potential in vivo applications, which has to our knowledge 
not been investigated before. Unidirectional collagen scaffolds were chosen as a 
model to study in vitro chondrogenesis since these scaffolds aid cellular infiltration 
[11]. C3H10T1/2 cells, resembling mesenchymal cells, were used as a cell culture 
model to study chondrogenic differentiation [25]. We first studied chondrogenic 
differentiation of C3H10T1/2 cells using soluble BMP2 supplemented to the culture 
medium as a reference to subsequently investigate whether cartilage regeneration 
could be resembled by (heparin-conjugated) unidirectional collagen scaffolds 
pre-incubated in BMP2.
Materials and Methods
Scaffold construction
Type I collagen fibrils were isolated from bovine achilles tendon [26]. Scaffolds 
were prepared by lyophilization of a 0.7% (w/v) collagen suspension in diluted 
acetic acid that was directionally frozen using a custom-made wedge system 
using liquid nitrogen [11]. Constructed unidirectional collagen scaffolds were 
strengthened by crosslinking using vapor fixation with 37% formaldehyde 
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(Scharlau, Barcelona, Spain) under vacuum for 30 min [27]. Subsequently, punches 
(diameter: 12 mm, height: 8 mm) were taken from the top of the scaffolds using 12 
mm punch devices (Acuderm Inc., Ft. Lauderdale, FL, USA), and processed to final 
dimensions of 12 mm diameter and 4 mm height by removal of the top and bottom 
of the punched scaffolds and subsequently dividing the scaffold in two parts. 
The scaffolds were wetted in demineralised water and remaining aldehydes were 
quenched by incubation in 1 M sodium phosphate buffer pH 6.5 (Merck, Darmstadt, 
Germany) containing 30 mM NaBH4 (Sigma-Aldrich, St. Louis, MO, USA) for 1 h at 
4 °C. Scaffolds were washed six times for 30 min with demineralised water, and 
crosslinked using 33 mM 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC, 
Fluka Chemie, Buchs, Switzerland) and 6 mM N-hydroxysuccinimide (NHS, Fluka 
Chemie) in 50 mM 2-morpholinoethane sulfonic acid (MES buffer, pH 5.0; 
Sigma-Aldrich) containing 40% (v/v) ethanol for 4 h in the presence and absence 
of 0.25% (w/v) heparin (Organon, Oss, The Netherlands). Scaffolds were washed 
with 0.1 M Na2HPO4 (Merck), 1 M NaCl (Merck), 2 M NaCl and demineralized water 
[28]. Finally, scaffolds were washed in phosphate buffered saline (PBS, pH 7.4) and 
sterilized with 25 kGy γ-irradiation from a 60Co source (Synergy Health Ede B.V., 
Ede, The Netherlands). Scaffolds crosslinked with EDC/NHS only and heparin- 
conjugated scaffolds are abbreviated as “Col” and “Col-Hep”, respectively.
Scanning electron microscopy
Scaffold morphology was analyzed using scanning electron microscopy (SEM, 
Gemini Sigma 300, Zeiss, Oberkochen, Germany). Scaffolds were cut longitudinally, 
mounted on stubs, and sputtered with an ultrathin layer of gold using a Polaron 
E5100 Coating System. Images were recorded at an accelerating voltage of 10 kV [11].
Cell culture
Murine mesenchymal C3H10T1/2 Clone 8 cells (American Type Culture Collection, 
Rockville, MD, USA) were seeded (2500 cells/cm2) and expanded in monolayer 
culture until 90% confluency in proliferation medium (BME, Gibco, Carsbad, CA, 
USA), supplemented with 10% fetal calf serum (FCS, Perbio Science, Belgium), 1% 
GlutaMAX-I (Gibco), 100 IU/ml penicillin and 100 µg/ml streptomycin (P/S; 
Amresco, Solon, OH, USA). Cells were harvested using 0.05% trypsin-EDTA (Gibco). 
Prior to cell seeding on the scaffolds, scaffolds were incubated in proliferation 
medium. Then, 250 µl cell suspensions (107 cells/ml in proliferation medium) 
were pipetted on the scaffolds while placed on an autoclaved Whatman™ 
chromatography paper (3030-917, GE Healthcare Life Sciences, Pittsburg, PA, USA) 
to extract fluids from the scaffolds and allow the cell suspension to infiltrate the 
scaffold by capillary force. Scaffolds were placed in a 12-well plate without 
additional medium to allow adherence of the cells to the scaffolds. After 3 h, 
144
scaffolds were transferred to a 12-well plate and 2 ml chondrogenic differentiation 
medium was added (Dulbecco’s modified Eagle’s medium (DMEM) + GlutaMax-I, 
Gibco), supplemented with 6.25 µg/ml insulin, 6.25 µg/ml transferrin, 6.25 ng/ml 
sodium selenite, 0.4 mg/ml proline, 1 mg/ml sodium pyruvate, 5.35 µg/ml linoleic 
acid, 10-4 M ascorbic acid 2-phosphate, 1.25 mg/ml bovine serum albumin and 
10-7 M dexamethasone (all from Sigma-Aldrich)). To investigate the effective dose 
of BMP2 (see section 2.2.1), the chondrogenic differentiation medium was supplemented 
with bone morphogenetic protein 2 (BMP2, carrier-free, R&D Systems, Minneapolis, 
MN, USA). To assess cartilage formation in scaffolds (see section 2.2.2), scaffolds 
with immobilized BMP2 were used, where scaffolds cultured in medium 
supplemented with BMP2 served as controls. To load scaffolds with BMP2, the 
scaffolds were placed on Whatman tissue to extract fluid from the scaffolds and 
subsequently the scaffolds were incubated in an Eppendorf tube with 100 µl PBS 
containing 1 µg or 10 µg BMP2 for 3 h. Next, scaffolds were washed to remove 
unbound BMP2 according to the following protocol: 1) scaffold were placed on 
Whatman tissue, 2) scaffolds were washed in proliferation medium, and 3) 
scaffold were placed on Whatman tissue. Medium was refreshed every 3 days. 
Scaffolds were harvested after 2 weeks.
  
Evaluation of the required BMP2 dose to induce chondrogenic differentiation 
of C3H10T1/2 cells
The effective BMP2 dose to induce chondrogenic differentiation was investigated 
by culturing the scaffolds in chondrogenic differentiation medium supplemented 
with different BMP2 concentrations: 10, 25, 50, 100 and 200 ng/ml. Control 
scaffolds were cultured without BMP2 in the medium. The following experimental 
conditions were included: 1) scaffold (Col), 2) heparin-conjugated scaffold 
(Col-Hep), 3) Col-Hep + 10 ng/ml soluble (sol.) BMP2, 4) Col-Hep + 25 ng/ml sol. 
BMP2, 5) Col-Hep + 50 ng/ml sol. BMP2, 6) Col-Hep + 100 ng/ml sol. BMP2, and 7) 
Col-Hep + 200 ng/ml sol. BMP2. Each condition was included in triplicate. The 
experiment was performed n=3. 
Chondrogenic differentiation of C3H10T1/2 cells on collagen and collagen-
heparin scaffolds with non-covalently bound BMP2
The effect of immobilizing BMP2 to unidirectional collagen scaffolds on chondrogenic 
differentiation of C3H10T1/2 cells was investigated by pre-incubating scaffolds 
with 1 or 10 µg BMP2 per scaffold. Based on results of 2.3.1, scaffolds cultured in 
chondrogenic differentiation medium supplemented with 100 ng/ml sol. BMP2 
were used as controls. The following conditions were included: 1) Col, 2) Col-Hep, 3) 
Col + 100 ng/ml sol. BMP2, 4) Col-Hep + 100 ng/ml sol. BMP2, 5) Col + 1 µg 
pre-incubated (pre-inc.) BMP2, 6) Col + 10 µg pre-inc. BMP2, 7) Col-Hep + 1 µg pre-inc. 
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BMP2, and 8) Col-Hep + 10 µg pre-inc. BMP2. Each condition was included in 
triplicate. The experiment was performed n=2. 
Histology and immunohistochemistry
Scaffolds were fixed in 4% formaldehyde in 0.1 M phosphate buffered saline (PBS) 
pH 7.4 and processed for paraffin embedding via dehydration through graded 
ethanol series and clearing in xylene. Scaffolds were sectioned to yield 5 µm slices. 
Sections were stained with haematoxylin and eosin (H&E) and Safranin-O with 
fast green counterstaining [29]. For immunohistochemical staining, endogenous 
peroxidase was blocked using a 0.3% hydrogen peroxide solution for 10 min. 
Sections were washed with phosphate buffered saline (PBS) for 5 min, and blocked 
with 5% bovine serum albumin in PBS for 30 min, followed by incubation with 
primary antibodies against type II collagen (1:200, II-6B3II, Developmental Studies 
Hybridoma Bank, Iowa City, IA, USA), chondroitin sulfate (1:200, CS56, Sigma-
Aldrich), or heparan sulfate (1:10, AO4B08 VSV tagged single chain variable 
fragment antibody, cross-reacting with heparin [30]) at room temperature for 
60 min. Subsequently, sections were washed three times in PBS for 5 min, followed 
by incubation at room temperature for 60 min with secondary antibodies; 
 peroxidase-conjugated goat anti-mouse IgG H+L (1:250, Pierce) for II-6B3II, 
peroxidase- conjugated goat anti-mouse polyvalent immunoglobulins IgG, IgA, 
IgM (1:200, Sigma) for CS56, and monoclonal mouse anti-VSV peroxidase- 
conjugated IgG from mouse hybridoma cell line P5D4 (1:200, American Type 
Culture Collection) for AO4B08. As a control, sections were incubated with 
secondary antibody only. Sections were washed three times in PBS for 5 min and 
diaminobenzidine solution (Sigma-Aldrich) was added for 10 min to observe 
staining. Sections were counterstained using Mayer’s hematoxylin solution 
(Sigma-Aldrich), dehydrated through graded ethanol series, cleared in xylene and 
enclosed in Entellan™ mounting medium (Merck). Sections were scored with - in 
case of the absence of staining, ± for little positive staining, + for moderate positive 
staining and ++ for strong positive staining.
Biochemical analysis
Scaffolds were digested with 2.5 U/ml papain (Sigma Aldrich) in digestion buffer 
(50 mM NaPO4, pH 6.5, 2 mM EDTA (Merck), 2 mM cysteine (Sigma-Aldrich)) [28] 
until no remnants of the scaffolds were visible. DNA content was measured using 
Hoechst 33342 solution (ThermoFisher Scientific) and calf thymus DNA as standard 
and a spectrofluorometer (Synergy 2, BioTek®, Winooski, VT, USA) [31]. A dimethyl-
methylene blue (DMMB) dye (Sigma-Aldrich, pH 3) was used to spectrophoto-
metrically quantify heparin conjugated to the collagen scaffolds and GAGs 
formed by C3H10T1/2 cells. Absorbances were measured at 525 nm with a BioTek 
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plate reader. A heparin standard was used to calculate GAG content [28]. Results 
are expressed as GAG per DNA (µg/µg).
qPCR
Total RNA was isolated in TRIzol® (Life Technologies, Carlsbad, CA, USA) using the 
RNeasy Mini Kit (Qiagen GmbH., Hilden, Germany, 74106) according to the 
manufacturer’s protocol. The quality of the extracted RNA was evaluated by 
measuring the A260/280 absorbance ratio using a NanoDrop instrument (Thermo 
Scientific, Rockford, IL, USA). TRIzol-extracted total RNA (500 ng) was converted to 
cDNA using the iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Inc., Hercules, 
CA, USA) using a T100™ Thermal Cycler (Bio-Rad Laboratories, Inc.) for 5 min at 
25 °C, 30 min at 42 °C and 5 min at 85 °C. MilliQ water was used as a no template 
control (NTC). The reverse transcriptase reaction mixture (20 µL) was diluted 
20 times in H2O (MilliQ). Gene expression was determined by SYBR Green qPCR 
(quantitative polymerase chain reaction) using iQ™ SYBR® Green Supermix 
(Bio-Rad Laboratories, Inc.) and 2 µL cDNA as a template, and NTC and MilliQ water 
controls. The following primer sequences were used in real-time PCR analyses: 
GAPDH forward 5’-GGCAAATTCAACGGCACA-3’; reverse 5’-GTTAGTGGGGTCTC-
GCTCCTG-3’; type II collagen forward 5’-TTCCACTTCAGCTATGGCGA-3’; reverse 
5’-GACGTTAGCGGTGTTGGGAG-3’; and aggrecan forward 5’-TACCGCTGTGAAGT-
GATGC-3’; reverse 5’-AGCGTGTGGAAATAGCTCTG-3’. qPCR was performed on a 
CFX96™ Real-Time System (Biorad) using the following amplification settings: 
5 min at 95 °C, followed by 45 cycles of 10 s at 95 °C, 20 s at 60°C and 20 s at 72 °C. 
Crossing-point (Cp) values were determined by using Bio-Rad CFX Manager 3.1 
software (Bio-Rad) and are expressed as quantification cycle (Cq). In case gene 
expression was too low to obtain a Cq value, these Cq values were set to 40 to be 
able to perform calculations. Gene expressions were normalized to glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH), and expressed as 2-ΔCq.
Statistics
Statistical analyses were performed using GraphPad Prism (GraphPad Software, 
Inc., version 5, La Jolla, CA, USA). Results are shown as mean ± standard deviation. 
To compare biochemical and qPCR results of different conditions one-way ANOVA 
with Tukey’s post-hoc tests were performed. P-values < 0.05 were considered to be 
statistically significant.
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Results
Construction of unidirectional collagen scaffolds with and  
without heparin
Directional freezing of collagen suspensions and lyophilization yielded collagen 
scaffolds with a unidirectional pore architecture (Fig. 1A). Scaffolds were 
strengthened by vapor fixation with formaldehyde and further crosslinked with 
EDC/NHS with and without heparin conjugation. The amount of heparin 
conjugated to the scaffolds was 31 ± 10 µg/mg collagen, thus 3.1% of the dry weight 
of the scaffold. In Col only scaffolds, no heparin was detectable (p < 0.001). Staining 
for heparin indicated that heparin was distributed evenly throughout the 
unidirectional Col-Hep scaffolds and was not found in Col scaffolds (Fig. 1B). 
Establishment of BMP2 dose to induce chondrogenic differentiation 
of C3H10T1/2 cells
Before investigating unidirectional scaffolds pre-incubated with BMP2, the BMP2 
concentration in culture medium needed to induce chondrogenic differentiation 
Figure 1  Scaffold characterization. A) Scanning electron micrograph of unidirectional pore 
architecture in collagen scaffolds after lyophilization and crosslinking with(out) heparin 
conjugation, showing an intact unidirectional pore architecture after vapor fixation with 
formaldehyde and further crosslinking with EDC/NHS with and without heparin 
conjugation. The scale bars represent 100 µm. B) Immunohistochemical staining for heparin 
showed that heparin was evenly distributed in Col-Hep scaffolds, whereas no heparin 
staining was observed in Col scaffolds. The scale bars represent 100 µm.
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was investigated. This concentration will be used as a reference when pre- 
incubating unidirectional collagen scaffolds with BMP2.
 After 2 weeks of culture, cells had infiltrated the scaffolds and were found 
throughout the scaffolds. The highest cell densities were present at the seeding 
side of the scaffolds and the cells were found distributed over the surface. Newly 
formed cartilage matrix, containing GAGs (Fig. 2A) and type II collagen (Fig. 2B), 
was present mainly at the cell seeding side of the scaffolds, but only for scaffolds 
cultured in the presence of BMP2. Some staining was found deeper in the scaffolds. 
In the presence of soluble BMP2, cells were larger and stained red (Fig. 2A), possibly 
indicating intracellular production of GAGs in the cells. An increase in BMP2 
concentration resulted in increased tissue formation. For C3H10T1/2 cells cultured 
in the presence of 10 and 25 µg/ml BMP2 little GAG and type II collagen staining 
was observed. Increasing the concentration up to 100 ng/ml clearly increased 
matrix formation. A further increase up to 200 ng/ml BMP2 only slightly increased 
the amount of staining compared to 100 ng/ml BMP2. Newly formed tissue was 
found deeper in the scaffold with increasing BMP2 concentration.
 The biochemical analyses (Fig. 2C) indicated the presence of GAGs when 
C3H10T1/2 cells were cultured in medium supplemented with BMP2. The general 
trend was that an increase in BMP2 concentration resulted in increased GAG/DNA 
levels. Only a little more GAGs were produced when increasing the BMP2 
concentration from 100 ng/ml to 200 ng/ml. GAG deposition was not significantly 
different between 50, 100 and 200 ng/ml BMP2.
 The optimum dosage of BMP2 to induce chondrogenic differentiation of C3H10T1/2 
cells was 100 ng/ml, and this concentration was therefore used as a control for 
scaffolds pre-incubated with BMP2 in the next experiment. 
Chondrogenic differentiation of C3H10T1/2 cells on collagen and 
collagen-heparin scaffolds with immobilized BMP2
For scaffolds pre-incubated with BMP2 and control scaffolds cultured for 2 weeks 
in chondrogenic differentiation medium supplemented with 100 ng/ml sol. BMP2, 
positive matrix staining for type II collagen (Fig. 3A) and chondroitin sulfate (CS, 
Fig. 3B) was observed, indicating the presence of cartilage-specific molecules. 
Cells were found throughout the scaffolds and tissue formation was mainly 
found at the cell seeding side of the scaffolds. Also fields of newly formed matrix 
were found throughout the scaffolds. In the absence of BMP2, matrix staining 
was negative for both type II collagen and CS. Only some intracellular staining 
was observed for CS. Similar results were found for scaffolds cultured in 100 ng/ml sol. 
BMP2 as in the previous experiment. For scaffolds pre-incubated with 1 µg BMP2 
before cell seeding, only little positive type I collagen and CS staining was 
observed. Pre-incubating scaffolds only once with 10 µg BMP2 before cell seeding 
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Figure 2  Scaffolds seeded with C3H10T1/2 cells cultured in chondrogenic differentiation 
medium with different BMP2 concentrations reveal that the lowest effective BMP2 dose is 
100 ng/ml. (A) Safranin-O and (B) type II collagen staining indicated increasing staining 
from 10-100 ng/ml BMP2, and GAGs and type II collagen were absent in scaffolds cultured 
in chondrogenic differentiation medium without supplemented BMP2. Scale bars represent 
100 µm. C) Biochemical assays showed that GAG/DNA levels increased with increasing 
BMP2 concentrations up to 100 ng/ml. *: p < 0.05, **: p < 0.001, ***: p < 0.0001. Sol. represents 
soluble, where BMP2 was added to the culture medium.
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Figure 3  Similar matrix formation between (heparin-conjugated) collagen scaffolds 
pre-incubated with 10 µg BMP2 and cultured in 100 ng/ml soluble BMP2. C3H10T1/2 cells 
were distributed over the scaffold surface, penetrated into the scaffolds, and cartilage 
matrix staining was observed throughout the scaffolds. (A) Type II collagen and (B) CS 
staining indicated little staining for scaffolds pre-incubated in 1 µg BMP2 and increased 
staining for scaffolds pre-incubated in 10 µg BMP2, resembling staining for scaffolds 
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 Heparin-conjugation to the scaffolds resulted in less intense type II collagen 
staining and more intense CS staining compared to Col scaffolds. An overview of 
the histological scoring per conditions is provided in Fig. 3C. 
 At the mRNA level, Col and Col-Hep scaffolds pre-incubated with 1 and 10 µg 
BMP2 showed comparable gene expression levels for type II collagen (Fig. 3D) and 
aggrecan (Fig. 3E) after culturing for 2 weeks. No differences were observed in 
type II collagen and aggrecan expression between Col-Hep + 100 ng/ml sol. BMP2 
and scaffolds pre-incubated with 1 and 10 µg BMP2. Only for Col + 100 ng/ml sol. 
BMP2, a significant upregulation of type II collagen was observed compared to Col 
and Col-Hep scaffolds pre-incubated with 1 and 10 µg BMP2. For aggrecan gene 
expression levels, the only significant difference was found between Col + 100 ng/ml 
sol. BMP2 and all other experimental conditions. This may be due to the addition 
of growth factor during refreshing the culture medium every 3 days, while 
no growth factor was added during cell culture for scaffolds pre-incubated with 
BMP2. Low gene expression levels were found (Cq value set at 40) for Col and 
Col-Hep scaffolds cultured without BMP2.
Discussion
Cartilage regeneration by implantation of acellular biomaterials has been shown 
to be more effective than microfracture surgery alone, further improved by the 
incorporation of biologics [14]. When biologicals are incorporated in scaffolds, 
immobilization is required because biologics cannot be added after implantation 
of scaffolds. Hence, we aimed to enhance the bioactivity of collagen scaffolds 
by the incorporation of BMP2 to yield implants stimulating cartilage regeneration 
in vivo.
 Cell infiltration is a typical limitation of in vitro studies [32], while in vivo cells 
are able to migrate through collagen scaffolds [32]. Unidirectional type I collagen 
cultured in medium supplemented with BMP2. Scale bars represent 100 µm. Sol. represents 
soluble BMP2 in the culture medium. C) Histological scores indicated similar staining 
intensity between scaffolds cultured in 100 ng/ml sol. BMP2 and pre-incubated in 10 µg 
BMP2. Only little staining was scored for pre-incubation in 1 µg BMP2. D) Gene expression 
levels of type II collagen and aggrecan relative to GAPDH. No differences were observed in 
type II collagen and aggrecan expression between Col-Hep + sol. BMP2 and scaffolds 
pre-incubated with 1 and 10 µg BMP2. Pre-inc. represents collagen scaffolds pre-incubated in 
BMP2. *: p < 0.05, ***: p < 0.0001.
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scaffolds were used as a model to study in vitro chondrogenesis because the 
anisotropic pore organization facilitates the influx of cells [11, 27]. Native human 
articular cartilage has an average thickness of 2.4 mm [33] and the unidirectional 
pore architecture facilitated the distribution of cells throughout the scaffolds 
with a thickness of 4 mm in vitro. Cells were distributed over the scaffold surface 
and completely penetrated the scaffold. Cartilage formation was found deep 
into the scaffold. This makes the unidirectional collagen scaffolds a suitable 
model for in vitro studies. Additionally, the unidirectional architecture mimics 
the orientation of unidirectional collagen fibrils and steers the arrangement of 
chondrocytes in vertical columns, while joint loading should ultimately remodel 
the tissue to resemble the complex organization of native cartilage [12, 33]. The use 
of bioactive implants may more effectively promote chondrogenic differentiation 
of MSCs [34]. 
 The chemical characteristics of scaffolds play an important role in cell-matrix 
interactions and cell differentiation [35]. In this study, the GAG heparin was 
conjugated to the scaffolds because of its high affinity binding to many growth 
factors, including basic fibroblast growth factor, vascular endothelial growth 
factor and BMP2 [36]. The incorporation of the GAGs in scaffolds yields negatively 
charged scaffolds, similar to the charge of proteoglycans in the cartilage matrix. 
In native tissue this results in load-dependent deformation due to the high water 
content [1]. As such, adjusting the heparin content conjugated to the scaffolds 
may provide control over the compressive modulus of the scaffolds [37]. Heparin- 
conjugation yielded the incorporation of 31 µg heparin per mg collagen. Lin et al. 
[37] described that the conjugation of 1.84 µg heparin per mg collagen scaffold 
already increased the compressive modulus seven-fold compared to control 
scaffolds. Immobilization of BMP2 to collagen scaffolds with (Col-Hep) and 
without (Col) conjugated heparin resulted in little cartilage matrix formation for 
scaffolds pre-incubated with a low dose of BMP2 (1 µg) and considerable cartilage 
matrix formation for scaffolds pre-incubated with a high dose of BMP2 (10 µg). 
Similar matrix formation between scaffolds incubated once in 10 µg BMP2 and 
100 ng/ml sol. BMP2 repeatedly supplemented to the culture medium was 
observed after two weeks. Also in other studies 100 ng/ml sol. BMP2 was an 
adequate concentration to induce chondrogenic differentiation of C3H10T1/2 cells 
[38, 39]. Our results are in accordance with a study by Li et al. [40], where BMP2 
loaded poly(ethylene argininylaspartate diglyceride scaffolds were compared to 
BMP2 added multiple times during culture. Although both Col and Col-Hep 
scaffolds induced cartilage matrix formation, heparin-conjugation resulted in 
more intense CS staining and less intense type II collagen staining compared to 
Col scaffolds. Tan et al. [41] described a similar divergent effect of heparin, where 
the presence of heparin induced an increase in proteoglycans and a decrease in 
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collagen. The highest amount of BMP2 used for scaffold pre-incubation in our 
study was 10 µg. In other studies similar amounts of growth factor were applied 
to induce cell differentiation [42] and tissue regeneration [37, 43]. The BMP2 
amounts applied in our study (micrograms range) were relatively little compared 
to amounts applied in clinical studies (milligrams range) to induce an effect in 
vivo, which is important for safe medical application since high non-physiological 
doses of growth factors are associated with adverse effects [20]. 
 The C3H10T1/2 cell line is widely used as a relevant cell culture model to study 
chondrogenic differentiation [25]. The cells display a fibroblastic morphology and 
can be differentiated towards osteoblasts, myoblasts, adipocytes and chondrocytes 
under specific stimuli [44]. We were able to induce chondrogenic differentiation 
of C3H10T1/2 cells and the formation of cartilage matrix under the influence of 
BMP2. We seeded 2.5 x 106 cells per scaffold to obtain high cell densities that may 
favor prechondrogenic cellular condensation [45-47]. A large number of cells was 
needed since the unidirectional pore architecture of the scaffolds facilitated the 
infiltration and distribution of the cells throughout the scaffolds. C3H10T1/2 cells 
are suitable as a first model to study in vitro chondrogenesis, but the use of bone 
marrow-derived MSCs may be of interest as they more closely resemble the 
clinical situation [48].
 In future studies, loading scaffolds with different biologics can be investigated. 
Although BMP2 may be a suitable candidate for chondrogenic differentiation of 
murine C3H10T1/2 cells, the addition of different growth factors may improve 
chondrogenesis. For example, TGF-β can be used to stimulate the formation of car-
tilage-specific ECM, such as inducing type II collagen production [25]. The use of 
small molecules and synthetic peptides mimicking growth factor functions may 
be promising since growth factors are expensive. Small molecules are easier to 
deliver, more stable and less immunogenic than growth factors. Isoliquititigenin 
and 4′-hydroxychalcone are such small molecules mimicking BMP2 signaling 
[49]. Moreover, Saito et al. prepared a synthetic peptide consisting of the BMP2 
amino acids 73-92, which promotes chondrogenic differentiation of MSCs [50].
Conclusion
In conclusion, unidirectional collagen and heparin-conjugated collagen scaffolds 
supported the in vitro differentiation of the pluripotent stem cell line C3H10T1/2 
towards the chondrogenic lineage under the influence of BMP2. Unidirectional 
Col and Col-Hep scaffolds pre-incubated with BMP2 may be suitable to induce 
prolonged cartilage repair in vivo. 
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Abstract 
The field of regenerative medicine has developed promising techniques to improve 
current neobladder strategies used for radical cystectomies or congenital anomalies. 
Scaffolds made from molecularly defined biomaterials are instrumental in the 
regeneration of tissues, but are generally confined to small flat patches and do not 
comprise the whole organ. We have developed a simple, one-step casting method 
to produce a seamless large hollow collagen-based scaffold, mimicking the shape 
of the whole bladder, and with integrated anastomotic sites for ureters and 
urethra. The hollow bladder scaffold is highly standardized, with uniform wall 
thickness and a unidirectional pore structure to facilitate cell infiltration in vivo. 
Human and porcine bladder urothelial and smooth muscle cells were able to 
attach to the scaffold and maintained their phenotype in vitro. The closed luminal 
side and the porous outside of the scaffold facilitated the formation of an urothelial 
lining and infiltration of smooth muscle cells, respectively. The cells aligned 
according to the provided scaffold template. The technology used is highly 
adjustable (shape, size, materials) and may be used as a starting point for research 
to an off-the-shelf medical device suitable for neobladders.
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Introduction
In case of muscle-invasive and refractory superficial bladder cancer and end stage 
(congenital) bladder disease, the current clinical standard is radical cystectomy in 
combination with urinary diversion [1, 2]. The method of diversion depends on, 
amongst others, the nature of the defect, and the patient’s needs and wishes. 
Orthotopic bladder reconstruction is increasingly applied for urinary tract 
reconstruction [3]. However, current methods rely on autologous tissues that are 
harvested from the gastrointestinal tract. This can lead to severe complications 
including anastomotic leakages, enteric fistulae, bowel obstruction, prolonged 
episodes of ileus, life-threatening infections, nutritional mal-absorption, and/or 
intestinal failure [1, 4].
 New techniques and materials generated in the field of regenerative medicine 
may provide useful alternatives. Regenerative medicine (RM) aims to regenerate 
tissues and organs by creating biological equivalents through the supplementa-
tion of scaffolding materials, bioactive components, cells or a combination thereof 
[5]. Within the field of RM different attempts have been made to reconstruct the 
bladder in both animal and human studies [6]. In 2006, a promising avenue for 
RM in producing a neobladder was published by Atala et al. where a collagen/
polyglycolic acid composite was used which was sutured together into a partial 
bladder/cup shape and seeded with urothelial and smooth muscle cells [7]. Initial 
clinical results were promising, but a recent related phase II clinical trial 
demonstrated that an autologous cell cultured scaffold composed of synthetic 
polymers did not improve bladder compliance and was associated with serious 
adverse events that surpassed the acceptable safety standard [8]. In addition, the 
complicated and expensive nature of the procedure may not be feasible in most 
clinical centers [9-11]. Alternatively, a well-structured molecularly defined 
acellular scaffold resembling the whole bladder may be an option, using the body 
as a bioreactor. Previously, flat acellular collagen scaffolds have been used for 
bladder augmentation in patients with exstrophy-epispadias complex and were 
found to be completely lined with urothelial cells after implantation [12]. A tubular 
acellular collagen-based urostomy implanted in a pig model showed good results 
with respect to the re-urothelialization of the construct using the body as a 
bioreactor [13]. Flat scaffolds can be manually shaped into a sphere to create a 
bladder-like construct using sutures and a silicon breast prosthesis, as was shown 
by Baumert et al., who also pre-seeded the scaffold with urothelial and smooth 
muscle cells, and wrapped the construct in omentum for further cell differentiation 
in vivo [14]. Omental wrapping of tubular acellular collagen scaffolds resulted in 
good vascularization and tissue integration of the scaffold [15]. Bladder shaped 
acellular scaffolds for in vivo cellularization may be an option for urinary 
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diversions and neobladder reconstructions and would be in line with statements 
from recent proceedings from the “2nd international consultation on bladder cancer: 
urinary diversion”, which indicated that widespread acceptance and success of a 
new technique is based on its simplicity [16]. For this, new methods in construct 
design are necessary. In this study, we have focused on the design of a novel, 
simple, standardized and adjustable process to produce resorbable seamless 
hollow scaffolds that mimic the size and shape of a human bladder and include 
appendices for anastomosis of the ureters and urethra. Cytocompatibility of 
bladder scaffolds, cellular influx and cell alignment were investigated using 
histology, immunohistochemistry, quantitative polymerase chain reaction, 
scanning electron microscopy and transmission electron microscopy.
Materials and Methods 
Construction of bladder scaffolds
A 0.7 % (w/v) suspension of highly purified bovine tendon type I collagen fibrils in 
0.25 M acetic acid (Scharlau, Spain) was prepared by overnight incubation at 4 °C 
[17]. The suspension was homogenized on ice using a Teflon glass Potter-Elvehjem 
device (Louwers Glass and Ceramic Technologies, Hapert, The Netherlands) with 
an intervening space of 0.35 mm (10 strokes). The suspension was deaerated by 
centrifugation at 117 g for 30 min at 4 °C. 500 mL of collagen suspension was 
poured into a custom-made aluminum (type 6082 T6) mold with a thermal 
conductivity of 205 W/m·K. The mold (inner and outer diameter of the spherical 
part: 8.5 and 9.2 cm, Fig. 1A) was specifically designed to mimic the shape of an 
adolescent human bladder [18], and three appendices were included to provide 
anastomosis sites for the ureters and urethra. The mold containing 500 mL 
collagen suspension was placed in a computer-controlled freezing bath (Proline 
RP890, Lauda GmbH, Lauda-Köningshofen, Germany). To obtain a scaffold with a 
wall thickness of 10 mm, the mold was frozen at -20 °C for 30 min or -73 °C for 
12 min, respectively, after which non-frozen collagen was removed from the mold 
(a schematic representation can be found in Fig. 1B and 1C). The mold was 
subsequently placed in a -20 °C freezer for complete solidification of the frozen and 
non-frozen collagen interface. Frozen constructs were lyophilized in a freeze dryer 
(Sublimator 500 II, Zirbus, Bad Grund, Germany) and subsequently γ-irradiated 
(25 kGy, Synergy Health B.V., Ede, The Netherlands).
Temperature measurements 
Temperature differences in the collagen suspension were measured during the 
freezing process in triplicate using two thermocouples (Testo 922, Testo AG, 
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Lenzkirch, Germany). Both sensors were placed in the bottom of the aluminum 
mold in the collagen suspension, where one sensor was placed on the aluminum 
surface and the other sensor 5 mm above it. The mold containing the collagen 
suspension was equilibrated at 4 °C, before transferring the mold to the comput-
er-controlled freezing bath, which was set at -20 °C or -73 °C. Temperature 
measurements at -20 °C or -73 °C were performed for 30 min and 10 min, 
respectively, and the temperature was recorded with time intervals of 1 min. 
Cooling rates were calculated from the slope from 0 °C until the end of the 
measurement. The results are shown as mean ± standard deviation in °C/min.
Scaffold characterization
Magnetic resonance imaging (MRI; 11.7T animal scanner, BioSpec, Bruker, 
Germany) was used to visualize the hollow structure of the scaffold with the 
following settings: Turbo-RARE pulse sequence; 37 ms echo time; 1500 ms 
repetition time; 180° flip angle; 0.195 x 0.195 x 1.5 mm/pixel spatial resolution; 
12 min total acquisition time. Using ImageJ (1.47i, Wayne Rasband, National 
Institutes of Health, USA), the slices were subsequently combined to generate a 
3D model. 
Pore size quantification
Scanning electron microscopy (SEM, JEOL SEM6340F, Tokyo, Japan) was used to 
characterize the intrinsic morphology of the scaffolds. Samples were mounted on 
stubs and sputtered with an ultrathin layer of gold using a Polaron E5100 Coating 
System. Images were recorded at an accelerating voltage of 10 kV. For both freezing 
temperatures, three bladder scaffolds were constructed by freezing and 
lyophilization, and evaluated. Punches were taken from the scaffolds from 14 
different locations (bottom: 1; bottom-middle axis: 4; middle axis 4; middle-top 
axis: 4; top: 1), followed by crosslinking using vapor fixation with 37 % 
formaldehyde under vacuum for 30 min [19]. From these punches, longitudinal 
and cross-sections were taken, and the inside and outside were evaluated. The 
longitudinal orientation was used to assess pore morphology. The cross-sections 
were used to investigate the pore size. Four images were recorded per cross-section 
and the lengths of the shortest axis of 40 pores per location were measured using 
the ImageJ trace tool.
Cell culture 
To assess the cytocompatiblity of bladder scaffolds, the following cells were used: 
primary porcine bladder urothelial cells (pbUCs) and smooth muscle cells 
(pbSMCs), human telomerase reverse transcriptase immortalized normal human 
urothelial cells (hTERT-NHUCs), further referred to as hbUCs, and primary bladder 
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smooth muscle cells (hbSMCs). Cells were seeded on scaffolds prepared by freezing 
at -20 °C because of the larger pore size compared to scaffolds frozen at -73 °C, 
favoring cell infiltration.
Primary porcine bladder urothelial and smooth muscle cells 
Mature porcine bladders were obtained from a local slaughterhouse and pbUCs 
and pbSMCs were isolated as previously described [20, 21]. After isolation, the cells 
were expanded for no more than 3 passages. Ø35 mm punches were excised from 
the large hollow spheres, washed with PBS and subsequently pre-incubated 
overnight with the respective media. pbUCs were cultured in keratinocyte 
serum-free medium (Life Technologies, Carlsbad, CA, USA) supplemented with 
50 µg/mL bovine pituitary extract, 5 ng/mL epidermal growth factor, 30 ng/mL 
cholera toxin (all Sigma Aldrich), 100 U/mL penicillin and 100 µg/mL streptomycin 
(Life Technologies). pbSMCs were cultured in smooth muscle cell medium 
(ScienCell™ Research Laboratories, Carlsbad, CA, USA) supplemented with 2% fetal 
bovine serum, smooth muscle cell growth supplement and 100 U/mL penicillin 
and 100 µg/mL streptomycin (all Life Technologies). Before seeding, the 
medium-soaked scaffolds were placed on a ~1 cm stack of sterile Whatman paper 
for about 5 min to remove excess medium, after which the scaffolds were 
transferred to a fresh stack. Then the cells were seeded on separate scaffolds 
(2.5 – 5 x 106 cells at a concentration of 5x106 cells/mL) where the pbSMCs were 
seeded on the outside of the scaffold and the pbUCs on the luminal sides. The cell 
suspension was allowed to sit on the scaffold for maximally 5 min after which 
the scaffold was carefully transferred to a 6-well plate with 2 mL medium. 
After all scaffolds were seeded, 4 mL medium was added until the scaffold was 
completely immersed. The seeded scaffolds were harvested after 1 and 7 days of 
culture. Samples were taken for immunohistochemistry and scanning electron 
microscopy. As a reference the pbSMCs and pbUCs were also seeded on glass slides 
and cultured for 7 days.
Human bladder urothelial and smooth muscle cells 
hbUCs (a kind gift of Dr. M.A. Knowles, Leeds, UK, [22]) were cultured in keratinocyte 
serum-free medium (Life Technologies, Carlsbad, CA, USA) supplemented with 
50 µg/mL bovine pituitary extract, 5 ng/mL epidermal growth factor, 30 ng/mL 
cholera toxin (all Sigma Aldrich), 100 U/mL penicillin and 100 µg/mL streptomycin 
(Life Technologies) up to passage 27. hbSMCs (ScienCell) were cultured in smooth 
muscle cell medium (ScienCell) supplemented with 2% fetal bovine serum, 
smooth muscle cell growth supplement and 100 u/mL penicillin and 100 µg/mL 
streptomycin (all Life Technologies) up to passage 8.
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 Punches (Ø12 mm) were excised from the large hollow spheres. The punches 
were dissected in 2 parts (luminal side for hbUCs and outside for hbSMCs). 
Scaffolds were washed 3 times with PBS and subsequently pre-incubated with the 
respective media. Before seeding, the medium-soaked scaffolds were placed on 
sterile Whatman paper to remove excess medium, after which the cells were 
seeded on separate scaffolds (1 x 106 cells at a concentration of 10 x 106 cells/mL). 
hbUCs and hbSMCs were seeded on the luminal side and the outside of the 
scaffolds, respectively, after which scaffolds were transferred to 12-well plates. 
After 3 h scaffolds were transferred to new 12-well plates and 2 ml medium was 
added. The scaffolds were cultured for 7 days. Samples were taken for histology, 
immunohistochemistry, quantitative polymerase chain reaction (qPCR) and 
transmission electron microscopy (TEM). As a reference for qPCR analysis of 
scaffolds cultured for 7 days, cell pellets were prepared from hbUCs and hbSMCs 
immediately after seeding by centrifugation at 104g for 7 min.
Scanning Electron Microscopy
For scanning electron microscopy, cultured samples were fixed using 2% (w/v) 
glutaraldehyde (Merck, Darmstadt, Germany) in 0.1 M phosphate buffer (pH 7.4). 
Hereafter, the samples were washed with 0.1 M phosphate buffer for three times 
and subsequently dehydrated using ascending series of ethanol solutions (30, 50, 
70 and 100%). Samples were dried using a critical point dryer (Polaron, Quorum 
Technologies, Rignmer, UK) using liquid CO2 and imaged as described.
Histology and immunohistochemistry
The histological samples were fixed overnight in 4% formalin, dehydrated through 
graded ethanol series, cleared in xylene, embedded in paraffin, and sectioned to 
yield 5 µm slices, which were mounted on superfrost slides (Thermo Scientific, 
Menzel GmbH & Co KG, Braunschweig, Germany). Sections were deparaffinized 
using xylene and graded ethanol series. Sections were stained with toluidine blue 
to visualize the morphology of the cells on the scaffolds.
 Immunohistochemistry was performed to assess the expression of specific 
UC and SMC markers. For porcine cells, samples were placed in Tissue-Tek (Sakura, 
Torrance, USA) and frozen in dry-ice cooled 2-methylbutane (Sigma-Aldrich, St. 
Louis, USA), sectioned (5 µm) using a cryostat microtome (Heidelberg, Heidelberg, 
Germany), mounted on superfrost slides and stored at -80 °C until use. In general, 
before staining, the slides were fixed using ice-cold acetone (-20 °C) for 10 min. For 
human cells, paraffin embedded sections were deparaffinized using xylene and 
graded ethanol series. Endogenous peroxidase was blocked using a 1% H2O2 
solution for 30 min and the slides were blocked with 1% (w/v) normal goat/rabbit 
serum in PBS for 10 min. Next, slides were incubated for 1-2 h with the following 
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primary antibodies: rabbit anti-bovine type I collagen IgG (1:200, AB746P, Merck 
Millipore, Watford, UK), mouse anti-human cytokeratin 7 IgG1 kappa (CK7, 1:400, 
clone OV-TL 12/30, AM255, Biogenex, Fremont, CA, USA) or mouse anti-α smooth 
muscle actin IgG2a (αSMA, 1:8000, clone 1A4, A2547, Sigma-Aldrich). Then, slides 
were incubated for 30 min with secondary antibodies. For fluorescent staining, 
Alexa 488 conjugated goat anti-rabbit IgG (1:200, Invitrogen, Carlsbad, CA, USA) 
for type I collagen, and Alexa 594 conjugated goat anti-mouse IgG H+L (1:200, 
Invitrogen) for CK7 and αSMA, were used, followed by a 15 min incubation with 
4′,6-diamidino-2-phenylindole dihydrochloride (DAPI, 5 µg/ml, Sigma-Aldrich) to 
stain nuclei, and mounting using wet mounting medium (Dako). For diamino-
benzidine (DAB) staining, slides were incubated with peroxidase-conjugated 
rabbit anti-mouse IgG (1:100, Dako, Glostrup, Denmark), followed by a 10 min 
incubation with DAB solution (Sigma-Aldrich) to visualize staining, and mounting 
using Permount™ mounting medium (Fisher Scientific, Fair Lawn, NJ, USA). As a 
control, slides were incubated with the secondary antibody only. After each 
incubation step, the slides were washed three times in PBS for 5 min.
Real-time polymerase chain reaction
Total RNA was isolated in TRIzol® (Life Technologies, Carlsbad, CA, USA) using the 
RNeasy Mini Kit (Qiagen GmbH., Hilden, Germany, 74106) according to the 
manufacturer’s protocol. The quality of the extracted RNA was evaluated by 
measuring the A260/280 absorbance ratio using a NanoDrop instrument (Thermo 
Scientific). TRIzol-extracted total RNA (500 ng) was converted to cDNA using the 
iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Inc., Hercules, CA, USA) and 
using a T100™ Thermal Cycler (Bio-Rad Laboratories, Inc.) for 5 min at 25 °C, 30 min 
at 42 °C and 5 min at 85 °C. MilliQ water was used as a no template control (NTC). 
The reverse transcriptase reaction mixture (20 µL) was diluted 20 times in H2O 
(MilliQ). Gene expression was determined by SYBR Green qPCR by using iQ™ 
SYBR® Green Supermix (Bio-Rad Laboratories, Inc.) and 2 µL cDNA as a template, 
and NTC and MilliQ water controls. The following primer sequences were used in 
real-time PCR analyses: GAPDH forward TCAAGGCTGAGAACGGGAAG; reverse 
TGGACTCCACGACGTACTCA; CK7 forward GGAGTGGGAGCCGTGAATATC; reverse 
GGATGGAATAAGCCTTCAGGA; and αSMA forward GCATGCAGAAGGAGATCA-
CA; reverse GCTGGAAGGTGGACAGAGAG. qPCR was performed on a LightCycler® 
LC480 instrument (Roche Diagnostics GmbH, Mannheim, Germany) using the 
following amplification settings: 5 min at 95 °C, followed by 45 cycles of 10 s at 
95 °C, 20 s at 60°C and 20 s at 72 °C. Crossing-point (Cp) values were determined by 
using LightCycler® 480 SW 1.5 software (Roche Diagnostics) and are expressed as 
quantification cycle (Cq). Gene expressions were normalized to glyceraldehyde- 3-
phosphate dehydrogenase (GAPDH). Results are shown as relative gene expression 
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levels, expressed as 2-ΔΔCq, of CK7 and αSMA for scaffolds seeded with hbUCs and 
hbSMCs. Control values of hbUCs and hbSMCs pellets were set at 1 for CK7 and 
αSMA, respectively.
Transmission electron microscopy
Samples were harvested and washed three times in PBS, followed by fixation in 
2% glutaraldehyde in phosphate buffer for 4 h, followed by washing 2 x 1 h in 
phosphate buffer and for 1 h in 1% (w/v) osmium tetroxide in phosphate buffer, 
dehydration using graded ethanol series and embedding in Epon 812. Ultrathin 
sections (60 nm) were cut and picked up on Formvar-coated grids, post-stained 
with lead citrate and uranyl acetate, and examined in a JEOL 1010 transmission 
electron microscope (JEOL, Tokyo, Japan).
Statistics
Statistical analyses were performed using GraphPad Prism (GraphPad Software, 
Inc., version 5, La Jolla, CA, USA). The effect of the freezing temperature on pore 
size was assessed by a two-tailed t-test. A one-way ANOVA with Tukey’s posthoc 
test was performed to determine differences in relative gene expression levels. 
Results are shown as mean ± standard deviation. P-values < 0.05 were considered 
to be statistically significant.
Results 
Scaffold construction and macroscopic evaluation
A collagen-based seamless hollow scaffold was constructed by freezing of a 
collagen suspension in a custom-made mold and lyophilization (Fig. 1A). The 
freezing process yielded a mechanically stable construct, where the outside was 
frozen (Fig. 1D). After removing the non-frozen fraction, the frozen part remained 
and had a spherical lumen (Fig. 1E). In the frozen construct the lumen of the 
appendices appeared to be clear of any collagen residues. After lyophilization the 
collagen scaffold could be removed from the mold (Fig. 1F). 
 The outer diameter of the scaffold was consistent with the inner diameter of 
the mold. The inside of the spherical part of the scaffold was hollow and the 
surface had a homogenous structure. Moreover, the lumens of the appendices 
remained hollow and straight. The appendices were firmly and seamlessly 
attached to the spherical part of the scaffold.
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Scaffold structure characterization and freezing mechanism 
Magnetic resonance imaging (MRI) was used to visualize scaffold structure and 
generate a 3D model of the scaffold. The overall shape of the scaffold, wall, lumen, 
and appendices with their lumen are easily distinguishable (Fig. 2A and 2B). The 
volume of the sphere was calculated using the MRI images and was determined 
to be approximately 380 ml. SEM images of different locations in the scaffold 
(spherical part and appendices) revealed a unique 3D unidirectional pore structure 
for scaffolds made at both -20 °C and -73 °C. The lumen showed low porosity with 
only few open structures whereas the outside of the scaffold was porous (Fig. 2 C-I). 
The radial pore structure has been observed in other collagen scaffold types and 
is the result of the inward growth of ice crystals during the freezing process 
[19, 23]. The outer diameter of the collagen scaffold was 8.5 cm (Fig. 2J), while the 
inner diameter depended on the freezing rate and time. The wall thickness of 
the spherical part of the scaffold was 11 ± 2 mm and 8 ± 1 mm, and the thickness of 
Figure 1  Construction and morphological evaluation of whole bladder scaffold with appendices. 
A) Custom-made aluminum mold; B and C) schematic representation of the freezing process 
and strategy to produce a seamless hollow construct with appendices. The mold was 
completely filled with a collagen suspension and placed in a computer-controlled freezing 
bath. After 30 min or 12 min freezing at -20 °C and -73 °C, respectively, the non-frozen 
collagen was removed from the mold; D) frozen hollow collagen construct; E) frozen hollow 
collagen construct cut in half to display the hollow inside; F) freeze dried scaffold which 
could easily be removed intact from the mold. Bars represent 1 cm. 
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the appendices was 6 ± 1 mm and 5 ± 1 mm for freezing at -20 °C and -73 °C, 
respectively. The inner diameter of the appendices was 5 ± 1 mm and 6 ± 0 mm for 
freezing at -20 °C and -73 °C, respectively. 
 The freezing process was evaluated by temperature measurements. For both 
freezing temperatures, the sensor placed on the aluminum surface always 
showed a lower temperature compared to the sensor located 5 mm above the 
aluminum surface. This indicates a temperature gradient inwards; the freezing 
process started at the aluminum surface and progressed through the collagen 
suspension. Freezing at -20 °C and -73 °C resulted in cooling rates of 0.45 ± 0.01 and 
3.84 ± 0.38 °C/min, respectively (Fig. 3A). Freezing at different temperatures 
Figure 2  Overview of the bladder scaffold and its structural characteristics. A) MRI slices 
of the bladder scaffold; B) 3D model based on MRI slices. C-I) SEM images of the bladder 
scaffold; C and E) exterior; F and G) cross-section of the wall; H and I) lumen; D) cross-section 
of the appendix. J) Macroscopical image of the bladder construct cut open. A, B, D, F and H 
were frozen at -20 °C and C, E and G were frozen at -73 °C. All bars in SEM micrographs 
represent 200 µm and macroscopical image bar represents 1 cm. 
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resulted in scaffolds with different pore sizes, the faster freezing protocol resulting 
in smaller pores (Fig. 3B). Freezing at -20 °C and -73 °C yielded pore sizes of 
respectively 70 ± 17 µm and 43 ± 10 µm for the spherical part (p < 0.0001) and 74 ± 
21 µm and 41 ± 12 µm for the appendices (p < 0.0001).
In vitro analysis of bladder scaffolds
General morphology and immunohistochemistry
To evaluate the cytocompatibility, porcine (Fig. 4) and human (Fig. 5) urothelial 
cells (UCs) and smooth muscle cells (SMCs) were separately cultured on the 
luminal side and the outer side of the bladder construct, respectively, for 7 days. 
The UCs seeded at the luminal part were mainly located at the outside of the 
scaffold where they formed a confluent lining over the scaffold surface as 
indicated by SEM (Fig. 4C) and toluidine blue staining (Fig. 5A). The SMCs were 
seeded on the porous outside of the scaffold and formed multilayers. The cells 
Figure 3  Freezing characteristics and pore size quantification. A) Temperature of the collagen 
suspension during freezing at -20 °C and -73 °C. One sensor was placed on the inner surface 
of the aluminum mold and the other sensor was placed in the collagen suspension 5 mm 
above the aluminum surface. B) Pore sizes of the spherical part and the appendices of the 
collagen scaffold constructed using freezing temperatures of -20 °C and -73 °C, * p < 0.0001; 
C and D) Pore morphology in cross-sections of the spherical part of the scaffold prepared 
using freezing at -20 °C (C) and -73 °C (D). The scale bars in SEM images represent 100 µm. 
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were able to penetrate deep into the scaffold, likely due to the unidirectionality of 
the scaffold (Fig. 5B). A confluent and aligned layer of SMCs was seen on the 
outside of the scaffolds (SEM (Fig. 4F) and light microscopy (Fig. 5B). The UCs and 
SMCs were able to attach to the scaffold and maintained their phenotype as 
Figure 4  Bladder scaffolds after 7 days of culture with porcine urothelial and smooth 
muscle cells and overview of reference staining. A) Overview staining of scaffolds seeded 
with porcine bladder urothelial cells (pbUCs), stained for type I collagen (green) and nuclei 
using DAPI (blue); B) pbUCs show positive staining for cytokeratin 7 (CK7, red); C) SEM 
micrograph of pbUCs showing a typical cobblestone morphology indicative for urothelial 
cells; D) overview staining of scaffolds seeded with porcine bladder smooth muscle cells 
(pbSMCs), stained for type I collagen (green) and nuclei using DAPI (blue); E) pbSMCs show 
positive staining for α-smooth muscle actin (αSMA, red); F) SEM micrograph of pbSMCs 
showing a stretched and aligned morphology. 5x106 cells were seeded in A, B and D. 2.5x106 
cells were seeded in C, E and F. Staining of porcine bladder and subsequently isolated cells 
with CK7 (G and H) and αSMA (J and K). As a control, scaffolds seeded with either 5x106 
pbUCs or pbSMCs were both negative for I) αSMA; or L) CK7, respectively. 
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indicated by the positive staining for cytokeratin 7 (CK7) and αSMA for UCs and 
SMCs, respectively (Fig 4). Reference stainings, including staining of bladder 
tissue, and bladder derived UC’s and SMC’s are given in Fig. 4G-L. Native porcine 
bladder epithelium was positive for CK7 before and after isolation (Fig. 4G and 
4H). The smooth muscle layer in the bladder was positive for αSMA (Fig. 4J and 
4K). The scaffolds cultured with pbUCs were positive for cytokeratin 7 (Fig. 4B) but 
Figure 5  Human bladder urothelial (hbUCs) and smooth muscle cells (hbSMCs) cultured 
for 7 days on bladder scaffolds. A) hbUCs were seeded at the luminal side of the scaffolds. 
After 7 days the cells mainly resided at the luminal side where they formed a confluent 
lining covering the surface of the scaffold (toluidine blue staining); B) hbSMCs seeded at 
the porous outside of the scaffold and penetrated into the scaffold (toluidine blue staining); 
C) hbUCs on the bladder scaffold showed positive staining for cytokeratin 7 (CK7); D) 
hbSMCs on the bladder scaffold showed positive staining for α-smooth muscle actin 
(αSMA). Scale bars represent 100 µm; E) CK7 expression by hbUCs, increased compared to 
the hbUCs pellet control. αSMA expression by hbSMCs, decreased compared to the hbSMCs 
pellet control. *: p < 0.05, ***: p < 0.0001. 
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Figure 6  Transmission electron microscopy (TEM) images of primary human bladder 
urothelial cells (hbUCs) and smooth muscle (hbSMCs) cultured for 7 days on bladder 
scaffolds. A) Cell-cell contacts and presence of an urothelial lining; B) Parallel orientation of 
cells with respect to the scaffold collagen; C) Protrusions of the cells reaching into the 
collagen scaffold; D) Adherence of a cell to the collagen scaffold; E) Cytokeratin filaments in 
cells (arrows) as an indication of the urothelial phenotype; F) Parallel arranged oblong 
hbSMCs on the porous outside of the scaffold; G) Alignment and adherence of cells to the 
scaffold, where the cells followed the irregularities of the scaffold; H) Collagen scaffold (*) 
and new collagen matrix (#) deposited by cells; I) Presence of actin filaments (arrows) as an 
indication of the muscle phenotype. The scale bars represent 30 µm (A, F), 10 µm (B, C, G), 
5 µm (D) and 2.5 µm (E, H, I). *: collagen scaffold. 
174
negative for αSMA (Fig. 4I). Vice versa, scaffolds cultured with pbSMCs were 
positive for αSMA (Fig. 4E) and negative for CK7 (Fig. 4L).
mRNA analysis
Gene expression of CK7 and αSMA was analyzed in hbUCs and hbSMCs cultured 
on bladder scaffolds and compared to expression in cell pellets (obtained from 
confluent cell cultures), respectively (Fig. 5E). CK7 expression was significantly 
upregulated for hbUCs cultured on bladder scaffolds compared to hbUCs pellets. 
The expression of αSMA by hbSMCs was lower after 7 days of culture compared to 
SMC pellets, which may be attributed to the considerable number of cells invading 
the scaffold (Fig. 5B). 
Transmission electron microscopy
Ultrastructural morphology of cultured hbUCs (Fig. 6A-E) and hbSMCs (Fig. 6F-I) 
was evaluated using TEM. The hbUCs resided closely together at the scaffold 
surface, making cell-cell contact and forming an urothelial lining (Fig. 6A). Cells 
aligned parallel to the collagen fibrils (Fig. 6B), and filopodia from the cells 
extended into the collagen scaffold (Fig. 6C). Firm adherence of cells to the 
scaffolds was indicated by the close contact areas observed (Fig. 6D). The presence 
of cytokeratin filaments (Fig. 6E, arrows) indicated the urothelial phenotype of 
the hbUCs. The hbSMCs seeded on the porous outside of the scaffold formed 
multilayered parallel arrangements and appeared morphologically oblong (Fig. 6F). 
The cells made contact with the collagen scaffold, oriented along the scaffold 
template and followed the orientation of the scaffold lamellae (Fig. 6G). The cells 
deposited new collagen matrix as indicated by the presence of collagen fibrils 
(Fig. 6H, the collagen scaffold and newly formed collagen are represented with * 
and #, respectively). Additionally, actin filaments (Fig. 6I, arrows) were observed 
in the cells, indicating the presence the smooth muscle phenotype.
Discussion
RM-based methodologies to improve (re)construction of urinary reservoirs have a 
long and relatively unfruitful history. The complexity of the envisioned procedures 
for engineering complete bladders has hampered implementation in general [11, 
16]. Taking this into account we have designed a novel, simple, reproducible and 
adjustable process capable of producing a resorbable seamless hollow scaffolds 
that mimic the size and shape of a human bladder and include appendices for 
anastomosis of the ureters and urethra. The casting and freezing method is 
flexible with respect to scaffold size, volume, wall thickness and pore size, and can 
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be adjusted by changing mold dimensions and freezing conditions. Pore sizes can 
be adapted by the freezing protocol that is applied. The size of growing ice crystals 
decreases with increasing growth velocity [24]. Fast freezing of collagen 
suspensions results in small ice crystals and therefore small pores. With slow 
freezing, ice crystals have time to grow, which leads to larger pores in collagen 
scaffolds [25, 26]. Cell infiltration depth increases by increasing the pore size [27]. 
In our study, the largest pore size obtained was 70 ± 17 µm using freezing at -20 °C. 
Previously, we have demonstrated that 0.7% (w/v) collagen scaffolds with 
comparable pore sizes to the collagen bladder scaffold allowed infiltration of cells 
in vivo [28]. SEM analysis revealed a closed lumen suited for urothelial lining and 
a porous exterior, which may, together with the unidirectional structure of the 
inside of the scaffold’s wall, favor in vivo infiltration of cells and nutrients.
 Recent advances in biomaterials for bladder tissue engineering have shown 
promising results [29-31]. The versatility of the hollow spherical construct 
described here allows the incorporation of other strategies currently being 
developed. For instance, other materials may be incorporated into the casing 
technique to change the material properties (e.g., mechanical strength or 
degradation rate) [15, 32]. Additional strength can be obtained by increasing the 
collagen content [26], chemical crosslinking of scaffolds using formaldehyde 
vapor fixation and/or crosslinking using e.g. carbodiimides [33], and by 
sterilization using γ-irradiation (with 15 kGy: 40 kPa) and ethylene oxide (42 kPa) 
[34]. Another methodology to reinforce the collagen bladder scaffold is by the 
incorporation of polymers. This may be performed by the incorporation of polymer 
meshes prior to freezing [35], or by using suspensions of collagen and water-soluble 
polymers [26]. Scaffolds may be seeded with autologous cells from non-bladder 
sources (e.g., adipose and bone marrow tissue) although this is generally laborious 
and costly [36-38], but techniques requiring minimal manipulation related to cell 
harvesting and seeding, that are simple but yet effective, are gaining interest 
[39].
 Although speculative, an acellular approach for bladder regeneration may 
probed. By combining the acellular hollow spherical scaffold with existing 
straightforward techniques such as omental pre-implantation, the scaffold can 
become vascularized. Omental pre-implantation appears to be an effective way 
for vascularization, with prevention of fibrosis [14]. Using tubular collagen 
constructs, omental wrapping proved to be instrumental in providing good 
 vascularization and integration of the scaffold [15]. Additionally, evidence suggests 
that the construct may be re-epithelialized from urothelial tissue in the ureters or 
from remaining bladder tissue when an acellular approach is pursued [12, 13]. 
In addition, the increasing understanding of the bioactive signaling within the 
bladder ECM may be combined with this approach (e.g. addition of effector 
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molecules such as growth factors), and could increase the success-rate of an 
acellular approach [40, 41]. This approach, emanating from an acellular bladder 
construct, can now be tested.
Conclusions
In this paper, a novel casting methodology was developed that resulted in a 
standardized collagen-based bladder scaffold with appendices, which is both 
easy to produce and customizable. In vitro analysis indicate cytocompatiblity for 
human and porcine urothelial and smooth muscle cells.
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Summary
Articular cartilage is hyaline tissue which covers the ends of the long bones and 
provides a low-friction and load-bearing surface for efficient and flexible motion 
of joints. The structure and function of cartilage is affected by traumatic injuries 
and osteoarthritis. Since the tissue possesses only minor natural healing response 
due to its avascularity, it remains a challenge to restore cartilage. Currently, 
patients may be treated surgically with knee arthroplasty to replace the knee 
joint. Regenerative approaches to regenerate articular cartilage include micro -
fracture surgery, mosaicplasty and autologous chondrocyte implantation. Micro -
fracture surgery, also known as bone marrow stimulation, may be the treatment 
of choice since patients can be treated with one-stage minimally invasive surgery 
and patients will most likely experience less pain, have a shorter recovery period 
and require shorter hospitalization time. The procedure avoids problems like 
donor-site morbidity, cell culture costs, off-the-shelf availability and reduces regulatory 
issues. Although promising short-term clinical results have been described, the 
newly formed tissue mainly consists of fibrocartilage, which does not resemble 
the mechanical and biological properties of healthy cartilage. The difficulty for 
the regeneration of hyaline cartilage by bone marrow stimulation may be 
explained by the lack of direct control over the chondrogenic process. A template 
to guide and stimulate the regeneration of more durable cartilage tissue may be a 
solution to this problem.
 Unidirectional collagen scaffolds can be implanted after bone marrow stimulation 
to guide the formation of cartilage tissue. The anisotropic pore architecture of 
the scaffolds facilitates the infiltration of autologous bone marrow-derived MSCs 
in the scaffolds and mimics the micro-environment of the extracellular matrix by 
acting as a template resembling native articular cartilage. A limitation of porous 
(unidirectional) collagen scaffolds is the rather weak mechanical strength. 
Cartilage regeneration guided by the unidirectional scaffold as a template and 
activated by incorporated biological stimuli has not been investigated. The aim of 
this thesis was to construct unidirectional collagen scaffolds with improved 
mechanical strength, incorporated 3D topographical features and biologics, to 
facilitate long-term implant survival and guided cartilage regeneration. An 
overview of all novel improvements introduced is described in chapter 1.
 In chapter 2 and 3, a systematic review and meta-analysis were performed. 
The aim was to provide a structured, thorough and transparent overview of 
literature related to the current evidence for the efficacy of cartilage regeneration 
by implantation of scaffolds after applying bone marrow stimulation in animal 
models (chapter 2: cell-free scaffolds versus spontaneous healing, chapter 3: 
cell-seeded scaffolds versus cell-free scaffolds). In chapter 2, literature data 
184
indicated that cartilage regeneration was improved by 16% by implantation of 
acellular scaffolds after bone marrow stimulation compared to bone marrow 
stimulation alone, which was further improved by 8% by the addition of biologics. 
No differences in cartilage regeneration between various material subgroups, 
biologics and animal models were detected, which may be explained by the 
heterogeneity between studies. In chapter 3, literature data indicated that 
implanting cell-laden scaffolds improved cartilage regeneration by 18.6% 
compared to acellular scaffolds. No differences were found in cartilage 
regeneration between the use of stem cells or somatic cells, but there was a 
difference between cell types. Culture conditions of cells did not affect cartilage 
regeneration.
 In chapter 4, the methodology and adjustability of the directional freezing 
technique to construct porous collagen scaffolds with aligned unidirectional 
pores were investigated. Unidirectional collagen scaffolds were developed by 
directional freezing using a custom-made wedge system. The mechanism of 
unidirectional ice crystal growth was elucidated, and ice crystal growth was 
manipulated to develop a wide range of unidirectional collagen scaffolds with 
distinctive pore structures. In chapter 5, the effect of pore orientation on cell 
seeding efficacy, cell distribution and tissue formation was researched. 
Anisotropic scaffolds facilitated superior cell infiltration compared to isotropic 
scaffold, and may be the scaffolds of choice to develop cellular constructs in vitro. 
Additionally, the anisotropic pore architecture enabled aligned tissue formation, 
important for the regeneration of tissues with an anisotropic extracellular matrix.
In chapter 6 and 7 various improvements for unidirectional collagen scaffolds 
were investigated. In chapter 6, specific 3D topographical features were introduced 
in collagen scaffolds taking into account the use of different diluted acids and 
freezing and lyophilization. In vitro analysis indicated cytocompatibility of 
scaffolds. Additionally, myosin staining was stronger and pMHC gene expression 
levels were upregulated for C2C12 cells cultured on scaffolds with frayed-like 
micro- morphologies compared to smooth micro-morphologies. Incorporation of 
3D micro-morphologies results in differences in cellular differentiation. In chapter 7, 
bioactive scaffolds were prepared to stimulate chondrogenesis in the prospect of 
potential in vivo applications. Immobilization of growth factors is required 
because no biologics can be added after implantation of scaffolds, and to prolong 
in vivo activity, limit diffusion and reduce the amount of growth factor needed for 
safe clinical application. The effect of bone morphogenetic protein 2 (BMP2) loaded 
(heparin-conjugated) unidirectional collagen scaffolds on chondrogenesis of 
C3H10T1/2 cells, a MSC cell line, was investigated in vitro, and compared to the 
effect of soluble BMP2. Pre-incubating scaffolds only once with 10 µg BMP2 before 
cell seeding resembled the results of supplementing the culture medium every 
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3 days for 2 weeks with 100 ng/ml soluble BMP2 (total 1 µg BMP2). The scaffolds 
prepared supported in vitro differentiation of the pluripotent stem cell line 
C3H10T1/2 towards the chondrogenic lineage under the influence of BMP2. 
Unidirectional collagen and heparin-conjugated collagen scaffolds pre-incubated 
with 10 µg BMP2 may be suitable to induce prolonged cartilage matrix synthesis 
in vivo.
 In chapter 8, we researched the translation of gained knowledge regarding 
scaffold construction to prepare a scaffold with unidirectional pores for bladder 
regeneration purposes. A novel methodology was developed that resulted in a 
standardized collagen-based bladder scaffold with appendices, which is both 
easy to produce and customizable. In vitro analysis indicated cytocompatiblity for 
human and porcine urothelial and smooth muscle cells.
 In conclusion, reinforced instructive bioactive unidirectional collagen scaffolds 
for cartilage regeneration were constructed and evaluated in vitro, which may be 
pre-clinically tested in future studies.
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Future perspectives
Novel regenerative medicine and tissue engineering approaches have been 
developed and widely explored as alternatives and/or additions to clinical strategies 
that aim to restore damaged cartilage tissue. In this thesis, the construction and 
evaluation of biomimetic collagen scaffolds for cartilage regeneration was investigated. 
Various modifications for unidirectional collagen scaffolds previously implanted 
in osteochondral defects by de Mulder et al. [1] were applied related to: 1) improved 
scaffold fabrication, 2) increased mechanical strength to provide long-lasting 
implants, 3) incorporation of 3D topographical features, and 4) enhanced bioactivity 
by loading of growth factors. Overall, these novel improvements may yield a 
medical device inducing superior cartilage regeneration compared to previously 
implanted ‘basic’ unidirectional collagen scaffolds.
 Currently, the development of advanced biomimetic and bioinstructive 
biomaterials is widely explored. The incorporation of multifunctional and stimuli- 
responsive properties may result in sophisticated implants for various regenerative 
medicine and tissue engineering applications. Various adaptations for unidirectional 
collagen scaffolds, such as morphology, strength and biologics, can be incorporated 
to mimic nature. Native articular cartilage has a complex zonal organization with 
unique biomechanical properties for low-friction articulation and optimally 
resisting joint loading. These zones, the superficial, middle, and deep zone, differ 
in extracellular matrix (ECM) structure and composition, including variations in 
collagen fiber diameter and orientation, glysosaminoglycan (GAG) content, and 
the density and morphology of chondrocytes [2]. The collagen fiber orientation 
and the number of crosslinks are depth-dependent, which accounts for differences 
in tensile strength and stiffness among the zones [3]. The collagen fiber diameter 
varies between zones from approximately 20 nm in the superficial zone to 
70-120 nm in the deep zone [4]. In the superficial zone collagen fibers are aligned 
parallel to the articular surface to optimally resist shear stresses during joint 
loading. In contrast, the orientation of collagen fibers in the deep zone is 
perpendicular to the articular surface, providing compressive strength to the 
tissue. In between, the random orientation of the collagen fibers in the middle 
zone provides a transition from the superficial to the deep zone [2-4]. Little 
amounts of proteoglycans and GAGs are present in the superficial zone [5], 
whereas most proteoglycans, mainly aggrecan, are found in the deep zone [4]. The 
amount of proteoglycans and GAGs, and as a result the compressive modulus, 
increases with tissue depth [6]. The highest cell densities are found in the 
superficial zone and the cell density decreases with tissue depth. To attract cells 
from the subchondral bone and to facilitate migration throughout the scaffold, 
scaffolds can be incorporated with stromal cell-derived factor-1 [7]. Specific 
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loading of stromal cell-derived factor-1 in scaffolds may result in a cell density 
gradient similar to native cartilage. Currently, by implantation of unidirectional 
collagen scaffolds with a perpendicular pore orientation relative to the articulation 
surface, the infiltration of cells is facilitated. Joint loading should ultimately 
remodel the tissue to resemble the complex organization of native cartilage [4, 6]. 
The incorporation of a zonal organization in scaffolds may further improve 
cartilage regeneration. In this study, collagen scaffolds with anisotropic pores 
were constructed using a custom-made wedge system, resulting in a vertical 
temperature gradient and controlled solidification. By adapting the temperature 
gradients applied also other pore orientations may be incorporated. Finite element 
modeling may offer opportunities to model the effects of variations applied to the 
wedge system on temperature gradients, such as steepness of the wedge and use of 
materials with different thermal conductivities, and the use of various insulators. 
 The addition of cartilage-specific components may create a microenvironment 
resembling native cartilage. The GAG chondroitin sulfate (CS) is an important 
ECM component of native articular cartilage [8]. The incorporation of CS in 
collagen scaffolds resembles the native environment and can be used to bind 
growth factors to the scaffolds [9-11]. Previously, it has been demonstrated that 
linkage of CS to type I collagen scaffolds stimulated the bioactivity of chondrocytes 
and increased the total amount of proteoglycans retained in the matrix [12]. Also 
the incorporation of other components including hyaluronic acid may be 
promising since hyaluronic acid also plays physical and biological roles in 
cartilage tissue [13]. 
Cartilage regeneration may be further enhanced by the addition of growth factors 
to scaffolds to stimulate chondrogenesis. These growth factors can be loaded in 
the scaffolds by their non-covalent interaction with GAGs [20]. Gradients of 
growth factors can be introduced by GAG gradients in collagen scaffolds [14]. The 
porous unidirectional scaffold architecture may facilitate gradient formation of 
(multiple) growth factors over long ranges due to the open porous intrinsic pore 
architecture (Fig. 1). By placing the scaffolds on Whatman™ chromatography 
paper to extract fluid from the scaffolds and simultaneously dripping a growth 
factor solution on top of the scaffolds, the majority of the growth factors may 
remain at the seeding side of the scaffolds while lower concentrations may be 
found deeper into the scaffolds.
 A limitation of growth factors such as bone morphogenetic proteins (BMPs) is 
their short half-live and location, resulting in large doses needed to induce the 
desired response. These non-physiological doses draw concerns related to costs 
and safety [15]. Therefore, an important consideration for using growth factors is 
the need of a suitable carrier that allows for controlled release and preservation of 
their bioactivity. In this thesis, heparin-conjugation in unidirectional collagen 
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scaffolds was explored to bind and release BMP-2. The use of small molecules and 
synthetic peptides mimicking the function of growth factors may be promising 
since small molecules are easier to deliver, more stable and less immunogenic 
than growth factors. Isoliquititigenin and 4′-hydroxychalcone are such small 
molecules mimicking BMP-2 signaling [16]. Moreover, a synthetic peptide 
consisting of the BMP-2 amino acids 73-92 has been shown to promote 
chondrogenic differentiation of MSCs [17].
 Improving the mechanical strength of unidirectional collagen scaffolds is 
required to provide long-lasting implants [18]. Scaffolds can be strengthened by 
increasing the collagen concentration prior to scaffold construction [19], or 
condensing collagen scaffolds by shrinking scaffolds as a whole. Previously, 
implanted unidirectional scaffolds were prepared from a 0.7% (w/v) collagen 
suspension [1]. Unidirectional collagen scaffolds reinforced by using a 2% (w/v) 
collagen suspension followed by shrinking maintained the unidirectional 
architecture (Fig. 2). These reinforced unidirectional scaffolds consisted of 
collagen only, without the need for incorporation of additional (synthetic) 
materials, which is beneficial for biocompatibility, biodegradability, and 
Figure 1  Illustration of incorporated growth factor gradients to regenerate osteochondral 
defects. Transforming growth factor beta (TGF-β) and bone morphogenetic protein 2 (BMP-2) 
can be incorporated in the scaffold to respectively regenerate cartilage and bone. 
TGF-β
BMP-2
Cartilage 
compartment
Bone
compartment
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bioactivity of the implants. Additionally, this strategy also prevents a potential 
mismatch in mechanical properties in case different materials are combined [20].
 Besides regeneration of articular cartilage, the underlying subchondral bone 
may also need to be repaired as it simultaneously undergoes degenerative 
changes as cartilage tissue. Therefore, scaffolds aiming to restore both cartilage 
and bone may be the implants of choice to regenerate osteochondral tissues. One 
of the major components of bone is calcium phosphate (CaP). In native bone, 
aligned CaP platelets are present in interstices within collagen fibrils and play an 
important role in the functional properties of bone. CaP can be deposited precisely 
by applying a method developed by Nijhuis et al. [21]. To deposit CaP in collagen 
scaffolds, scaffolds can be soaked in simulated body fluid and subsequently the 
addition of urease from Canavalia ensiformis results in the conversion of urea into 
ammonia and carbon dioxide. As the initial pH increases to 8, the solubility of CaP 
decreases and subsequently results in deposition of CaP. By placing scaffolds 
partially in simulated body fluid, the spatial incorporation of CaP in collagen 
scaffolds may be used to induce a spatial differentiation pattern of MSCs towards 
bone- and cartilaginous-like tissue [22].
 In this thesis, various improvements for unidirectional collagen scaffolds 
were proposed to enhance cartilage regeneration. Besides in vitro research 
described in this thesis, in vivo investigations are required to identify whether 
these aspects related to mechanical strength, incorporation of intrinsic surface 
structures and loading of biologics indeed enhance cartilage regeneration. 
Figure 2  Methodologies of reinforcing unidirectional collagen scaffolds based on increasing 
the collagen concentration and condensing collagen fibrils. The unidirectional pore architecture 
is still present after all reinforment procedures. Scale bars represent 100 µm. 
0.7% (w/v) collagen scaold
unmodied scaold
Reinforcement techniques:
1) Increasing collagen concentration
2% (w/v) scaold
2) Shrinking treatment
2% (w/v) shrunken scaold
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Implantation of unidirectional collagen scaffolds with improved mechanical 
strength, incorporated instructive surface topographies and biologics may result 
in long-term implant survival and guided cartilage regeneration, and superior 
cartilage regeneration compared to control unidirectional collagen scaffolds or 
spontaneous natural healing of defects. To evaluate the effect of scaffolds on 
cartilage regeneration in animal models, an important consideration is the 
translational value of animal studies, which depends on the comparability to the 
clinical situation. Healthy animal models are often used, while osteoarthritic 
animal models are clinically more relevant. Also, the choice for smaller or larger 
animal models is important. Smaller animal models are mostly used due to 
feasibility, while large animal models may more closely resemble humans but are 
associated with higher costs [23]. Moreover, the experimental design may affect 
the degree of cartilage regeneration, whereas aspects such as implant location, 
follow-up period and rehabilitation protocol need to be considered. Overall, results 
from animal studies could provide insights in strategies for future (pre) clinical 
research related to biomaterial properties, incorporation of biologics, choice of a 
suitable animal model, and their effect on cartilage regeneration. 
 With the improvements described in this thesis and future directions, 
unidirectional collagen may be used as a novel implant to regenerate cartilage in 
the future.
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Samenvatting
Articulair kraakbeen is hyalien weefsel dat de uiteinden van de lange botten bedekt 
en zorgt voor lage wrijving en een gewichtsdragend oppervlak, resulterend in efficiënte 
en flexibele beweging van gewrichten. De structuur en functie van kraakbeen kan 
worden beschadigd door traumatische letsels en osteoartrose. Doordat het weefsel 
van nature weinig zelfregenererend vermogen heeft, door de afwezigheid van bloed - 
vaten, blijft het een uitdaging om beschadigd kraakbeen te herstellen. Momenteel 
kunnen patiënten chirurgisch worden behandeld door middel van het vervangen 
van het kniegewricht door een prothese. Daarnaast zijn er ook regeneratieve 
behandelingen die zich richten op het herstellen van kraakbeen, zoals de microfrac-
tuurbehandeling, mozaïekplastiek en autologe chondrocyten implantatie. Het 
toepassen van de microfractuurbehandeling, ook bekend als beenmergstimulatie, 
kan de voorkeur hebben omdat patiënten kunnen worden behandeld middels een 
minimaal invasieve ingreep, met als gevolg dat patiënten waarschijnlijk minder 
pijn zullen ervaren en een kortere herstelperiode (in het ziekenhuis) nodig zullen 
hebben. Tevens omzeilt deze behandeling problemen geassocieerd met celbevattende 
therapieën, zoals morbiditeit op de locatie waar donorweefsel wordt geoogst, 
celkweekkosten, beperkte ‘off-the-shelf’ beschikbaarheid, en regelgevende kwesties. 
Ondanks veelbelovende klinische resultaten op korte termijn blijkt dat nieuw - 
gevormd weefsel momenteel voornamelijk bestaat uit fibreus kraakbeen, dat niet 
dezelfde mechanische en biologische eigenschappen heeft als gezond kraakbeen. 
Het probleem om hyalien kraakbeen te regenereren middels beenmergstimulatie 
kan worden toegeschreven aan het gebrek van controle over de chondrogenese. Het 
gebruik van een template om de regeneratie van duurzamer kraakbeenweefsel te 
sturen en te stimuleren is een mogelijke oplossing voor dit probleem.
 Unidirectionele collageenscaffolds kunnen worden geïmplanteerd na been-
mergstimulatie om de groei van kraakbeenweefsel te sturen. De anisotrope 
architectuur van de poriën in de scaffolds faciliteert de infiltratie van autologe 
mesenchymale stamcellen vanuit het beenberg in de scaffolds en bootst het 
micromilieu na van de extracellulaire matrix van natuurlijk kraakbeen. Een 
beperking van poreuze (unidirectionele) collageenscaffolds is de beperkte 
mechanische sterkte. Kraakbeenregeneratie middels het gebruik van unidirectio-
nele collageenscaffolds als sjabloon en daarnaast met toegevoegde biologische 
stimuli is nog niet onderzocht. 
 Het doel van dit proefschrift was om unidirectionele collageenscaffolds te 
maken met verbeterde mechanische sterkte en met toegevoegde 3D oppervlakte-
structuren en biologische stimuli om langdurig de vorming van kraakbeenweefsel 
te sturen. Een overzicht van alle nieuwe geïntroduceerde verbeteringen is 
beschreven in hoofdstuk 1.
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 In hoofdstuk 2 en 3 staan een systematische review met meta-analyse 
beschreven. Het doel was om een gestructureerd, volledig en transparant 
overzicht te verkrijgen van de literatuur met betrekking tot de effectiviteit van 
kraakbeenregeneratie middels het implanteren van scaffolds na beenmergstimulatie 
in diermodellen (hoofdstuk 2: celvrije scaffolds in vergelijking met spontane 
natuurlijke genezing, hoofdstuk 3: scaffolds met cellen in vergelijking met celvrije 
scaffolds). In hoofdstuk 2 bleek na analyse van de literatuurdata dat kraakbeen-
regeneratie met 16% verbeterde door het implanteren van celvrije scaffolds na 
beenmergstimulatie ten opzichte van het alleen uitvoeren van beenmergstimu-
latie, en dat het toevoegen van biologische stimuli 8% extra verbeterde kraak-
beenregeneratie opleverde. Er werden geen verschillen gevonden in kraakbeenre-
generatie door gebruik te maken van scaffolds van verschillende materialen, door 
het toevoegen van verschillende biologische stimuli of door het gebruik maken 
van verschillende diermodellen, wat kan worden verklaard door de heterogeniteit 
tussen de studies. In hoofdstuk 3 bleek na analyse van de literatuurdata dat het 
implanteren van scaffolds met cellen resulteerde in 19% verbeterde kraakbeen-
regeneratie vergeleken met celvrije scaffolds. Er werden geen verschillen gevonden 
in kraakbeenregeneratie door het gebruik stamcellen of somatische cellen, maar 
wel tussen verschillende celtypen. Kweekcondities hadden geen effect op kraak-
beenregeneratie.
 Hoofdstuk 4 beschrijft de methodologie en veelzijdigheid van een directionele 
invriestechniek om poreuze collageenscaffolds met unidirectionele poriën te 
ontwikkelen. Unidirectionele collageenscaffolds werden ontwikkeld middels 
directioneel invriezen met een speciaal ontworpen systeem bestaande uit wigjes. 
Het mechanisme achter het systeem, resulterend in de unidirectionele groei van 
ijskristallen, was doorgrond. Daarnaast was de groei van ijskristallen gemanipuleerd 
om unidirectionele collageenscaffolds te ontwikkelen met uiteenlopende porie-
structuren. 
 In hoofdstuk 5 is het effect van de oriëntatie van de poriën onderzocht in 
relatie tot de efficiëntie van het zaaien van cellen, de distributie van cellen in de 
scaffolds en de vorming van weefsel. Anisotrope scaffolds faciliteerden infiltratie 
van cellen beter in vergelijking met scaffolds met een willekeurige oriëntatie van 
de poriën, en daarom lijkt het gebruik van anisotrope scaffolds veelbelovend voor 
de ontwikkeling van cellulaire scaffolds in vitro. Daarnaast resulteerde de anisotrope 
architectuur van de poriën in anisotrope weefselvorming, wat belangrijk is voor 
de regeneratie van weefsels met een anisotrope extracellulaire matrix.
 In hoofdstuk 6 en 7 werden verschillende verbeteringen voor unidirectionele 
collageenscaffolds onderzocht. Hoofdstuk 6 beschrijft het aanbrengen van specifieke 
3D structuren in collageenscaffolds middels het gebruik van verschillende verdunde 
zuren tijdens het productie proces. Uit in vitro analyses bleek dat de scaffolds 
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cytocompatibel zijn. Daarnaast kleurde myosine sterker aan en was de pMHC 
genexpressie verhoogd voor C2C12 cellen gekweekt op scaffolds met rafelige 
structuren vergeleken met gladde structuren. Het toevoegen van 3D structuren 
kan differentiatie van cellen beïnvloeden. In hoofdstuk 7 werden bioactieve 
scaffolds gemaakt die chondrogenese stimuleren. Het immobiliseren van 
groeifactoren in scaffolds is noodzakelijk omdat na implantatie van de scaffolds 
er geen biologische stimuli meer kunnen worden toegevoegd, om de activiteit in 
vivo te verlengen, de diffusie te beperken en de hoeveelheid benodigde groeifactor 
te verminderen voor het veilig kunnen toepassen in de kliniek.  In vitro werd het 
effect onderzocht van (heparine-geconjugeerde) unidirectionele collageen-
scaffolds waaraan bot morfogenetische eiwit 2 (BMP2) was toegevoegd op de 
chondrogenese van C3H10T1/2 cellen, een mesenchymale stamcel cellijn, en 
vergeleken met het effect van vrij BMP2. Het eenmalig preïncuberen van scaffolds 
met 10 µg BMP2 voor het zaaien van cellen resulteerde in vergelijkbare resultaten 
als wanneer 100 ng/ml oplosbaar BMP2 elke 3 dagen gedurende 2 weken werd 
toegevoegd aan het kweekmedium (totaal 1 µg BMP2). De scaffolds bevorderden 
de differentiatie van de pluripotente cellijn C3H10T1/2 naar de chondrogene lijn 
in vitro onder de invloed van BMP2. Unidirectionele collageen en heparine- 
geconjugeerde collageenscaffolds gepreïncubeert met 10 µg BMP2 kunnen 
geschikt zijn om in vivo langdurige vorming van kraakbeenweefsel te induceren.
 In hoofdstuk 8 hebben we onderzocht of we de verworven kennis met 
betrekking tot het maken van scaffolds konden inzetten om een scaffold te maken 
met unidirectionele poriën voor de regeneratie van de blaas. Een nieuwe methode 
was ontwikkeld die resulteerde in een gestandaardiseerde blaasscaffold, inclusief 
anastomoses, gemaakt van collageen, en die zowel eenvoudig is om te produceren 
als aanpasbaar is. Uit in vitro analyse is gebleken dat de blaasscaffold cytocompatibel 
is voor urotheel- en gladde spiercellen van zowel de mens als het varken.
 Concluderend zijn versterkte instructieve bioactieve unidirectionele collageen-
scaffolds voor kraakbeenregeneratie gemaakt en in vitro bestudeerd. Deze kunnen 
in toekomstige studies verder preklinisch worden getest.
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Nieuwe methoden voor regeneratieve geneeskunde en weefseltechnologie zijn 
ontwikkeld en uitgebreid onderzocht als alternatieven en/of aanvullingen op 
klinische strategieën die zijn gericht op het herstellen van beschadigd kraakbeen-
weefsel. In dit proefschrift zijn biomimicerende collageenscaffolds voor kraak-
beenregeneratie vervaardigd en geëvalueerd. Verschillende modificaties zijn 
verricht aan unidirectionele collageenscaffolds die eerder zijn geïmplanteerd 
door de Mulder et al. [1], waaronder: 1) verbeterd productieproces van scaffolds, 2) 
versterkte mechanische eigenschappen voor het langdurig functioneren van de 
implantaten, 3) integratie van 3D oppervlaktestructuren, en 4) verhoogde 
bioactiviteit door het toevoegen van groeifactoren. Deze nieuwe verbeteringen 
kunnen resulteren in een medisch hulpmiddel die het herstel van kraakbeen 
beter stimuleert in vergelijking met de eenvoudigere unidirectionele collageens-
caffolds die eerder zijn geïmplanteerd.
 Momenteel wordt de ontwikkeling van geavanceerde en biomimetische 
bioinstructieve biomaterialen uitgebreid onderzocht. Het integreren van multi-
functionele en stimuliresponsieve eigenschappen kan resulteren in geavanceerde 
implantaten voor diverse toepassingen binnen de regeneratieve geneeskunde 
en weefseltechnologie. Diverse aanpassingen kunnen worden gedaan aan uni-
directionele collageenscaffolds, bijvoorbeeld gerelateerd aan morfologie, sterkte 
en biologische activiteit, om moeder natuur na te bootsen. Articulair kraakbeen 
heeft een complexe zonale organisatie met unieke biomechanische eigenschappen, 
wat resulteert in weinig wrijving en het optimaal weerstaan van belasting door 
het gewricht. De extracellulaire matrix (ECM) in deze zones, de oppervlakkige, 
middelste en diepe zone, verschillen in structuur en samenstelling waarbij er 
onder andere variaties zijn in de diameter en oriëntatie van de collageenvezels, 
de hoeveelheid glysosaminoglycanen (GAGs), en de dichtheid en morfologie 
van chondrocyten [2]. De oriëntatie van de collageenvezels en de hoeveelheid 
crosslinks is diepteafhankelijk, wat zorgt voor verschillen in treksterkte en 
stijfheid tussen de zones [3]. De diameter van de collageenvezels varieert tussen 
de zones van ongeveer 20 nm in de oppervlakkige zone tot 70-120 nm in de diepe 
zone [4]. In de oppervlakkige zone hebben de collageenvezels een parallelle 
oriëntatie ten opzichte van het gewrichtsoppervlak om optimaal schuifkrachten 
op te vangen tijdens belasting van het gewricht. Daarentegen hebben collageen-
vezels in de diepe zone een loodrechte oriëntatie ten opzichte van het gewrichts-
oppervlak waardoor compressiekrachten kunnen worden opvangen. De collageen - 
vezels in de middelste zone hebben een willekeurige oriëntatie en vormen een 
overgang van de oppervlakkige naar de diepe zone [2-4]. In de oppervlakkige zone 
zijn lage hoeveelheden proteoglycanen en GAGs aanwezig [5], terwijl in de diepe 
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zone veel proteoglycanen, waaronder hoofdzakelijk aggrecan, aanwezig zijn [4]. 
De hoeveelheid proteoglycanen en GAGs, en daarbij de compressiemodulus, 
neemt toe met de diepte van het weefsel [6]. De hoogste dichtheid aan cellen is 
aanwezig in de oppervlakkige zone en deze neemt ook af met de diepte van het 
weefsel. Om cellen vanuit het subchondrale bot aan te trekken en om migratie 
door de scaffolds te faciliteren kunnen de scaffolds worden opgeladen met stromal 
cell-derived factor-1 [7]. Het specifiek toevoegen van stromal cell-derived factor-1 
aan de scaffolds kan mogelijk resulteren in een gradiënt van celdichtheid, 
vergelijkbaar met natuurlijk kraakbeen. Momenteel wordt de infiltratie van cellen 
gefaciliteerd door het implanteren van unidirectionele collageenscaffolds met de 
oriëntatie van de poriën loodrecht op het gewrichtsoppervlak. Door belasting van 
het gewricht moet het weefsel uiteindelijk remodelleren zodat de complexe 
organisatie van natuurlijk kraakbeen wordt nagebootst [4, 6]. Door het integreren 
van een zonale organisatie in scaffolds kan kraakbeenregeneratie mogelijk 
worden verbeterd. Zoals beschreven in dit proefschrift zijn de anisotrope colla-
geenscaffolds gemaakt middels systeem bestaande uit een koudebron en een 
wig, wat zorgt voor een verticale temperatuurgradiënt en gecontroleerd invriezen. 
Door het aanpassen van deze temperatuurgradiënt kunnen mogelijk ook 
verschillende oriëntaties van de poriën worden geïntroduceerd eindige elementen 
modellering kan hierbij functioneel zijn om de effecten van aanpassingen verricht 
aan het wigsysteem op temperatuurgradiënten te onderzoeken, zoals de steilheid 
van de wig, het gebruik van materialen met verschillende thermische 
geleidbaarheid en het gebruik van verschillende isolatoren.
 Het toevoegen van kraakbeenspecifieke componenten kan de micro-omgeving 
van natuurlijk kraakbeen nabootsen. De GAG chondroïtinesulfaat (CS) is een 
belangrijke ECM component in natuurlijk gewrichtskraakbeen [8]. Het toevoegen 
van CS aan collageenscaffolds bootst hiermee de natuurlijke omgeving na en kan 
tevens worden gebruikt om groeifactoren te binden aan de scaffolds [9-11]. Het is 
eerder aangetoond dat het koppelen van CS aan type I collageenscaffolds de 
bioactiviteit van chondrocyten stimuleert en zorgt voor een verhoogde productie 
van proteoglycanen door de chrondrocyten in de ECM [12]. Ook het toevoegen van 
andere componenten zoals hyaluronzuur kan veelbelovend zijn, omdat 
hyaluronzuur ook fysische en biologische functies heeft in kraakbeenweefsel [13]. 
 Verder kan kraakbeenregeneratie mogelijk worden verbeterd door het 
toevoegen van groeifactoren aan scaffolds om chondrogenese te stimuleren. Deze 
groeifactoren kunnen worden geïntegreerd in de scaffolds middels hun 
niet-covalente interactie met GAGs [20]. Door middel van het aanbrengen van 
GAG gradiënten kunnen vervolgens gradiënten van groeifactoren worden 
aangebracht [14]. De open poreuze intrinsieke porie architectuur van unidirectio-
nele collageenscaffolds kan mogelijk het aanbrengen van gradiënten van 
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(meerdere) groeifactoren over lange afstanden faciliteren (Fig. 1). Het plaatsen 
van de scaffolds op Whatman chromatografiepapier maakt het mogelijk om 
vloeistof uit de scaffolds te extraheren en tegelijkertijd een groeifactoroplossing 
op de scaffolds te druppelen, waarbij het merendeel van de groeifactoren zich zal 
bevinden aan de kant waar de groeifactoroplossing op de scaffolds is gedruppeld, 
terwijl dieper in de scaffolds lagere concentraties aanwezig zijn.
 Een beperking van groeifactoren -zoals bot morfogenetische eiwitten (BMPs)- 
is hun korte halfwaardetijd en locatie, wat resulteert in hoge benodigde doses om 
de gewenste effecten te induceren. Het gebruik van niet-fysiologische doses leidt 
tot discussies over kosten en veiligheid [15]. Daarom is een belangrijke overweging 
voor het gebruik van groeifactoren of er ook niet een geschikt dragermateriaal 
moet worden gebruikt dat zorgt voor gecontroleerde afgifte en behoud van de 
biologische activiteit. In dit proefschrift is de conjugatie van heparine aan uni-
directionele collageenscaffolds onderzocht om vervolgens BMP2 te binden en af 
te geven. Daarnaast kunnen kleine moleculen en synthetische peptiden die de 
functie van groeifactoren nabootsen veelbelovend zijn, omdat deze gemakkelijker 
op de juiste locatie te krijgen zijn, stabieler zijn en minder immunogeen zijn dan 
groeifactoren. Ook zijn de kleine moleculen door hun relatief eenvoudige synthese 
vaak goedkoper. Isoliquititigenin en 4’-hydroxychalcone zijn voorbeelden van 
Figuur 1  Illustratie van aangebrachte groeifactorgradiënten voor de regeneratie van osteo-
chondrale defecten. Transformerende groeifactor beta (TGF-β) en bot morfogenetische eiwit 2 
(BMP-2) kunnen worden aangebracht om respectievelijk kraakbeen en bot te regenereren. 
TGF-β
BMP-2
Kraakbeen 
compartiment
Bot
compartiment
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moleculen die de werking BMP-2 nabootsen [16]. Daarnaast is aangetoond dat een 
synthetisch peptide bestaande uit de BMP-2 aminozuren 73-92 chondrogene 
differentiatie van MSCs bevorderd [17].
 Het verbeteren van de mechanische sterkte van unidirectionele collageens-
caffolds is een vereiste voor het langdurig functioneren van implantaten [18]. 
Scaffolds kunnen worden versterkt door het verhogen van de collageenconcentra-
tie in de scaffolds [19], of door het laten krimpen van de scaffolds als geheel met 
als gevolg een hoge collageendichtheid. Eerder geïmplanteerde unidirectionele 
scaffolds waren gemaakt van een 0.7% (w/v) collageensuspensie [1]. Het 
versterken van unidirectionele collageenscaffolds door het gebruik van een 2% 
(w/v) collageensuspensie, gevolgd door het krimpen van de scaffolds, resulteerde 
in behoud van de unidirectionele architectuur (Fig. 2). Deze versterkte unidirecti-
onele scaffolds zijn gemaakt van enkel collageen, zonder toevoeging van 
additionele (synthetische) materialen, wat gunstig is voor de biocompatibiliteit, 
biodegradeerbaarheid en bioactiviteit van de implantaten. Tevens wordt hierdoor 
een mogelijke mismatch tussen de mechanische eigenschappen van verschillende 
materialen voorkomen [20].
 Naast de regeneratie van articulair kraakbeen moet wellicht ook het onder -
liggende subchondrale bot gerepareerd worden, omdat het tegelijkertijd met kraak - 
beenweefsel degeneratieve veranderingen ondergaat. Om deze osteochondrale 
defecten te laten regenereren lijken scaffolds die zowel het herstel van kraakbeen 
Figuur 2  Methoden om unidirectionele collageenscaffolds te versterken, gebaseerd op het 
verhogen van de collageenconcentratie en het condenseren van collageenvezels. De uni-
directionele porie architectuur blijft behouden na het uitvoeren van alle procedures. 
Maatstreepjes vertegenwoordigen 100 µm. 
0.7% (w/v) collageenscaold
ongewijzigde scaold
Versterkingstechnieken:
1) Toename collageenconcentratie
2% (w/v) scaold
2) Krimp behandeling
2% (w/v) gekrompen scaold
Figure 2. Methodologies of reinforcing unidirectional collagen scaffolds based on condensing 
collagen fibrils: 1) increasing the collagen concentration, and 2) shrinking of the scaffolds by 
treatment with calcium chloride. Scanning electron microscopy images indicate the preservation of 
the unidirectional pore architecture in reinforced unidirectional collagen scaffolds.   
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als dat van bot bevorderen de beste optie. Een van de belangrijkste componenten 
van bot is calciumfosfaat (CaP). In natuurlijk bot zijn uitgelijnde CaP plaatjes 
aanwezig in tussenruimten in de collageenvezels, waar ze een belangrijke rol 
spelen in de functionele eigenschappen van bot. CaP kan nauwkeurig worden 
neergelegd middels het toepassen van een methode ontwikkeld door Nijhuis et al. 
[21]. Om CaP in collageenscaffolds te brengen kunnen de scaffolds worden 
gewassen in zogenaamde gesimuleerde lichaamsvloeistof, waarna het enzym 
urease van Canavalia ensiformis gebruikt kan worden voor de omzetting van urea 
in ammonia en koolstofdioxide. Als gevolg van een stijging van de pH naar pH 8 
neemt de oplosbaarheid van CaP af, wat resulteert in de depositie van CaP. Door de 
scaffolds gedeeltelijk in gesimuleerd lichaamsvloeistof te plaatsen kan plaatselijk 
CaP in collageenscaffolds worden aangebracht. In dit gedeelte van de scaffolds 
kunnen MSCs differentiëren in de richting van bot, terwijl in het CaP-vrije 
gedeelten de MSCs kunnen differentiëren richting kraakbeen [22].
 In dit proefschrift zijn diverse verbeteringen voor unidirectionele collageen-
scaffolds aangedragen om het herstel van kraakbeen te bevorderen. Naast het in 
vitro onderzoek beschreven in dit proefschrift is ook in vivo onderzoek nodig om 
vast te stellen of de onderzochte aspecten met betrekking tot mechanische 
sterkte, incorporatie van intrinsieke oppervlaktestructuren en het toevoegen van 
biologische stimuli inderdaad het herstel van kraakbeen verbeteren. Implantatie 
van unidirectionale collageenscaffolds met verbeterde mechanische sterkte en 
toegevoegde oppervlaktestructuren en biologische stimuli, resulteert mogelijk in 
het langdurig functioneren van implantaten en gestuurde kraakbeenregeneratie 
en in beter kraakbeenherstel in vergelijking met eenvoudige unidirectionele col-
lageenscaffolds en de spontane genezing van defecten. Voor het evalueren van 
het effect van de scaffolds op kraakbeenregeneratie in diermodellen is de 
translationele waarde van dierproeven een belangrijke overweging, die afhangt 
van de vergelijkbaarheid met de klinische situatie. Vaak worden er gezonde 
diermodellen gebruikt, terwijl osteoarthrotische diermodellen klinisch relevanter 
zijn. Ook de keuze voor kleinere of grotere diermodellen is belangrijk. Kleinere 
diermodellen worden meestal gebruikt vanwege haalbaarheid, terwijl grote 
diermodellen dichterbij de mens staan, maar ook resulteren in hogere kosten en 
meer ethische bezwaren [23]. Daarnaast kan de experimentele opzet een 
belangrijke rol spelen bij de mate waarin kraakbeen wordt geregenereerd, waarbij 
aspecten zoals de locatie van het implantaat, follow-up periode en revalidatiepro-
tocol moeten worden overwogen. Tezamen kunnen de resultaten van dierproeven 
inzicht geven in strategieën voor toekomstig (pre)klinisch onderzoek met 
betrekking tot de eigenschappen van biomaterialen, integratie van biologische 
factoren, de keuze van een geschikt diermodel, en hun effect op het herstel van 
kraakbeen.
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 Met de verbeteringen beschreven in dit proefschrift en toekomstvisie kunnen 
unidirectionele collageenscaffolds in de toekomst wellicht worden gebruikt als 
nieuwe implantaten voor de regeneratie van kraakbeen.
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Dankwoord
Promoveren doe je niet alleen. De mensen om mij heen hebben ervoor gezorgd dat 
ik terug kan kijken op een leuke tijd. Naast het werkgerelateerde aspect heb ik 
juist ook erg genoten van de gezelligheid op en naast het werk. Daarom wil ik in 
dit dankwoord iedereen bedanken die hierin een belangrijke rol heeft gespeeld.
Beste prof. Brock, beste Roland, hartelijk dank dat ik op de afdeling Biochemie 
mijn promotieonderzoek heb kunnen doen met u als promotor. Het was erg fijn 
dat uw deur altijd open stond om de voortgang van het promotieonderzoek door 
te spreken en juist in de afrondende fase uw concrete visie te horen. Ook bedankt 
voor de gezellige tijd, zoals tijdens de afdelingsuitjes en kerstdiners. Ik ben blij dat 
de zelfgebrouwde biertjes in de smaak vielen, net als uw zelfgemaakte glühwein 
tijdens de kerstdiners. Wellicht kunnen we deze samenwerking onderhouden.
Beste Toin en Willeke, ik wil jullie als copromotoren en dagelijkse begeleiders 
bedanken dat ik in jullie werkgroep, de Matrix Biochemie, de kans heb gekregen 
om mijn promotieonderzoek uit te voeren. Vooral omdat ik mijn project zelf vorm 
kon geven qua onderwerpen en samenwerkingen was het een leuk en uitdagend 
project om aan te werken, bedankt dat jullie mij daar de ruimte in gaven. Toin, 
bedankt voor je wetenschappelijke input. Ook hoop ik ooit nog een artikel van jou 
te lezen over GAG sequencing. Hopelijk wordt dit een ‘10-plusser’ die goed bijdraagt 
aan de ‘Bonzo punten’. Willeke, bedankt voor de prettige samenwerking en 
begeleiding. Het was heel fijn dat je altijd snel de tijd nam om e.e.a. door te spreken 
of na te kijken.
Natuurlijk wil ik ook graag de analisten van Matrix Biochemie bedanken. Elly, ik 
wil jou in het bijzonder bedanken voor al je hulp de afgelopen jaren. Als enige 
tissue engineering analist kwam ik natuurlijk met al mijn vragen naar jou toe. 
Jouw behulpzaamheid en kennis heb ik altijd erg gewaardeerd. Ik moet mij 
excuseren voor mijn rommelige, overigens wel gestructureerde labtafel (hierover 
verschilden de meningen), waarbij soms mijn rommel richting jouw labtafel 
verschoof. Maar goed, dat gebeurde andersom ook. Ook bedankt voor het in de 
gaten houden van mijn agenda wanneer ik koekjesbeurt had. Dat heeft mij vele 
taarten bespaard. Arie, onder andere dankzij jou ben ik geïnfecteerd geraakt met 
het reisvirus. Door jouw enthousiasme heb ik de afgelopen jaren ook een paar 
mooie tripjes gemaakt. Ik moet ook maar eens een keer naar Bali gaan om te 
kijken of het echt zo geweldig is als jij altijd doet overkomen. Verder bedankt voor 
je behulpzaamheid en gezelligheid op de afdeling. Altijd was je bereid om het een 
en ander uit te leggen, erg fijn. Theo, hartelijk dank voor je hulp met de TEM 
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analyses, gezelligheid in de Aesculaaf en aan de koffietafel. Marianne, bedankt 
voor de gezellige jaren op de afdeling en succes de komende tijd. Els, ook bedankt 
voor de afgelopen fijne jaren. Ronnie, ook al hebben we maar een half jaar samen 
gewerkt, bedankt. 
Voor mijn gevoel is dit toch een van de belangrijkste alinea’s van mijn dankwoord, 
het bedanken van mijn mede-promovendi. Fijne collega’s, vrienden, dit dankwoord 
is te kort om mijn dank uit te spreken over hoeveel waardering ik heb voor de 
mooie tijd die we samen hebben gehad tijdens onze promotie. Zo waren er de 
 afdelingsuitjes, kerstdiners, Aesculaafjes, BBQ’s, St. Anneke, Zomerfeesten, verjaar- 
dagen, stappen, congressen, pizza avondjes, en natuurlijk niet te vergeten onze 
AIO retraites naar Den Haag, Antwerpen, Keulen en York. Ook was er de ruimte 
om naast de mooie leuke dingen in het leven de serieuze zaken te bespreken. Het 
was een toptijd en ik hoop dat we elkaar nog veel blijven zien. Graag wil ik voor 
jullie allemaal persoonlijk mijn waardering uitspreken. 
Henk, ‘collagen master’, jij hebt ervoor gezorgd dat ik mij direct vanaf week 1 al 
thuis voelde in Nijmegen. Meteen het eerste weekend zijn we samen naar NEC – 
FC Groningen geweest en nam je mij op sleeptouw naar verschillende feestjes. 
Het was een goede introductietijd en het begin van een mooie periode in Nijmegen. 
Jij bent iemand die altijd voor iedereen klaar staat en het beste voor heeft met 
iedereen. Ook bedankt voor de leuke samenwerkingen op het werk en je kennis 
van collageen en andere eiwitten. Henk, ik moet jou als echte NEC supporter 
helaas toch teleurstellen met het feit dat ik nu op vijandelijk grondgebied woon en 
ook hier mijn brood verdien.
Corien, jij verdient het ook zeker om de aandacht te krijgen in dit dankwoord die je 
toekomt. Als U-genootjes konden we mooi af en toe lekker spuien, maar eigenlijk 
was het vooral leuk en  gezellig. Jammer dat die gezellige tijd zo snel is omgevlogen. 
Ik ben blij dat je mij tijdens mijn verdediging wilt bijstaan als paranimf.
Luuk, collega en huisgenoot in de ‘Collagen Mansion’, bedankt voor de mooie 
gezellige jaren. Snel nadat je met je promotieonderzoek was begonnen zijn we 
samen met Paul in de ‘Collagen Mansion’ gaan wonen. Een mooie tijd op een 
perfecte locatie aan de Via Gladiola. Ik moet nog regelmatig terug denken aan 
onze congressen in Barcelona en Boston, een toptijd.
René, ook jou wil ik bedanken voor de gezelligheid van de afgelopen jaren. Jij bent 
altijd zo heerlijk relaxt, jij lijkt je niet zo snel druk te maken. Kun je mij dat leren? 
Ik ben benieuwd welke richting jij op gaat na je promotieonderzoek. Vergeet niet, 
we kunnen altijd nog samen onze βCollagen Mansion Bierbrouwerijβ uitbreiden. 
Moge we in de toekomst nog vele heerlijke bieren brouwen.
Sophieke, bedankt voor de gezelligheid, het was leuk om met je samen te werken. 
Succes met je opleiding tot gynaecoloog.
215
Dankwoord
Ch
ap
te
r  
  1
0
Cintia, as a Brazilian post-doc you ended up with only Dutch PhD students. As 
such, we changed our annually ‘AIO retreat’ to the ‘AIO retreat including our best 
(and only) post-doc’. Thank you for the ‘gezelligheid’. I wish you and Frank the best 
for the future. 
Etiënne, Myrtille en Danique, ondanks dat we maar kort samen hebben gewerkt 
wil ik jullie bedanken voor de fijne tijd.
Ook wil ik graag enkele andere promovendi en medewerkers van de afdeling 
Biochemie bedanken voor de gezelligheid: Rike, Dirk en Sander Grefte. 
In de loop der jaren heb ik ook een aantal studenten begeleid tijdens hun stage. 
Merlijn, Loes, Paul, Guus, Eva, Angela en Dana, bedankt.
Tijdens mijn promotieonderzoek heb ik de gelegenheid gekregen om met meerdere 
afdelingen en mensen samen te werken. Hierdoor heb ik veel mensen leren 
kennen die een bijdrage hebben geleverd aan dit proefschrift. 
Allereerst wil ik de collega’s van Urologie bedanken omdat ze naast het weten-
schappelijke gedeelte ook hebben bijdragen aan het sociale gedeelte. Marije, 
hartelijk bedankt voor de gezelligheid de afgelopen jaren. Paul, we kennen elkaar 
al uit het 1ste jaar van de studie Technische Geneeskunde. Erg leuk dat we beiden 
in Nijmegen waren beland en zelfs qua werkzaamheden veel met elkaar te maken 
kregen. Ook bedankt voor de gezellige tijd als medebewoner in de Collagen 
Mansion. Peter, thank you for being such a nice colleque and for the good times. 
Also the good times during your stay in the Collagen Mansion is something to 
remember in the future. I wish you and Alena all the best in the future. Dorien, 
hartelijk dank voor de hulp tijdens de experimenten en gezelligheid. Silvia, Kees, 
Onno en Gerald, bedankt voor jullie hulp. Boy, we zagen elkaar voornamelijk bij 
borrels en feestjes, bedankt voor de gezelligheid. Egbert en prof. Feitz, beste Wout, 
jullie wil ik graag bedanken voor de wetenschappelijk input.
Van de afdeling Orthopedie wil ik graag Pieter Buma, Veronica Gonzales, Gerjon 
Hannink en Léon Driessen bedanken. Bedankt voor de samenwerking tijdens 
diverse projecten.
Van de afdeling Biomaterialen wil ik allereerst graag Sander Leeuwenburgh 
bedanken. Beste Sander, bedankt dat je de afgelopen jaren mijn mentor wilde zijn 
en voor de tijd die je vrijmaakte voor de mentorgesprekken. Uiteindelijk gingen 
deze gesprekken volgens mij meer over ons vakgebied. Ook de verschillende 
samenwerkingen heb ik altijd erg gewaardeerd.  Ik vind het leuk dat je wilde 
deelnemen in de manuscriptcommissie. Arnold Nijhuis, bedankt voor helpen 
opzetten van een samenwerkingsproject tussen Biochemie en Biomaterialen om 
osteochondrale scaffolds te ontwikkelen middels een door jou ontwikkeld 
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systeem om gecontroleerd calcium fosfaat te laten neerslaan. Helaas waren de 
resultaten niet zo goed als gehoopt. Alexey, we hebben samen geprobeerd om 
verschillende projecten van de grond te krijgen. De ideeën waren er zeker, maar de 
tijd niet. Wellicht dat onze potentiële opvolgers ermee aan de slag kunnen. Het 
was zeker niet slecht voor de samenwerking tussen beide afdelingen. Bedankt 
voor de leuke gezellige tijd, o.a. bij NIRM congressen en de NBTE. Dear Jie, thank 
you for the help with the systematic review. Kambiz, thank you for the good times 
at NIRM conferences.  
Van de afdeling Reumatologie wil ik graag Laurie de Kroon, Peter van der Kraan 
en Elly Vitters bedanken voor hun hulp met enkele experimenten.
Van de afdeling SYRCLE wil ik graag Rob de Vries bedanken voor zijn hulp met de 
systematische reviews. Joanna in ’t Hout van de afdeling Health Evidence wil 
ik bedanken voor de hulp met de statische analyses. Het is heel erg fijn dat jullie 
altijd klaar stonden om mee te denken over de projecten.
Van de afdeling Solid State Chemistry van de Radboud Universiteit wil ik graag 
Elias Vlieg, Willem van Enkevort, Alaa Adawy en Erik de Ronde bedanken voor 
hun hulp wat betreft het ontwikkelen van de unidirectionele collageenscaffolds.
Van het Microscopic Imaging Center wil ik graag Huib Croes en Jack Fransen 
bedanken. Vele uren heb ik gespendeerd achter de SEM en bij vragen was er altijd 
goede ondersteuning.
Van de Technische Dienst van de Sociale Wetenschappen wil ik graag Norbert 
Hermesdorf en Wil Corbeek bedanken voor het meedenken, helpen ontwerpen en 
maken van verschillende materialen die ik heb gebruikt tijdens mijn onderzoek. 
Paul Jab, bedankt voor uw hulp om samen de TEM foto’s door te spreken. Dat was 
heel leerzaam.
Sander en Sabine, onze vriendschap gaat al heel ver terug en ik ben blij dat we 
elkaar nog steeds regelmatig opzoeken. Ontzettend bedankt voor jullie vriend - 
schap, goede gesprekken en gezelligheid, die mij heel dierbaar zijn. Ook wil ik alle 
studievrienden, Thomas, Jon, René, Paul, Sander, Michiel, Frank, Pim en Stefan 
bedanken voor de leuke momenten. Joost, Evert-Jan, Renate, Maarten en Robin, 
bedankt voor jullie vriendschap.
Beste Jan, Cocky, Bram & Linda en Guus & Vera, wat een geluk om zo’n fijne 
schoonfamilie erbij te krijgen. Bedankt voor de fijne tijden samen en de 
belangstelling in mijn promotieonderzoek. Cocky, wellicht na je master ook nog 
een promotieonderzoek? Ik hoop dat we met zijn allen nog veel leuke dingen mee 
mogen maken.
217
Dankwoord
Ch
ap
te
r  
  1
0
Lieve pap en mam, jullie weten dondersgoed wat jullie voor mij betekenen. Jullie 
steun de afgelopen jaren heeft ervoor gezorgd dat ik sta waar ik nu sta en dat ik 
ben wie ik nu ben. Ik kan alleen maar blij zijn met jullie als mijn ouders. Arjan, 
super broertje, ik ben heel trots op wat jij allemaal hebt bereikt. Ik vind het heel 
speciaal dat jij mijn paranimf bent. Ik hoop dat wij, pap, mam, Arjan & Lisa en ik 
& Lies, nog veel samen mogen genieten in de toekomst. 
Lieve lieve lieve Lies, het is maar goed dat ik naar Nijmegen ben gegaan voor mijn 
promotieonderzoek. Dat ik jou daar heb ontmoet is het mooiste wat mij is 
overkomen. Wat is het heerlijk om jou aan mijn zij te hebben. Ik geniet er elke dag 
van en ik kijk uit naar een heerlijke toekomst samen met jou!

